C067795 | 10-decarbamoylmitomycin C | 10-decarbamoylmitomycin C results in increased activity of CASP9 protein | 17530733 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one inhibits the reaction [XIAP protein binds to CASP9 protein]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased activity of and results in increased cleavage of CASP9 protein" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased activity of CASP9 protein]" | 20833157 |
C552819 | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate results in increased cleavage of CASP9 protein | 23001822 |
C471674 | 10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone | "10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased activity of CASP9 protein" | 23088786 |
C449673 | 1,1,4-tris(acetyloxy)-2-nonene | "[GSTA4 gene mutant form results in increased susceptibility to 1,1,4-tris(acetyloxy)-2-nonene] which results in increased activity of CASP9 protein" | 24353929 |
C447943 | 11-keto-boswellic acid | 11-keto-boswellic acid analog results in increased activity of CASP9 protein | 21056033 |
C412791 | 1,2,3,4,6,7-hexachlorinated naphthalene | "1,2,3,4,6,7-hexachlorinated naphthalene results in increased activity of CASP9 protein" | 27501765 |
C575652 | 1,2,3,5,6,7-hexachloronaphthalene | "1,2,3,5,6,7-hexachloronaphthalene results in increased activity of CASP9 protein" | 27501765 |
C101879 | (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid | "(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein]]" | 14535961 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Gallic Acid results in increased cleavage of CASP9 protein]" | 27060209 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]" | 18850067 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased activity of CASP9 protein" | 21903591|2382612 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased cleavage of CASP9 protein" | 21903591 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "CCAR1 protein affects the reaction [1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased activity of CASP9 protein]" | 21903591 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "[Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased activity of CASP9 protein" | 15070698 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt affects the reaction [Bortezomib results in increased cleavage of CASP9 protein]" | 15509775 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]" | 22002103 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]" | 22002103 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased cleavage of CASP9 protein]" | 22915474 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein | 26208482 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein] | 26208482 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | "4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein]" | 26208482 |
C552420 | 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane | "1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP9 protein" | 20674558 |
C552420 | 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane" | 20674558 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Cadmium results in increased activity of CASP9 protein]" | 22692000 |
C416442 | 1,4-anthraquinone | "1,4-anthraquinone analog results in increased activity of CASP9 protein" | 17912452 |
C416442 | 1,4-anthraquinone | "1,4-anthraquinone analog results in increased activity of CASP9 protein" | 17912452 |
C560296 | 1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one | "1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one results in increased cleavage of CASP9 protein" | 21504179 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in increased cleavage of and results in increased activity of CASP9 protein" | 15498850 |
C072581 | 16-hydroxycleroda-3,13(14)-dien-15,16-olide | "16-hydroxycleroda-3,13(14)-dien-15,16-olide results in increased cleavage of and results in increased activity of CASP9 protein" | 21530604 |
C448659 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 19371599 |
C548433 | 1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate | "1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate results in increased activity of CASP9 protein" | 25452174 |
C036423 | 1-aminomethylphosphonic acid | [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased expression of CASP9 protein | 26006246 |
C036423 | 1-aminomethylphosphonic acid | 1-aminomethylphosphonic acid results in increased expression of CASP9 protein | 23983455 |
C105351 | 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | "CASP9 protein affects the susceptibility to 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene" | 19768117 |
C494665 | 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid | "20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]" | 25094029 |
C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of CASP9 protein" | 23318440 |
C574037 | 2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one | "2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in decreased expression of CASP9" | 24300195 |
C530171 | 2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate | "2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate results in increased activity of CASP9 protein" | 19166338 |
C094859 | 2,2',3,3',4,6'-hexachlorobiphenyl | "2,2',3,3',4,6'-hexachlorobiphenyl results in increased activity of CASP9 protein" | 17445852 |
C477694 | 2,2',4,4',5-brominated diphenyl ether | "2,2',4,4',5-brominated diphenyl ether results in increased activity of CASP9 protein" | 23124135 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased activity of CASP9 protein" | 27589474 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CASP9 mRNA" | 27589474 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CASP9 protein" | 27060917 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CASP9 mRNA" | 25462306 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of CASP9 protein] | 25291404 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein] | 16407847 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP9 protein] | 21165570 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of CASP9 protein]" | 20696234 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18594523 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [SOD2 protein affects the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 18594523 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP9 protein]" | 24726520 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein] | 19786087 |
C006183 | 2-(2-aminoethyl)pyridine | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein | 17327230 |
C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "[sorafenib co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] results in increased cleavage of CASP9 protein" | 20117835 |
C001105 | 2,2'-dipyridyl disulfide | "2,2'-dipyridyl disulfide results in increased activity of CASP9 protein" | 11331359 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CASP9 mRNA" | 19114083 |
C070055 | 2,3',4,4',5-pentachlorobiphenyl | "2,3',4,4',5-pentachlorobiphenyl results in increased activity of CASP9 protein" | 19362103 |
C093026 | 2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside | "2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of and results in increased activity of CASP9 protein]" | 23911879 |
C587734 | 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | "2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased cleavage of CASP9 protein" | 25950987 |
C587734 | 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | "Caspase Inhibitors inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased cleavage of CASP9 protein]" | 25950987 |
C440850 | 2,4,3',5'-tetramethoxystilbene | "2,4,3',5'-tetramethoxystilbene results in increased activity of CASP9 protein" | 20490654 |
C541132 | 2,4,4',5-tetrachlorobiphenyl | "2,4,4',5-tetrachlorobiphenyl results in increased activity of CASP9 protein" | 19362103 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CASP9 protein" | 20638727 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CASP9 protein" | 19362103 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP9 protein]" | 24726520 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP9 protein" | 24726520 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of CASP9 mRNA" | 24726520 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "wortmannin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP9 protein]" | 24726520 |
C562254 | 2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione | "2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased cleavage of and results in increased activity of CASP9 protein" | 21741372 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of CASP9 mRNA" | 21346803 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP9 protein | 15850772 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein]] | 26577515 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased activity of CASP9 protein] | 12438947 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 20856197 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | TP53 protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | 19801490 |
C408604 | 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole | 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein] | 16407847 |
C450643 | (2)-5,6,7,8,4'-pentamethoxyflavanone | "(2)-5,6,7,8,4'-pentamethoxyflavanone results in increased cleavage of CASP9 protein" | 19450678 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein" | 18444175 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid results in increased cleavage of CASP9 protein" | 18444175 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein" | 21214929 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein" | 21214929 |
C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in increased activity of CASP9 protein | 25845326 |
C007997 | 25-hydroxycholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein]" | 25845326 |
C007997 | 25-hydroxycholesterol | Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
C007997 | 25-hydroxycholesterol | BAY 11-7085 inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
C007997 | 25-hydroxycholesterol | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
C062897 | 28-deoxonimbolide | 28-deoxonimbolide results in increased activity of CASP9 protein | 21381696 |
C000599179 | 28-O-acetylbetulin-3-ylglucopyranoside | 28-O-acetylbetulin-3-ylglucopyranoside results in increased activity of CASP9 protein | 26772157 |
C000599179 | 28-O-acetylbetulin-3-ylglucopyranoside | 28-O-acetylbetulin-3-ylglucopyranoside results in increased activity of CASP9 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate analog results in increased activity of CASP9 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate results in increased activity of CASP9 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate analog results in increased activity of CASP9 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate results in increased activity of CASP9 protein | 26772157 |
C570662 | 2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one | "2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in increased cleavage of and results in increased activity of CASP9 protein" | 23639247 |
C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 23022152 |
C012796 | 2-butenal | 2-butenal results in increased activity of CASP9 protein | 23535401 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased activity of CASP9 protein | 12717745|1281561 |
C031278 | 2-chloroethyl ethyl sulfide | Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased activity of CASP9 protein] | 12815614 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of CASP9 mRNA | 12208782 |
C545239 | 2'-epi-2'-O-acetylthevetin B | 2'-epi-2'-O-acetylthevetin B results in increased activity of CASP9 protein | 19874809 |
C030370 | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | "2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of CASP9 mRNA" | 20206263 |
C022830 | 2-methoxyestradiol | 2-methoxyestradiol results in increased expression of CASP9 protein modified form | 23967052 |
C500344 | 2-methoxyestradiol-3,17-bis-O,O-sulfamate | "2-methoxyestradiol-3,17-bis-O,O-sulfamate results in increased cleavage of and results in increased activity of CASP9 protein" | 15258464 |
C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein | 11226294 |
C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] | 11226294 |
C009907 | 2-methylcyclopentadienyl manganese tricarbonyl | 2-methylcyclopentadienyl manganese tricarbonyl results in increased activity of CASP9 protein | 11880503 |
C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein] | 26208482 |
C079391 | 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide | "2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide inhibits the reaction [dihydrolipoic acid results in increased activity of CASP9 protein]" | 21462292 |
C514772 | 3,3',4,4',5,5'-hexahydroxystilbene | "3,3',4,4',5,5'-hexahydroxystilbene results in increased activity of CASP9 protein" | 24398169 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased activity of CASP9 protein" | 16158945 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased cleavage of CASP9 protein" | 21167276 |
C551466 | 3,3',5,5'-tetrahydroxystilbene | "3,3',5,5'-tetrahydroxystilbene results in increased activity of CASP9 protein" | 20484155 |
C482492 | 3,4,5,4'-tetramethoxystilbene | "3,4,5,4'-tetramethoxystilbene results in increased expression of CASP9 protein modified form" | 23770989 |
C061213 | 3',4',7-trihydroxyisoflavone | "3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA]" | 22914566 |
C061213 | 3',4',7-trihydroxyisoflavone | "3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein" | 22914566 |
C061213 | 3',4',7-trihydroxyisoflavone | "3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA" | 22914566 |
C061213 | 3',4',7-trihydroxyisoflavone | "Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein]" | 22914566 |
C061213 | 3',4',7-trihydroxyisoflavone | "Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA]" | 22914566 |
C504711 | 3,4-dideoxyglucosone-3-ene | "3,4-dideoxyglucosone-3-ene results in increased activity of CASP9 protein" | 16046310 |
C108729 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone | "3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]" | 17237268 |
C068870 | 3,4-dihydro-5-methyl-1(2H)-isoquinolinone | "3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]" | 16505238 |
C554666 | 3,4-methylenedioxypyrovalerone | "3,4-methylenedioxypyrovalerone results in increased activity of CASP9 protein" | 27255387 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C025160 | 3-aminobenzamide | 3-aminobenzamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
C416782 | 3-bromoacetylamino benzoic acid ethyl ester | 3-bromoacetylamino benzoic acid ethyl ester results in increased cleavage of and results in increased activity of CASP9 protein | 11077052 |
C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [BO-1012 results in increased cleavage of CASP9 protein] | 24823293 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
C025946 | 3-methyladenine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]]] | 20104024 |
C025946 | 3-methyladenine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | 20426806 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein] | 16497721 |
C047368 | 3-methylquercetin | 3-methylquercetin results in decreased expression of CASP9 protein | 22992727 |
C033643 | 3-nitrofluoranthene | 3-nitrofluoranthene results in increased activity of CASP9 protein | 19041363 |
C015392 | 3-nitropropionic acid | 3-nitropropionic acid results in increased activity of CASP9 protein | 15571979 |
C581004 | 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile | "3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased cleavage of CASP9 protein" | 24036456 |
C496751 | 4-(1H-imidazol-1-yl)retinoic acid | 4-(1H-imidazol-1-yl)retinoic acid results in increased cleavage of and results in increased activity of CASP9 protein | 17387344 |
C000602001 | 4-(3,5-dimethoxystyryl)phenyl acetate | "4-(3,5-dimethoxystyryl)phenyl acetate results in increased cleavage of CASP9 protein" | 26138072 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP9 protein | 12203115 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | TNFSF10 protein promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP9 protein] | 12203115 |
C405354 | 4,5,6,7-tetrabromobenzotriazole | "[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein" | 16489027 |
C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in increased cleavage of CASP9 protein" | 24161432 |
C506606 | 4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide | "[4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide co-treated with Paclitaxel] results in increased activity of CASP9 protein" | 16170024 |
C055331 | 4-aminocrotonic acid | "(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein]]" | 14535961 |
C055331 | 4-aminocrotonic acid | 4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein] | 14535961 |
C475622 | 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine | "4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein]" | 26208482 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | 24825450 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | 16322078|1726390 |
C027576 | 4-hydroxy-2-nonenal | pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | 16322078 |
C027576 | 4-hydroxy-2-nonenal | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | 16322078 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | 21187080 |
C584368 | 4'-methoxy licoflavanone | 4'-methoxy licoflavanone results in increased cleavage of CASP9 protein | 23850732 |
C584368 | 4'-methoxy licoflavanone | [4'-methoxy licoflavanone results in increased expression of FAS protein] which results in increased cleavage of CASP9 protein | 23850732 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein | 21442130 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein | 21442130 |
C585202 | 4-methylethcathinone | 4-methylethcathinone results in increased activity of CASP9 protein | 27255387 |
C498826 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in increased cleavage of CASP9 protein | 26549707 |
C041594 | 4-nonylphenol | 4-nonylphenol results in increased cleavage of CASP9 protein | 22056370 |
C041594 | 4-nonylphenol | 4-nonylphenol results in decreased expression of CASP9 mRNA | 27109770 |
C041594 | 4-nonylphenol | 4-nonylphenol results in increased expression of CASP9 mRNA | 27087316 |
C494898 | 4-oxofenretinide | 4-oxofenretinide results in increased activity of CASP9 protein | 16540676 |
C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased activity of CASP9 protein | 20156547 |
C029728 | 4-phenylenediamine | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP9 protein] | 20156547 |
C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide affects the expression of CASP9 mRNA | 20829426 |
C492721 | 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) | "5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) inhibits the reaction [Doxorubicin results in increased expression of CASP9 mRNA]" | 19286953 |
C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of CASP9 protein | 15831436 |
C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of CASP9 protein] | 15831436 |
C110962 | 5,6-dichlorobenzimidazole | "5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein]" | 15688023 |
C573233 | 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one | "5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one results in increased expression of CASP9 protein" | 26405812 |
C080669 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one | "5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of CASP9 protein" | 19135124 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]" | 22002103 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | 5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP9 protein | 22002103 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | CASP9 protein affects the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein] | 22002103 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | Quercetin inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 affects the expression of CASP9 mRNA | 27589474 |
C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased expression of CASP9 protein | 27589474 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein]" | 22002103 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | 5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP9 protein | 22002103 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | CASP9 protein affects the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein] | 22002103 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | Quercetin inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
C576268 | 6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide | "6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide analog results in increased activity of CASP9 protein" | 27720946 |
C471843 | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | [6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine co-treated with Paclitaxel] results in increased activity of CASP9 protein | 16170024 |
C046414 | 6-codeinone | 6-codeinone results in increased activity of CASP9 protein | 12894543 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Indomethacin results in increased activity of CASP9 protein]" | 17341418 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein]" | 23711929 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein]" | 25845326 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein]" | 25845326 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein]" | 19477266 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA]" | 19477266 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [T-2 Toxin results in increased activity of CASP9 protein]" | 21296132 |
C530630 | 6(hydroxymethyl)-1,4-anthracenedione | "6(hydroxymethyl)-1,4-anthracenedione results in increased activity of CASP9 protein" | 17912452 |
C583883 | 6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone | "6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP9 protein" | 23212307 |
C583883 | 6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone | "pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP9 protein]" | 23212307 |
C531937 | 6-O-angeloylenolin | 6-O-angeloylenolin results in increased cleavage of CASP9 protein | 21192922 |
C580599 | 6-OH-BDE-47 | 6-OH-BDE-47 results in decreased expression of CASP9 mRNA | 27589474 |
C580599 | 6-OH-BDE-47 | 6-OH-BDE-47 results in decreased expression of CASP9 protein | 27589474 |
C041398 | 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester | "7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester results in decreased activity of CASP9 protein" | 21467741 |
C114369 | 7,8-diacetoxy-4-methylcoumarin | "7,8-diacetoxy-4-methylcoumarin results in increased activity of CASP9 protein" | 19061872 |
C540361 | 7,8-diacetoxy-4-methylthiocoumarin | "7,8-diacetoxy-4-methylthiocoumarin results in increased activity of CASP9 protein" | 19061872 |
C553817 | 7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one | "7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one results in increased expression of CASP9 protein modified form" | 19936915 |
C054852 | 7-hydroxystaurosporine | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of CASP9 protein | 15767555 |
C003001 | 7-ketocholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein]" | 25845326 |
C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased activity of CASP9 protein | 25845326 |
C003001 | 7-ketocholesterol | Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
C003001 | 7-ketocholesterol | BAY 11-7085 inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
C003001 | 7-ketocholesterol | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
C522803 | 7-monohydroxyethylrutoside | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 17285121 |
C522803 | 7-monohydroxyethylrutoside | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 17285121 |
C042834 | 9,10-anthraquinone | "9,10-anthraquinone analog results in increased activity of CASP9 protein" | 26915975 |
C005399 | 9,10-phenanthrenequinone | "9,10-phenanthrenequinone results in increased activity of CASP9 protein" | 29108775 |
C005399 | 9,10-phenanthrenequinone | "Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP9 protein]" | 29108775 |
C574274 | 9-hydroxycanthin-6-one | 9-hydroxycanthin-6-one results in increased cleavage of CASP9 protein | 29225138 |
C025724 | 9-methoxycamptothecin | 9-methoxycamptothecin results in increased activity of CASP9 protein | 23369935 |
C512352 | abexinostat | abexinostat results in increased cleavage of CASP9 protein | 19417023 |
C512352 | abexinostat | Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP9 protein] | 19417023 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein] | 20104024 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
C501332 | ABT-737 | [ABT-737 co-treated with Celecoxib] results in increased activity of CASP9 protein | 20104024 |
C501332 | ABT-737 | ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
C501332 | ABT-737 | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C501332 | ABT-737 | ABT-737 results in increased cleavage of CASP9 protein | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
C501332 | ABT-737 | Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein] | 20104024 |
C501332 | ABT-737 | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
C501332 | ABT-737 | PIK3C3 mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
C501332 | ABT-737 | [Quercetin results in increased susceptibility to ABT-737] which results in increased activity of CASP9 protein | 23353698 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of CASP9 | 12005112 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CASP9 mRNA | 17562736 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of CASP9 protein | 11343246 |
D000082 | Acetaminophen | Acetaminophen results in increased cleavage of CASP9 protein | 14747384 |
D000082 | Acetaminophen | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] | 11343246 |
D000082 | Acetaminophen | Acetaminophen results in decreased activity of CASP9 | 20079345 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of CASP9 protein | 26767949 |
D000082 | Acetaminophen | Acetaminophen results in increased cleavage of CASP9 protein | 19922764 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CASP9 mRNA | 21807079|2209391 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CASP9 protein | 22093918 |
D000082 | Acetaminophen | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA] | 22093918 |
D000082 | Acetaminophen | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 protein] | 22093918 |
D000082 | Acetaminophen | morin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] | 26767949 |
C464485 | acetamiprid | [iprodione co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C464485 | acetamiprid | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C464485 | acetamiprid | [pyrachlostrobin co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C043377 | acetochlor | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of CASP9 protein] | 25291404 |
C043377 | acetochlor | acetochlor results in increased cleavage of CASP9 protein | 25291404 |
C099158 | acetyl-aspartyl-glutamyl-valyl-aspartal | acetyl-aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP9 protein | 10774788 |
C487680 | acetylbritannilatone | acetylbritannilatone analog results in increased activity of CASP9 protein | 27262408 |
C487680 | acetylbritannilatone | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acetylbritannilatone analog results in increased activity of CASP9 protein] | 27262408 |
C487680 | acetylbritannilatone | TP53 protein affects the reaction [acetylbritannilatone analog results in increased activity of CASP9 protein] | 27262408 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP9 protein]] | 26375285 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased activity of CASP9 protein] | 12815614 |
D000111 | Acetylcysteine | Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein] | 18594523 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [9,10-phenanthrenequinone results in increased activity of CASP9 protein]" | 29108775 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]] | 21418039 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 19771260 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP9 protein] | 16169029 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | 17574045 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21166495 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 15496615 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] | 21310227 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP9 protein] | 22578287 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP9 protein] | 27313093 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA] | 23867903 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] | 26282491 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein] | 26282491 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein] | 26282491 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] | 20848084 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein]] | 21418039 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein] | 28804952 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein] | 25940438 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP9 protein] | 28918123 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP9 protein] | 28548367 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein] | 19082730 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein] | 27313093 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 23711929 |
D000111 | Acetylcysteine | Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
D000111 | Acetylcysteine | [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein | 17309078 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 22692000 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | 18336854 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 24157283 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21616140 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 mRNA] | 21549813 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased expression of CASP9 protein] | 18336854 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] | 20576514 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 21616140 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP9 protein] | 24614525 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [CASP9 protein binds to CYCS protein]] | 24634002 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 21145380 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 24634002 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 18629305 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP9 protein] | 23405080 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | 18483861 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein] | 22714038 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein] | 19477266 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA] | 19477266 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | 22085843 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9] | 18791325 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA] | 28296042 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] | 28296042 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | 15158148 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19135140 |
C401206 | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [hispanolone analog results in increased activity of CASP9 protein] | 25930665 |
C401206 | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP9 protein]] | 25930665 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal analog inhibits the reaction [hispanolone analog results in increased activity of CASP9 protein] | 25930665 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal analog inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP9 protein]] | 25930665 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 23747833 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal results in decreased activity of CASP9 protein | 16027529 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | [acetyl-leucyl-glutamyl-histidyl-aspartal results in decreased activity of CASP9 protein] which results in decreased susceptibility to sodium arsenite | 23219847 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal results in decreased activity of CASP9 protein | 21801448|2314313 |
D017255 | Acitretin | Acitretin results in increased activity of CASP9 protein | 18624760 |
D000157 | Aconitine | Aconitine results in increased expression of CASP9 protein | 24840785 |
D000171 | Acrolein | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
D000171 | Acrolein | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
D000171 | Acrolein | Acrolein results in increased activity of CASP9 protein | 15843039|1719679 |
D000171 | Acrolein | Acrolein results in increased cleavage of CASP9 protein | 15843039 |
D000171 | Acrolein | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17320762 |
D000171 | Acrolein | FASLG protein affects the reaction [Acrolein results in increased activity of CASP9 protein] | 17320762 |
D000171 | Acrolein | SB 203580 inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
D000171 | Acrolein | U 0126 inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
D000171 | Acrolein | wortmannin inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
D000171 | Acrolein | Acrolein results in increased activity of CASP9 protein | 19596284 |
D000171 | Acrolein | Acrolein results in decreased activity of CASP9 protein | 11803030 |
D020106 | Acrylamide | Acrylamide results in increased expression of CASP9 mRNA | 28159594 |
D020106 | Acrylamide | salvin inhibits the reaction [Acrylamide results in increased expression of CASP9 mRNA] | 28159594 |
C109238 | acyline | acyline results in increased activity of CASP9 protein | 17268770 |
C109238 | acyline | acyline results in increased activity of CASP9 protein | 17268770 |
D000241 | Adenosine | Adenosine results in increased activity of CASP9 protein | 11570579 |
D000241 | Adenosine | Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein] | 11570579 |
D000241 | Adenosine | Adenosine results in increased activity of CASP9 protein | 16469385 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased cleavage of CASP9 protein | 22743290 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CASP9 mRNA | 27017951 |
C031143 | AICA ribonucleotide | AICA ribonucleotide results in increased cleavage of CASP9 protein | 22137261 |
C031143 | AICA ribonucleotide | AICA ribonucleotide results in increased activity of CASP9 protein | 16469385 |
C004363 | alantolactone | alantolactone results in increased activity of CASP9 protein | 24252419 |
C004363 | alantolactone | alantolactone results in increased cleavage of CASP9 protein | 22721982 |
C012708 | alborixin | alborixin results in increased activity of CASP9 protein | 27378626 |
D019386 | Alendronate | TNFSF11 inhibits the reaction [Alendronate results in increased expression of CASP9 protein] | 19405951 |
D019386 | Alendronate | Alendronate results in increased expression of CASP9 protein | 19405951 |
D000496 | Alloxan | Alloxan results in increased activity of CASP9 protein | 21982801 |
D000496 | Alloxan | Alloxan results in increased expression of CASP9 protein | 23092809 |
D000496 | Alloxan | Alloxan results in increased expression of CASP9 protein modified form | 22138235 |
D000496 | Alloxan | "saccharic acid-1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP9 protein]" | 21982801 |
D000496 | Alloxan | Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein] | 23092809 |
D000496 | Alloxan | Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form] | 22138235 |
C038491 | allyl sulfide | allyl sulfide results in increased activity of CASP9 protein | 17647244 |
C518327 | aloe emodin | aloe emodin results in increased activity of CASP9 protein | 19928967 |
C518327 | aloe emodin | aloe emodin results in increased expression of CASP9 protein modified form | 19928967 |
C518327 | aloe emodin | [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9 | 19928967 |
C518327 | aloe emodin | Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form] | 19928967 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of CASP9 mRNA | 27732882 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased activity of CASP9 protein | 28070108 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of and results in increased cleavage of and results in increased activity of CASP9 protein | 27732882 |
D000517 | alpha-Chlorohydrin | quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein] | 27732882 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased activity of CASP9 protein | 18334599 |
C011512 | alpha-naphthoflavone | [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter | 29094188 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]] | 29094188 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA] | 29094188 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter] | 29094188 |
D024502 | alpha-Tocopherol | alpha-Tocopherol analog results in increased cleavage of CASP9 protein | 20686688 |
D024502 | alpha-Tocopherol | alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein | 21869839 |
C064176 | alpha-viniferin | alpha-viniferin analog results in increased activity of CASP9 protein | 16158945 |
C064176 | alpha-viniferin | alpha-viniferin results in increased activity of CASP9 protein | 16158945 |
C000154 | alpinumisoflavone | alpinumisoflavone results in increased cleavage of CASP9 protein | 23850732 |
C000154 | alpinumisoflavone | [alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP9 protein | 23850732 |
C005197 | alternariol | alternariol results in increased activity of CASP9 protein | 22542754 |
C018206 | alternariol monomethyl ether | alternariol monomethyl ether results in increased activity of CASP9 protein | 22001388 |
C010845 | aluminum chloride | aluminum chloride results in increased activity of CASP9 protein | 25263842 |
C010845 | aluminum chloride | aluminum chloride results in increased expression of CASP9 mRNA | 23065425|2526384 |
C010845 | aluminum chloride | aluminum chloride results in increased expression of CASP9 protein | 27476752 |
C067527 | aluminum maltolate | aluminum maltolate results in increased activity of CASP9 protein | 24878590 |
C077990 | alvocidib | alvocidib affects the cleavage of CASP9 protein | 10896673 |
C077990 | alvocidib | [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of CASP9 protein | 15634644 |
C077990 | alvocidib | alvocidib results in increased activity of CASP9 protein | 12170773 |
C077990 | alvocidib | BCL2 protein mutant form inhibits the reaction [alvocidib results in increased activity of CASP9 protein] | 12170773 |
C109925 | AM 281 | AM 281 inhibits the reaction [Win 55212-2 results in increased activity of CASP9 protein] | 28495606 |
D000584 | Amiloride | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein] | 16059913 |
D000622 | Aminolevulinic Acid | Aminolevulinic Acid analog results in increased activity of CASP9 protein | 17245620|2113848 |
D000622 | Aminolevulinic Acid | pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | 21138480 |
D000622 | Aminolevulinic Acid | 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | 20426806 |
D000622 | Aminolevulinic Acid | Aminolevulinic Acid analog results in increased activity of CASP9 protein | 20426806 |
D015761 | 4-Aminopyridine | 4-Aminopyridine results in increased activity of CASP9 protein | 24378259 |
D000638 | Amiodarone | Amiodarone results in increased expression of CASP9 mRNA | 19774075 |
D000638 | Amiodarone | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of CASP9 protein | 21292685 |
D000638 | Amiodarone | [Amiodarone co-treated with TNF protein] results in increased activity of CASP9 protein | 23042730 |
D000640 | Amitrole | [Amitrole co-treated with Ditiocarb] promotes the reaction [Dichlorvos results in increased activity of CASP9 protein] | 17640809 |
D000643 | Ammonium Chloride | "(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein]]" | 14535961 |
D000643 | Ammonium Chloride | 4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein] | 14535961 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CASP9 mRNA | 16483693 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased activity of CASP9 protein | 14535961|1872252 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased expression of CASP9 protein | 16483693 |
D000661 | Amphetamine | Amphetamine results in increased activity of CASP9 protein | 16638611 |
C088115 | anacardic acid | [anacardic acid co-treated with TNF protein] results in increased cleavage of CASP9 protein | 18349320 |
C030419 | andrographolide | [andrographolide co-treated with Cisplatin] results in increased expression of CASP9 mRNA | 24563380 |
C030419 | andrographolide | andrographolide results in increased activity of CASP9 protein | 19097688 |
C030419 | andrographolide | andrographolide results in increased expression of CASP9 mRNA | 24563380 |
C030419 | andrographolide | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]] | 19097688 |
C030419 | andrographolide | Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein] | 19097688 |
C030419 | andrographolide | andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] | 20946909 |
C030419 | andrographolide | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
C030419 | andrographolide | Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
D000841 | Anisomycin | Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
C540917 | anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione | "anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione results in increased cleavage of CASP9 protein" | 19146838 |
C529696 | anthracenylmethyl homospermidine | anthracenylmethyl homospermidine results in decreased activity of CASP9 | 19595733 |
D000880 | Anthraquinones | Anthraquinones analog results in increased cleavage of CASP9 protein | 19686834 |
C010680 | antibiotic G 418 | antibiotic G 418 results in increased activity of CASP9 protein | 15241557 |
C010680 | antibiotic G 418 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein] | 15241557 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CASP9 mRNA | 24449571 |
C102351 | apicidin | apicidin results in increased activity of CASP9 protein | 18313654|1907061 |
D047310 | Apigenin | Apigenin results in increased cleavage of CASP9 protein | 15486995|1939799 |
D047310 | Apigenin | [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP9 mRNA | 24070738 |
D047310 | Apigenin | [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP9 protein | 24070738 |
D047310 | Apigenin | [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP9 protein | 29247770 |
D047310 | Apigenin | Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] | 28025107 |
D047310 | Apigenin | Apigenin results in increased activity of CASP9 protein | 28025107 |
D047310 | Apigenin | Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] | 28025107 |
D047310 | Apigenin | Apigenin inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein] | 25557508 |
D016718 | Arachidonic Acid | Arachidonic Acid results in increased activity of CASP9 protein | 19540902|1972012 |
C000228 | aristolochic acid I | aristolochic acid I results in increased expression of CASP9 protein modified form | 26656393 |
C061640 | arjunolic acid | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 21420465 |
D001147 | Arsanilic Acid | Arsanilic Acid results in increased activity of CASP9 protein | 23848144 |
D001149 | Arsenates | [Arsenates co-treated with chromium hexavalent ion] results in increased activity of CASP9 protein | 19895865 |
D001151 | Arsenic | Arsenic results in increased expression of CASP9 mRNA | 11134558 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP9 mRNA | 28454103 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP9 protein | 28454103 |
C006632 | arsenic trioxide | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 19371599 |
C006632 | arsenic trioxide | "3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]" | 17237268 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]] | 21418039 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 19771260 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein]] | 21418039 |
C006632 | arsenic trioxide | AKT1 mutant form promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 21655183 |
C006632 | arsenic trioxide | ARL6IP5 protein promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 18387645 |
C006632 | arsenic trioxide | arsenic trioxide analog results in increased cleavage of and results in increased activity of CASP9 protein | 22753750 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein | 17237268 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Plant Extracts] results in increased cleavage of CASP9 protein | 26160715 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Ethacrynic Acid results in increased cleavage of CASP9 protein] | 23082001 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein] | 21889928 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein] | 21418039 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [sorafenib results in increased activity of CASP9 protein] | 25416439 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CASP9 protein | 22963400 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP9 protein | 12148893|1249211 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | 17374990|1940830 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of CASP9 protein | 12480548|1838764 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP9 protein | 23980369 |
C006632 | arsenic trioxide | BCL2L11 mutant form inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 21655183 |
C006632 | arsenic trioxide | BCL2 protein inhibits the reaction [arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]] | 21889928 |
C006632 | arsenic trioxide | BCL2 protein inhibits the reaction [lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein]] | 21889928 |
C006632 | arsenic trioxide | [Bortezomib co-treated with arsenic trioxide] results in increased activity of CASP9 protein | 21518486 |
C006632 | arsenic trioxide | [Bortezomib co-treated with arsenic trioxide] results in increased expression of CASP9 protein | 24377552 |
C006632 | arsenic trioxide | Bortezomib promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 20471514 |
C006632 | arsenic trioxide | [Curcumin co-treated with arsenic trioxide] results in increased cleavage of CASP9 protein | 20605902 |
C006632 | arsenic trioxide | Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein] | 23041229 |
C006632 | arsenic trioxide | Fluorouracil promotes the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | 22963400 |
C006632 | arsenic trioxide | Genistein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 20219070 |
C006632 | arsenic trioxide | GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein] | 23082001 |
C006632 | arsenic trioxide | KNK 437 promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 19371599 |
C006632 | arsenic trioxide | lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein] | 21889928 |
C006632 | arsenic trioxide | MAPK8 protein affects the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 20534739 |
C006632 | arsenic trioxide | MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein] | 23082001 |
C006632 | arsenic trioxide | MIR203A protein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 23737871 |
C006632 | arsenic trioxide | Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 21418039 |
C006632 | arsenic trioxide | salvin promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 23239002 |
C006632 | arsenic trioxide | SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein] | 17237268 |
C006632 | arsenic trioxide | sorafenib promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 25416439 |
C006632 | arsenic trioxide | STMN1 inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 20657188 |
C006632 | arsenic trioxide | [Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein | 18281123 |
C006632 | arsenic trioxide | TNF protein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 17673311 |
C006632 | arsenic trioxide | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP9 mRNA | 25815518 |
C006632 | arsenic trioxide | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP9 protein | 25815518 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | 18336854 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 24157283 |
C006632 | arsenic trioxide | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in increased expression of CASP9 protein modified form]" | 28587418 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CASP9 protein | 18336854 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP9 protein | 21565247|2415728 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | 15688020 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of CASP9 protein | 24801902 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP9 protein modified form | 28587418 |
C006632 | arsenic trioxide | "Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in increased expression of CASP9 protein modified form]" | 28587418 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [CASP9 protein binds to CYCS protein]] | 24634002 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 21145380 |
C006632 | arsenic trioxide | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 24634002 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [CYCS protein binds to CASP9 protein] | 24634002 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP9 protein | 21145380 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of CASP9 protein | 24634002 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP9 mRNA | 19730151 |
C015001 | arsenite | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP9 protein]] | 26375285 |
C015001 | arsenite | arsenite results in increased activity of CASP9 protein | 26375285 |
C015001 | arsenite | epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP9 protein] | 26375285 |
C015001 | arsenite | arsenite affects the expression of CASP9 protein | 20083129 |
C015001 | arsenite | [arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP9 protein | 22387748 |
C015001 | arsenite | arsenite results in decreased cleavage of and results in decreased activity of CASP9 protein | 22387748 |
C015001 | arsenite | arsenite results in increased cleavage of CASP9 protein | 17553788 |
C039726 | artesunate | artesunate affects the expression of CASP9 protein | 24704559 |
C519899 | AS602868 | AS602868 results in increased cleavage of and results in increased activity of CASP9 protein | 18182997 |
C519899 | AS602868 | irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP9 protein] | 18182997 |
D001194 | Asbestos | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D001194 | Asbestos | Asbestos results in increased activity of CASP9 protein | 15618436 |
D001194 | Asbestos | FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein] | 15618436 |
D001194 | Asbestos | U 0126 inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D017639 | Asbestos, Amosite | "4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 14766669 |
D017639 | Asbestos, Amosite | "Asbestos, Amosite results in increased activity of CASP9 protein" | 12540492|1476666 |
D017639 | Asbestos, Amosite | "Deferoxamine inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492|1476666 |
D017639 | Asbestos, Amosite | "Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492|1476666 |
D017639 | Asbestos, Amosite | "Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492 |
D017639 | Asbestos, Amosite | "Asbestos, Amosite results in increased activity of CASP9 protein" | 12540492|1635736 |
D017639 | Asbestos, Amosite | "pifithrin inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 16357363 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite inhibits the reaction [Asbestos, Crocidolite results in increased activity of CASP9 protein]" | 22608188 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased activity of CASP9 protein" | 22608188 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased cleavage of CASP9 protein" | 17191120 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased cleavage of CASP9 protein" | 12626342 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CASP9 protein modified form" | 24918270 |
D017638 | Asbestos, Crocidolite | "rottlerin inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of CASP9 protein]" | 12626342 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 23711929 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | 15158148 |
D001205 | Ascorbic Acid | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] | 16973328 |
C017032 | asiatic acid | "asiatic acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP9 protein]" | 29108773 |
D001241 | Aspirin | Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein] | 17644113 |
D001241 | Aspirin | Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 14753751 |
D001241 | Aspirin | Aspirin results in increased activity of CASP9 protein | 11034327 |
D001241 | Aspirin | Aspirin results in increased cleavage of and results in increased activity of CASP9 protein | 15481331 |
D001241 | Aspirin | BCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein] | 16199534 |
D001241 | Aspirin | [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein | 16199534 |
D001241 | Aspirin | Aspirin results in increased activity of CASP9 protein | 16880202 |
C082414 | astin B | astin B results in increased activity of CASP9 protein | 25219577 |
D000069059 | Atorvastatin Calcium | [Atorvastatin Calcium co-treated with Celecoxib] results in increased cleavage of CASP9 protein | 18172863 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in increased activity of CASP9 protein | 15705602|1647022 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in increased activity of CASP9 protein | 18339080 |
D000069059 | Atorvastatin Calcium | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium results in increased activity of CASP9 protein] | 18339080 |
D000069059 | Atorvastatin Calcium | U 0126 inhibits the reaction [Atorvastatin Calcium results in increased activity of CASP9 protein] | 18339080 |
D001280 | Atrazine | Atrazine results in increased expression of CASP9 mRNA | 25929836 |
D001280 | Atrazine | Atrazine results in decreased expression of CASP9 mRNA | 22378314 |
D001280 | Atrazine | Atrazine results in increased expression of CASP9 mRNA | 21333729 |
D001280 | Atrazine | kolaviron inhibits the reaction [Atrazine results in increased expression of CASP9 mRNA] | 21333729 |
D001280 | Atrazine | Atrazine affects the expression of CASP9 | 21726175 |
D001280 | Atrazine | Atrazine results in increased expression of CASP9 mRNA | 26075868 |
D001280 | Atrazine | Atrazine results in increased expression of CASP9 protein | 26075868 |
D001280 | Atrazine | kolaviron inhibits the reaction [Atrazine affects the expression of CASP9] | 21726175 |
D001310 | Auranofin | Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein | 20542334 |
C426023 | austenitic steel | [Nickel co-treated with austenitic steel analog] results in increased expression of CASP9 mRNA | 23638002 |
D001374 | Azacitidine | Azacitidine results in increased expression of CASP9 mRNA | 23395740 |
C010329 | azadirachtin | azadirachtin results in increased expression of CASP9 mRNA | 20429769 |
C010329 | azadirachtin | azadirachtin results in increased expression of CASP9 protein | 20429769 |
C479321 | azadiradione | azadiradione results in increased activity of CASP9 protein | 21381696 |
C040929 | bafilomycin A1 | bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
C012765 | bakuchiol | [TNFSF10 protein co-treated with bakuchiol] results in increased cleavage of CASP9 protein | 27033605 |
C060988 | baohuoside I | baohuoside I results in increased activity of CASP9 protein | 19289254 |
C060988 | baohuoside I | baohuoside I results in increased cleavage of CASP9 protein | 22687635 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
C580697 | BDMC-A | BDMC-A results in increased cleavage of CASP9 protein | 24365254 |
C004456 | beauvericin | beauvericin results in increased expression of CASP9 mRNA | 29203277 |
D001507 | Beclomethasone | Beclomethasone results in increased activity of CASP9 protein | 11734450 |
C487081 | belinostat | belinostat results in increased cleavage of CASP9 protein | 18223231 |
C487081 | belinostat | Bortezomib promotes the reaction [belinostat results in increased cleavage of CASP9 protein] | 18223231 |
D000069461 | Bendamustine Hydrochloride | Bendamustine Hydrochloride results in increased activity of CASP9 protein | 12948851 |
D000069461 | Bendamustine Hydrochloride | Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP9 protein] | 12948851 |
D001546 | Bentonite | Bentonite inhibits the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of CASP9 mRNA] | 25296281 |
D001554 | Benzene | Benzene results in increased expression of CASP9 mRNA | 19162166 |
D001554 | Benzene | Benzene results in increased expression of CASP9 protein | 17171516 |
C026487 | benzo(e)pyrene | benzo(e)pyrene results in increased activity of CASP9 protein | 18586875|1995963 |
C026487 | benzo(e)pyrene | Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | 19959636 |
C026487 | benzo(e)pyrene | resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | 19959636 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased cleavage of CASP9 protein | 16041517 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CASP9 mRNA | 21393351|2423996 |
D001564 | Benzo(a)pyrene | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP9 protein] | 16041517 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CASP9 protein | 27208085 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CASP9 protein | 22051199 |
D001564 | Benzo(a)pyrene | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] | 22051199 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP9 protein" | 21983885 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "TP53 protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP9 protein]" | 21983885 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein] | 22898888 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein] | 20226831 |
C427308 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein] | 18723477 |
C427308 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein] | 17308071 |
C427308 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17320762 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein] | 20226831 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein] | 21067863 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP9 protein] | 19360361 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | 19423619 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP9 protein] | 20156547 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone affects the reaction [rubimaillin results in increased activity of CASP9 protein] | 19716835 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein] | 15241557 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein] | 18723477 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | 17574045 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP9 protein] | 21126053 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP9 protein] | 27313093 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [erythritol anhydride results in increased activity of CASP9 protein] | 14998682 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein] | 22898888 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein] | 27313093 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein | 15476743|2453406 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin] | 18594523 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel] | 18594523 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one" | 20833157 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane" | 20674558 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Doxorubicin | 18594523 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to methyl antcinate A | 20557081 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Paclitaxel | 18594523 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to TNFSF10 protein | 23711929 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein] | 12831782 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Tretinoin results in increased activity of CASP9 protein] | 16291826 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Nanotubes, Carbon" | 22664788 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP9 protein] | 16263807 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid] | 15276415 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein | 15276415 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein | 10604926|1077478 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein] | 22079975 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of and results in increased activity of CASP9 protein | 15498850 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP9 protein | 16880202 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acetylbritannilatone analog results in increased activity of CASP9 protein] | 27262408 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein] | 24291039 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Lithocholic Acid results in increased cleavage of and results in increased activity of CASP9 protein] | 19054763 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [NCQ 344 results in increased activity of CASP9 protein] | 10996300 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [NCQ 436 results in increased activity of CASP9 protein] | 10996300 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Quercetin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein] | 20096292 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
C103712 | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein] | 12831782 |
C103712 | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D001599 | Berberine | [Berberine co-treated with Niacinamide] results in increased cleavage of CASP9 protein | 26712469 |
D001599 | Berberine | Berberine results in increased cleavage of CASP9 protein | 16505103 |
D004958 | Estradiol | [Estradiol co-treated with EGF protein] results in decreased expression of CASP9 mRNA | 24758408 |
D004958 | Estradiol | Estradiol results in decreased expression of CASP9 mRNA | 23373633 |
D004958 | Estradiol | Estradiol results in increased activity of CASP9 protein | 19095654 |
D004958 | Estradiol | ABCC8 protein promotes the reaction [Estradiol results in increased activity of CASP9 protein] | 19095654 |
D004958 | Estradiol | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA | 20732338 |
C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in increased expression of CASP9 mRNA | 19175174 |
C023888 | beta-hexachlorocyclohexane | [Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of CASP9 mRNA | 19175174 |
C026609 | beta-solamarine | beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 17619073 |
C026609 | beta-solamarine | beta-solamarine results in increased activity of CASP9 protein | 17619073 |
C026609 | beta-solamarine | beta-solamarine results in increased cleavage of CASP9 protein | 20647040 |
C002070 | betulinic acid | betulinic acid results in increased activity of CASP9 protein | 26772157 |
C002070 | betulinic acid | betulinic acid results in increased activity of CASP9 protein | 26772157 |
D001688 | Biological Products | Biological Products results in decreased expression of CASP9 protein | 28219700 |
C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased activity of CASP9 protein | 23458715 |
C006780 | bisphenol A | bisphenol A affects the expression of CASP9 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CASP9 mRNA | 27561114 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP9 protein | 21277958 |
C006780 | bisphenol A | bisphenol A affects the expression of CASP9 protein | 23900028 |
C006780 | bisphenol A | bisphenol A promotes the reaction [Genistein results in increased cleavage of CASP9 protein] | 24884420 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CASP9 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CASP9 protein | 27189055 |
C006780 | bisphenol A | bisphenol A results in increased activity of CASP9 protein | 25461564 |
C006780 | bisphenol A | bisphenol A results in increased expression of and results in increased cleavage of CASP9 protein | 25461564 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP9 mRNA | 25461564|2729622 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP9 protein | 17322771 |
D001761 | Bleomycin | [Polyphenols co-treated with Bleomycin] results in increased expression of CASP9 mRNA | 26800624 |
D001761 | Bleomycin | [Tea co-treated with Bleomycin] results in increased expression of CASP9 mRNA | 26800624 |
D001761 | Bleomycin | Bleomycin results in increased activity of CASP9 protein | 22687607 |
D001761 | Bleomycin | Bleomycin results in increased cleavage of and results in increased activity of CASP9 protein | 15371238 |
D001786 | Blood Glucose | Blood Glucose results in increased activity of CASP9 protein | 15246841 |
D001786 | Blood Glucose | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form | 24058562 |
D001786 | Blood Glucose | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form] | 24058562 |
C478223 | BMS 310705 | BMS 310705 results in increased activity of CASP9 protein | 14529678 |
C000591165 | BO-1012 | 3-methyladenine promotes the reaction [BO-1012 results in increased cleavage of CASP9 protein] | 24823293 |
C000591165 | BO-1012 | BO-1012 results in increased cleavage of CASP9 protein | 24823293 |
D000069286 | Bortezomib | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt affects the reaction [Bortezomib results in increased cleavage of CASP9 protein]" | 15509775 |
D000069286 | Bortezomib | AKT1 protein inhibits the reaction [[Bortezomib co-treated with sorafenib] results in increased cleavage of CASP9 protein] | 16985072 |
D000069286 | Bortezomib | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein] | 18723477 |
D000069286 | Bortezomib | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein] | 18723477 |
D000069286 | Bortezomib | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein] | 24291039 |
D000069286 | Bortezomib | "[Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased activity of CASP9 protein" | 15070698 |
D000069286 | Bortezomib | [Bortezomib co-treated with arsenic trioxide] results in increased activity of CASP9 protein | 21518486 |
D000069286 | Bortezomib | [Bortezomib co-treated with arsenic trioxide] results in increased expression of CASP9 protein | 24377552 |
D000069286 | Bortezomib | [Bortezomib co-treated with Butyrates] results in increased cleavage of and results in increased activity of CASP9 protein | 12893773 |
D000069286 | Bortezomib | [Bortezomib co-treated with sorafenib] results in increased cleavage of CASP9 protein | 16985072 |
D000069286 | Bortezomib | [Bortezomib co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | 17620439|1926161 |
D000069286 | Bortezomib | [Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP9 protein | 16904634 |
D000069286 | Bortezomib | [Bortezomib co-treated with vorinostat] results in increased activity of CASP9 protein | 18005386|1864136 |
D000069286 | Bortezomib | [Bortezomib co-treated with vorinostat] results in increased cleavage of and results in increased activity of CASP9 protein | 12893773 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP9 protein] | 19417023 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 20471514 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [belinostat results in increased cleavage of CASP9 protein] | 18223231 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [Butyrates results in increased activity of CASP9 protein] | 15173093 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [romidepsin results in increased cleavage of CASP9 protein] | 18223231 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [vorinostat results in increased activity of CASP9 protein] | 15173093 |
D000069286 | Bortezomib | Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein | 16024631|1751042 |
D000069286 | Bortezomib | Bortezomib results in increased cleavage of CASP9 protein | 15509775|1611831 |
D000069286 | Bortezomib | Bortezomib results in increased expression of CASP9 protein | 17156654 |
D000069286 | Bortezomib | [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] which results in increased cleavage of CASP9 protein | 17326159 |
D000069286 | Bortezomib | CASP2 protein affects the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP9 protein] | 18723477 |
D000069286 | Bortezomib | CASP9 gene SNP results in increased susceptibility to Bortezomib | 20864405 |
D000069286 | Bortezomib | CASP9 results in increased susceptibility to Bortezomib | 18723477 |
D000069286 | Bortezomib | [gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein | 24291039 |
D000069286 | Bortezomib | [lonafarnib co-treated with Bortezomib] results in increased cleavage of CASP9 protein | 16118318 |
D000069286 | Bortezomib | [nutlin 3 co-treated with Bortezomib] results in increased activity of CASP9 protein | 20850924 |
D000069286 | Bortezomib | SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP9 protein] | 16617327 |
D000069286 | Bortezomib | TNFSF10 protein promotes the reaction [Bortezomib results in increased cleavage of CASP9 protein] | 17510429 |
D000069286 | Bortezomib | [trichostatin A co-treated with Bortezomib] results in increased cleavage of CASP9 protein | 21345073 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CASP9 mRNA | 22079614 |
C083806 | brucine | brucine results in increased activity of and results in increased cleavage of CASP9 protein | 16443926 |
C083806 | brucine | brucine results in increased activity of CASP9 protein | 21684292 |
C083806 | brucine | [brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein | 16443926 |
C083806 | brucine | Cyclosporine inhibits the reaction [brucine results in increased activity of and results in increased cleavage of CASP9 protein] | 16443926 |
C083806 | brucine | Cyclosporine inhibits the reaction [[brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | 16443926 |
D019819 | Budesonide | Budesonide results in increased activity of CASP9 protein | 11734450 |
C022777 | bufalin | bufalin results in increased activity of CASP9 protein | 27444971 |
D002045 | Bupivacaine | Bupivacaine results in decreased expression of CASP9 protein | 20194319 |
D016642 | Bupropion | Bupropion results in increased activity of CASP9 protein | 21354251 |
D002064 | Buserelin | Buserelin results in increased expression of CASP9 protein | 15965100 |
D002066 | Busulfan | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein | 20933509 |
D002066 | Busulfan | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] | 19732952 |
D020001 | 1-Butanol | 1-Butanol results in increased cleavage of and results in increased activity of CASP9 protein | 22564901 |
D020001 | 1-Butanol | Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP9 protein] | 22564901 |
D002078 | Butoxamine | Butoxamine results in increased cleavage of CASP9 protein | 19106745 |
D020122 | tert-Butylhydroperoxide | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] | 27050144 |
D020122 | tert-Butylhydroperoxide | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] | 27050144 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased cleavage of CASP9 protein | 17003459|2705014 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of CASP9 protein | 20510348 |
D020122 | tert-Butylhydroperoxide | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] | 19772912 |
D020122 | tert-Butylhydroperoxide | Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] | 19772912 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased cleavage of CASP9 protein | 15877105 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of CASP9 protein | 15877105 |
C026105 | butylidenephthalide | butylidenephthalide results in increased cleavage of CASP9 protein | 16987298 |
C026105 | butylidenephthalide | butylidenephthalide results in increased cleavage of CASP9 protein | 16987298 |
D002087 | Butyrates | [Bortezomib co-treated with Butyrates] results in increased cleavage of and results in increased activity of CASP9 protein | 12893773 |
D002087 | Butyrates | Bortezomib promotes the reaction [Butyrates results in increased activity of CASP9 protein] | 15173093 |
D002087 | Butyrates | Butyrates results in increased activity of and results in increased cleavage of CASP9 protein | 20346929 |
D002087 | Butyrates | Butyrates results in increased activity of CASP9 protein | 15173093|1517750 |
D002087 | Butyrates | GSN protein inhibits the reaction [Butyrates results in increased activity of CASP9 protein] | 15213223 |
D020148 | Butyric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D020148 | Butyric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D020148 | Butyric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D020148 | Butyric Acid | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D020148 | Butyric Acid | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D020148 | Butyric Acid | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
C547107 | C60-bis(N,N-dimethylpyrrolidinium) | "C60-bis(N,N-dimethylpyrrolidinium) results in increased activity of CASP9 protein" | 19905986 |
C400541 | CA 074 methyl ester | CA 074 methyl ester inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
D002101 | Cacodylic Acid | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid] | 15276415 |
D002101 | Cacodylic Acid | CASP9 protein results in increased susceptibility to Cacodylic Acid | 15276415 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 22768170 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 23954723 |
D002104 | Cadmium | Cadmium results in increased cleavage of and results in increased activity of CASP9 protein | 19442655 |
D002104 | Cadmium | "1,3-dimethylthiourea inhibits the reaction [Cadmium results in increased activity of CASP9 protein]" | 22692000 |
D002104 | Cadmium | Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 22692000 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 22692000 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 19182378 |
D002104 | Cadmium | hwanggunchungyitang inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19182378 |
D002104 | Cadmium | Cadmium inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 16263807 |
D002104 | Cadmium | Cadmium inhibits the reaction [TNF protein results in increased activity of CASP9 protein] | 16263807 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 14977363|1647875 |
D002104 | Cadmium | Cadmium results in increased cleavage of CASP9 protein | 23741317|2564379 |
D002104 | Cadmium | Acetylcysteine inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19135140 |
D002104 | Cadmium | Cadmium results in increased activity of CASP9 protein | 19135140 |
D002104 | Cadmium | Selenium inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19135140 |
C028031 | cadmium acetate | Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP9 protein] | 16169029 |
C028031 | cadmium acetate | cadmium acetate results in increased activity of CASP9 protein | 15450950|1616902 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 mRNA | 25035189 |
D019256 | Cadmium Chloride | Selenium inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 25035189 |
D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [Fluorouracil results in decreased expression of CASP9 mRNA] | 23941782 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of CASP9 protein | 16264267 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased cleavage of CASP9 protein | 24419708 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 mRNA | 23941782 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 protein | 28342888 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 protein modified form | 24291162 |
D019256 | Cadmium Chloride | Fluorouracil inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 23941782 |
D019256 | Cadmium Chloride | TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] | 28342888 |
D019256 | Cadmium Chloride | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]" | 18850067 |
D019256 | Cadmium Chloride | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 21420465 |
D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with Potassium Dichromate] results in increased activity of CASP9 protein | 25409916 |
D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with Potassium Dichromate] results in increased expression of CASP9 mRNA | 25409916 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of CASP9 protein | 18850067|2142046 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 mRNA | 25409916 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 protein | 28342888 |
D019256 | Cadmium Chloride | Sirolimus inhibits the reaction [TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]] | 28342888 |
D019256 | Cadmium Chloride | TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] | 28342888 |
D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 18629305 |
D019256 | Cadmium Chloride | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP9 protein] | 23405080 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of CASP9 mRNA | 15842833 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 16263807 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [TNF protein results in increased activity of CASP9 protein] | 16263807 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of CASP9 protein | 16478757|1659761 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased cleavage of CASP9 protein | 23405080 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 mRNA | 28390674 |
D019256 | Cadmium Chloride | ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 18629305 |
D019256 | Cadmium Chloride | IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
D019256 | Cadmium Chloride | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
D019256 | Cadmium Chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein | 26396915 |
D019256 | Cadmium Chloride | zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 28390674 |
D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein | 26607349 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP9 protein | 26607349 |
D019256 | Cadmium Chloride | MIR125A mRNA inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] | 26607349 |
D019256 | Cadmium Chloride | Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein] | 26607349 |
D019256 | Cadmium Chloride | Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] | 26607349 |
D019187 | Cadmium Compounds | Cadmium Compounds results in increased activity of CASP9 protein | 25684395 |
C037123 | cadmium sulfate | cadmium sulfate results in increased cleavage of CASP9 protein | 23958785 |
C028337 | cadmium telluride | cadmium telluride results in increased cleavage of and results in increased activity of CASP9 protein | 21291946 |
D002110 | Caffeine | Caffeine inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
D002110 | Caffeine | Caffeine results in increased cleavage of and results in increased expression of CASP9 protein | 16522534 |
D002110 | Caffeine | "[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA" | 20230807 |
D002110 | Caffeine | "Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA]" | 20230807 |
C080866 | cagA protein, Helicobacter pylori | "cagA protein, Helicobacter pylori results in decreased cleavage of CASP9 protein" | 26427350 |
C080866 | cagA protein, Helicobacter pylori | "ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in decreased cleavage of CASP9 protein]" | 26427350 |
C471767 | cajanol | [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein | 20638373 |
C471767 | cajanol | cajanol results in increased activity of CASP9 protein | 20638373 |
D000001 | Calcimycin | Calcimycin results in increased activity of CASP9 protein | 25410152 |
D000001 | Calcimycin | Calcimycin results in increased activity of CASP9 protein | 25410152 |
D002118 | Calcium | Calcium affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 24184500 |
D002118 | Calcium | "[Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 24184500 |
D002129 | Calcium Oxalate | Calcium Oxalate results in increased activity of CASP9 protein | 25446497 |
D002129 | Calcium Oxalate | Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein] | 25446497 |
D002166 | Camptothecin | [Camptothecin co-treated with FAS protein] results in increased activity of CASP9 protein | 15958570 |
D002166 | Camptothecin | [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP9 protein | 19633536 |
D002166 | Camptothecin | Camptothecin results in increased cleavage of CASP9 protein | 10896673|2482329 |
D002166 | Camptothecin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP9 protein] | 16263807 |
D002166 | Camptothecin | Cadmium Chloride inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 16263807 |
D002166 | Camptothecin | Cadmium inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 16263807 |
D002166 | Camptothecin | Camptothecin results in increased activity of CASP9 protein | 16263807 |
D002166 | Camptothecin | Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 19497415 |
D002193 | Cantharidin | Cantharidin results in increased cleavage of and results in increased activity of CASP9 protein | 27113412 |
D002193 | Cantharidin | Cantharidin results in increased expression of CASP9 mRNA | 27113412 |
D002193 | Cantharidin | Cantharidin results in increased expression of CASP9 protein | 27113412 |
D002211 | Capsaicin | [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | 19939880 |
D002211 | Capsaicin | Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP9 protein] | 22200406 |
D002211 | Capsaicin | Capsaicin results in increased activity of CASP9 protein | 19502594|1969925 |
D002211 | Capsaicin | Capsaicin results in increased cleavage of CASP9 protein | 21647434 |
D002211 | Capsaicin | Capsaicin results in increased expression of CASP9 mRNA | 19502594 |
D002211 | Capsaicin | CAT protein inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein] | 21647434 |
D002211 | Capsaicin | EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein] | 21647434 |
D002211 | Capsaicin | Capsaicin affects the expression of CASP9 protein | 16477149 |
D002211 | Capsaicin | Capsaicin results in increased expression of CASP9 protein | 16125681 |
C104525 | caraway oil | caraway oil inhibits the reaction [Ethanol results in increased cleavage of CASP9 protein] | 25859307 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased activity of CASP9 protein | 25562542 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of CASP9 protein | 25445725 |
D002251 | Carbon Tetrachloride | Lipids inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | 25445725 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of CASP9 protein | 12388182 |
D002251 | Carbon Tetrachloride | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | 12388182 |
C111238 | carboxycinnamic acid bishydroxamide | carboxycinnamic acid bishydroxamide results in increased cleavage of CASP9 protein | 15897598 |
D054715 | Cardiotoxins | Cardiotoxins results in increased cleavage of CASP9 protein | 17786558 |
D054715 | Cardiotoxins | pimagedine inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] | 17786558 |
D054715 | Cardiotoxins | pyrazolanthrone inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] | 17786558 |
C524865 | carfilzomib | [carfilzomib co-treated with vorinostat] results in increased activity of CASP9 protein | 20233973 |
D002331 | Carnitine | Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP9 mRNA] | 23213347 |
C546626 | caseargrewiin F | caseargrewiin F results in increased activity of CASP9 protein | 25452174 |
D061945 | Caspase Inhibitors | "Caspase Inhibitors inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased cleavage of CASP9 protein]" | 25950987 |
C054133 | casticin | casticin results in increased cleavage of and results in increased activity of CASP9 protein | 27862857 |
D002392 | Catechin | Catechin results in increased activity of CASP9 protein | 20206613 |
D002392 | Catechin | Catechin results in increased expression of CASP9 mRNA | 23706674 |
C034221 | catechol | catechol results in increased activity of CASP9 protein | 23776099 |
C561931 | CAY 10580 | CAY 10580 inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] | 25094029 |
C099555 | CD 437 | CD 437 results in increased activity of CASP9 protein | 10766194 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | [ABT-737 co-treated with Celecoxib] results in increased activity of CASP9 protein | 20104024 |
D000068579 | Celecoxib | ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
D000068579 | Celecoxib | [Atorvastatin Calcium co-treated with Celecoxib] results in increased cleavage of CASP9 protein | 18172863 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]] | 20104024 |
D000068579 | Celecoxib | Celecoxib analog results in increased cleavage of and results in increased activity of CASP9 protein | 15499625 |
D000068579 | Celecoxib | Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | Celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
D000068579 | Celecoxib | Celecoxib promotes the reaction [tetracycline CMT-3 results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
D000068579 | Celecoxib | Celecoxib results in increased activity of CASP9 protein | 12824303 |
D000068579 | Celecoxib | Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein | 15197583|1557275 |
D000068579 | Celecoxib | Celecoxib results in increased cleavage of CASP9 protein | 17612393|1966545 |
D000068579 | Celecoxib | docetaxel promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
D000068579 | Celecoxib | FADD mutant form inhibits the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15572759 |
D000068579 | Celecoxib | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | PIK3C3 mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | tetracycline CMT-3 promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
D000068579 | Celecoxib | TNFSF10 protein promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15572759 |
D000068579 | Celecoxib | wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
D000068579 | Celecoxib | Celecoxib results in increased activity of CASP9 protein | 17201140|1776134 |
D000068579 | Celecoxib | Celecoxib results in decreased expression of CASP9 mRNA | 28201806 |
D000068579 | Celecoxib | Celecoxib results in increased activity of CASP9 protein | 17717820 |
C030583 | ceric oxide | ceric oxide results in increased expression of CASP9 protein | 24987704 |
C086276 | cerivastatin | cerivastatin results in increased activity of CASP9 protein | 15705602|1647022 |
D002569 | Cerulenin | Cerulenin results in increased activity of CASP9 protein | 20805790 |
D002108 | Ceruletide | Ceruletide results in increased cleavage of and results in increased activity of CASP9 protein | 16339139 |
C062876 | cetrorelix | cetrorelix results in increased activity of CASP9 protein | 17268770 |
C062876 | cetrorelix | cetrorelix results in increased activity of CASP9 protein | 17268770 |
C119032 | CFM 1 | CFM 1 results in increased activity of CASP9 protein | 23826121 |
D002599 | Chalcone | Chalcone results in increased cleavage of CASP9 protein | 20620131 |
D002599 | Chalcone | MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein] | 20620131 |
C095591 | chan su | chan su results in increased cleavage of and results in increased activity of CASP9 protein | 16012733 |
C016299 | chelerythrine | chelerythrine results in increased cleavage of CASP9 protein | 26124276 |
C016299 | chelerythrine | chelerythrine results in increased activity of CASP9 protein | 21664962 |
C016299 | chelerythrine | malonic acid inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | 21664962 |
C016299 | chelerythrine | Rotenone inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | 21664962 |
D002635 | Chenodeoxycholic Acid | [Chenodeoxycholic Acid co-treated with tauroursodeoxycholic acid] results in increased activity of CASP9 protein | 14976352 |
D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased activity of CASP9 protein | 14976352 |
D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased cleavage of and results in increased activity of CASP9 protein | 19054763 |
C006972 | chloroacetic acid | chloroacetic acid results in increased cleavage of CASP9 protein | 23103613 |
D017338 | Cladribine | BCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein] | 15516989 |
D017338 | Cladribine | Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP9 protein] | 12948851 |
D017338 | Cladribine | Cladribine results in increased activity of CASP9 protein | 11672427|1294885 |
D017338 | Cladribine | Cladribine results in increased cleavage of and results in increased activity of CASP9 protein | 15516989 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA | 23281070 |
D020111 | Chlorodiphenyl (54% Chlorine) | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] | 23281070 |
D002726 | Chlorogenic Acid | Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP9 protein] | 28479099 |
D002738 | Chloroquine | Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C023676 | chloroquine diphosphate | chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA] | 29133031 |
C023676 | chloroquine diphosphate | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
C023676 | chloroquine diphosphate | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
D004390 | Chlorpyrifos | [Chlorpyrifos affects the localization of CASP9 protein] which results in increased activity of CYCS protein | 23416140 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased cleavage of CASP9 protein | 24793810 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CASP9 protein | 26435000 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CASP9 protein modified form | 23416140 |
D004390 | Chlorpyrifos | MitoTEMPO inhibits the reaction [Chlorpyrifos results in increased expression of CASP9 protein] | 26435000 |
D004390 | Chlorpyrifos | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein] | 22714038 |
D004390 | Chlorpyrifos | Chlorpyrifos affects the expression of CASP9 mRNA | 17452286 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased activity of CASP9 protein | 22714038 |
D002784 | Cholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein]" | 19477266 |
D002784 | Cholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA]" | 19477266 |
D002784 | Cholesterol | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein] | 19477266 |
D002784 | Cholesterol | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA] | 19477266 |
D002784 | Cholesterol | Cholesterol analog results in increased activity of CASP9 protein | 19477266 |
D002784 | Cholesterol | Cholesterol analog results in increased expression of CASP9 mRNA | 19477266 |
C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased activity of CASP9 protein | 19556603 |
C074702 | chromium hexavalent ion | dipropylenetriamine-NONOate inhibits the reaction [chromium hexavalent ion results in increased activity of CASP9 protein] | 19556603 |
C074702 | chromium hexavalent ion | pimagedine promotes the reaction [chromium hexavalent ion results in increased activity of CASP9 protein] | 19556603 |
C074702 | chromium hexavalent ion | [Arsenates co-treated with chromium hexavalent ion] results in increased activity of CASP9 protein | 19895865 |
C043561 | chrysin | chrysin results in increased cleavage of CASP9 protein | 18331776|2577093 |
C043561 | chrysin | [Cisplatin co-treated with chrysin] results in increased cleavage of CASP9 protein | 25770930 |
C472594 | chrysophsin | chrysophsin promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA] | 26335193 |
C472594 | chrysophsin | chrysophsin results in increased expression of CASP9 mRNA | 26335193 |
C472594 | chrysophsin | [Epirubicin analog co-treated with chrysophsin analog] results in increased expression of CASP9 mRNA | 26335193 |
C472594 | chrysophsin | Epirubicin promotes the reaction [chrysophsin results in increased expression of CASP9 mRNA] | 26335193 |
C039671 | ciglitazone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein] | 21067863 |
C039671 | ciglitazone | DDIT3 mutant form inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein] | 21067863 |
C039671 | ciglitazone | [Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein | 21067863 |
D002927 | Cimetidine | Cimetidine results in increased activity of CASP9 protein | 17273750|2012700 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of CASP9 mRNA | 28219650 |
C063451 | cinobufotalin | cinobufotalin results in increased cleavage of CASP9 protein | 22898211 |
D002939 | Ciprofloxacin | Ciprofloxacin results in increased activity of CASP9 protein | 11875713 |
D002953 | Citrinin | Citrinin results in increased activity of CASP9 protein | 21622943 |
D002953 | Citrinin | Citrinin results in increased expression of CASP9 protein modified form | 22564900 |
C057741 | clavulone II | clavulone II results in increased cleavage of and results in increased activity of CASP9 protein | 15920677 |
C028677 | clivorine | clivorine results in increased activity of CASP9 protein | 19437449 |
C028677 | clivorine | EGF protein inhibits the reaction [clivorine results in increased activity of CASP9 protein] | 19437449 |
C068329 | clofarabine | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein | 20933509 |
D002994 | Clofibrate | Clofibrate results in increased expression of CASP9 mRNA | 16081524 |
D002994 | Clofibrate | Clofibrate results in decreased expression of CASP9 mRNA | 17585979 |
D002997 | Clomipramine | Clomipramine results in increased activity of CASP9 protein | 28482088 |
D003000 | Clonidine | Clonidine results in increased activity of CASP9 protein | 28115640 |
D003035 | Cobalt | Cobalt results in increased expression of CASP9 mRNA | 22983774 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [Deoxycholic Acid results in increased cleavage of CASP9 protein] | 21362092 |
C018021 | cobaltous chloride | cobaltous chloride inhibits the reaction [Gentamicins results in increased cleavage of CASP9 protein] | 23145036 |
C018021 | cobaltous chloride | cobaltous chloride results in increased activity of CASP9 protein | 21687937|2338047 |
C018021 | cobaltous chloride | pifithrin inhibits the reaction [cobaltous chloride results in increased activity of CASP9 protein] | 23380477 |
C018021 | cobaltous chloride | TP53 protein promotes the reaction [cobaltous chloride results in increased activity of CASP9 protein] | 23380477 |
D003042 | Cocaine | Cocaine results in increased expression of CASP9 protein | 16686379 |
D003042 | Cocaine | Cocaine affects the expression of CASP9 mRNA | 15681117 |
D003042 | Cocaine | Cocaine affects the expression of CASP9 protein | 16179556 |
D003042 | Cocaine | Cocaine results in increased activity of CASP9 protein | 10604926|1139246 |
D003042 | Cocaine | SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] | 15365088 |
C463759 | codonoposide | codonoposide results in increased activity of CASP9 protein | 15863893 |
C024989 | coenzyme Q10 | coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein] | 27087047 |
D003078 | Colchicine | Colchicine results in increased activity of CASP9 protein | 22342440 |
C036978 | concanamycin A | "concanamycin A inhibits the reaction [enterotoxin C, staphylococcal analog results in increased activity of CASP9 protein]" | 27742270 |
C036978 | concanamycin A | "concanamycin A inhibits the reaction [enterotoxin C, staphylococcal results in increased activity of CASP9 protein]" | 27742270 |
D003300 | Copper | Copper results in increased expression of CASP9 mRNA | 25461751 |
D003300 | Copper | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein | 17327230 |
D003300 | Copper | [Copper binds to Isatin binds to trimethylenediamine] which results in increased cleavage of CASP9 protein | 17327230 |
D003300 | Copper | [Disulfiram binds to Copper] which results in increased activity of CASP9 protein | 24690739 |
D003300 | Copper | [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | 22951949 |
D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in increased expression of CASP9 protein | 20931265 |
D003300 | Copper | Copper analog results in increased activity of CASP9 protein | 22000994 |
D003300 | Copper | Copper analog results in increased cleavage of CASP9 protein | 21319953 |
D003300 | Copper | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | 22085843 |
D003300 | Copper | [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein | 22085843 |
C464760 | copper-1,10-phenanthroline | "copper-1,10-phenanthroline results in increased cleavage of CASP9 protein" | 24638265 |
D019327 | Copper Sulfate | Copper Sulfate results in increased activity of CASP9 protein | 17640809 |
D019327 | Copper Sulfate | andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] | 20946909 |
D019327 | Copper Sulfate | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
D019327 | Copper Sulfate | Copper Sulfate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 28442376 |
D019327 | Copper Sulfate | Copper Sulfate results in increased activity of CASP9 protein | 20946909 |
D019327 | Copper Sulfate | Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] | 20946909 |
D019327 | Copper Sulfate | Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
C058120 | cordycepin | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] | 21310227 |
C058120 | cordycepin | cordycepin results in increased activity of CASP9 protein | 21310227|2193367 |
C058120 | cordycepin | cordycepin results in increased expression of CASP9 mRNA | 28987792 |
D003373 | Coumaric Acids | Coumaric Acids results in increased cleavage of CASP9 protein | 25824411 |
D003375 | Coumestrol | Coumestrol results in increased expression of CASP9 protein | 28986287 |
C029036 | crocin | crocin inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] | 27353299 |
C037886 | cryptotanshinone | cryptotanshinone results in increased activity of CASP9 protein | 26564229 |
C102326 | cucurbitacin E | cucurbitacin E results in increased cleavage of CASP9 protein | 27106530 |
C038106 | cucurbitacin I | cucurbitacin I results in increased cleavage of CASP9 protein | 24858077 |
C029892 | cupric chloride | cupric chloride results in increased expression of CASP9 protein | 23313662|2417044 |
C029892 | cupric chloride | [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein | 20920558 |
C029892 | cupric chloride | MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein] | 20920558 |
C029892 | cupric chloride | pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] | 20920558 |
D003474 | Curcumin | [Curcumin co-treated with arsenic trioxide] results in increased cleavage of CASP9 protein | 20605902 |
D003474 | Curcumin | [Curcumin co-treated with lonidamine] results in increased cleavage of CASP9 protein | 20605902 |
D003474 | Curcumin | [Curcumin co-treated with Sirolimus] results in increased activity of CASP9 protein | 19373661 |
D003474 | Curcumin | Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein] | 27375190 |
D003474 | Curcumin | Curcumin results in decreased expression of CASP9 mRNA | 16101141 |
D003474 | Curcumin | Curcumin results in decreased expression of CASP9 protein | 17148446 |
D003474 | Curcumin | Curcumin results in increased activity of CASP9 protein | 17671742 |
D003474 | Curcumin | Curcumin results in increased cleavage of and results in increased activity of CASP9 protein | 16023083 |
D003474 | Curcumin | Curcumin results in increased cleavage of CASP9 protein | 14555224|2159464 |
D003474 | Curcumin | Curcumin results in increased expression of CASP9 protein | 18555241 |
D003474 | Curcumin | zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein]] | 27375190 |
D003474 | Curcumin | [Curcumin co-treated with gemcitabine] results in decreased expression of CASP9 protein | 17440100 |
D003474 | Curcumin | Curcumin results in increased cleavage of and results in increased activity of CASP9 protein | 17277231 |
D003474 | Curcumin | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein] | 20869986 |
D003474 | Curcumin | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased expression of CASP9 mRNA] | 20869986 |
D003474 | Curcumin | Curcumin results in increased activity of CASP9 protein | 19095035 |
C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CASP9 protein | 23454832 |
D003513 | Cycloheximide | [Cycloheximide co-treated with TNF] results in increased activity of CASP9 protein | 12925536 |
D003513 | Cycloheximide | [Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein | 18222423 |
D003513 | Cycloheximide | ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased activity of CASP9 protein] | 12925536 |
D003513 | Cycloheximide | Cycloheximide results in increased activity of CASP9 protein | 14502240 |
D003520 | Cyclophosphamide | BCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP9 protein] | 11723234 |
D003520 | Cyclophosphamide | Cyclophosphamide results in increased cleavage of and results in increased activity of CASP9 protein | 17898787 |
D003520 | Cyclophosphamide | Cyclophosphamide results in increased activity of CASP9 protein | 11723234 |
D016572 | Cyclosporine | [Cyclosporine co-treated with NGF protein] results in increased activity of CASP9 protein | 24244623 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [brucine results in increased activity of and results in increased cleavage of CASP9 protein] | 16443926 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [[brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | 16443926 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [FAS protein results in increased activity of CASP9 protein] | 15548389 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP9 protein] | 26884717 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
D016572 | Cyclosporine | NGFR protein affects the reaction [[Cyclosporine co-treated with NGF protein] results in increased activity of CASP9 protein] | 24244623 |
D016572 | Cyclosporine | Cyclosporine results in increased cleavage of and results in increased activity of CASP9 protein | 22155090 |
C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of CASP9 mRNA | 23726867 |
C017160 | cypermethrin | cypermethrin results in increased expression of CASP9 mRNA | 21316461 |
C017160 | cypermethrin | cypermethrin results in increased expression of CASP9 mRNA | 27704156 |
C017160 | cypermethrin | cypermethrin results in increased cleavage of and results in increased activity of CASP9 protein | 22048644 |
C017160 | cypermethrin | cypermethrin results in increased expression of CASP9 mRNA | 22528246 |
C017160 | cypermethrin | HBEGF protein inhibits the reaction [cypermethrin results in increased cleavage of and results in increased activity of CASP9 protein] | 22048644 |
D003571 | Cytochalasin B | Cytochalasin B results in increased cleavage of CASP9 protein | 27640744 |
D003609 | Dactinomycin | [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 17707539 |
D003609 | Dactinomycin | Dactinomycin results in increased cleavage of CASP9 protein | 26670606 |
C004315 | danthron | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP9 protein] | 21126053 |
C004315 | danthron | danthron results in increased activity of and results in increased expression of CASP9 protein | 21126053 |
C004315 | danthron | danthron results in increased expression of CASP9 mRNA | 21126053 |
D003620 | Dantrolene | Dantrolene inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 23022152 |
C515055 | darinaparsin | darinaparsin results in increased cleavage of CASP9 protein | 25316819 |
D000069439 | Dasatinib | Dasatinib results in increased activity of CASP9 protein | 19398150 |
D000069439 | Dasatinib | Dasatinib results in increased cleavage of CASP9 protein | 18550857 |
D003630 | Daunorubicin | Daunorubicin affects the expression of CASP9 mRNA | 27780733 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of CASP9 mRNA | 23914054 |
C017180 | decamethrin | decamethrin results in increased activity of CASP9 protein | 21555338|2755367 |
C017180 | decamethrin | rosiglitazone inhibits the reaction [decamethrin results in increased activity of CASP9 protein] | 27553674 |
C017180 | decamethrin | decamethrin results in increased cleavage of CASP9 protein | 26588882 |
C014347 | decitabine | [decitabine affects the methylation of CASP9 gene] which affects the expression of CASP9 protein | 18649362|1864936 |
C014347 | decitabine | [decitabine co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 18636160 |
C014347 | decitabine | decitabine results in increased cleavage of CASP9 protein | 18636160 |
C014347 | decitabine | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] | 19732952 |
C072799 | declopramide | declopramide results in increased activity of CASP9 protein | 11953831 |
C072799 | declopramide | BCL2 protein inhibits the reaction [declopramide results in increased activity of CASP9 protein] | 11953831 |
C072799 | declopramide | declopramide results in increased activity of CASP9 protein | 11953831 |
D003676 | Deferoxamine | "Deferoxamine inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492|1476666 |
C464444 | dehydroxymethylepoxyquinomicin | dehydroxymethylepoxyquinomicin results in increased cleavage of CASP9 protein | 15501958 |
C464444 | dehydroxymethylepoxyquinomicin | pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of CASP9 protein] | 15501958 |
C100698 | demethoxyfumitremorgin C | demethoxyfumitremorgin C results in increased activity of CASP9 protein | 28359723 |
D003840 | Deoxycholic Acid | Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein] | 17644113 |
D003840 | Deoxycholic Acid | cobaltiprotoporphyrin inhibits the reaction [Deoxycholic Acid results in increased cleavage of CASP9 protein] | 21362092 |
D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased activity of CASP9 protein | 17644113 |
D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased cleavage of and results in increased activity of CASP9 protein | 19054763 |
D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased cleavage of CASP9 protein | 21362092 |
D003847 | Deoxyglucose | [Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein | 20138251 |
D003847 | Deoxyglucose | Deoxyglucose promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein] | 23041229 |
D003847 | Deoxyglucose | Deoxyglucose results in increased cleavage of and results in increased activity of CASP9 protein | 23041229 |
C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of CASP9 protein | 22269384 |
C007262 | deoxynivalenol | deoxynivalenol results in increased activity of CASP9 protein | 22269384 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CASP9 protein | 22269384 |
C007262 | deoxynivalenol | deoxynivalenol results in increased activity of and results in increased cleavage of CASP9 protein | 22491426 |
D003891 | Desipramine | Desipramine results in increased activity of CASP9 protein | 20549303 |
C040424 | destruxin B | destruxin B results in increased cleavage of and results in increased activity of CASP9 protein | 23751424 |
C040424 | destruxin B | destruxin B results in increased cleavage of CASP9 protein | 24434019 |
D003907 | Dexamethasone | Dexamethasone results in increased activity of CASP9 protein | 11734450|1557475 |
D003907 | Dexamethasone | Dexamethasone results in increased cleavage of CASP9 protein | 16445836 |
D003907 | Dexamethasone | isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP9 protein] | 15574755 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of CASP9 mRNA | 15944155 |
D003907 | Dexamethasone | Dexamethasone results in increased activity of CASP9 protein | 11399061 |
D003907 | Dexamethasone | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein] | 11399061 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP9 protein] | 15388240 |
D020927 | Dexmedetomidine | Dexmedetomidine results in increased activity of CASP9 protein | 18724006 |
D064730 | Dexrazoxane | Dexrazoxane results in decreased expression of CASP9 mRNA | 26873546 |
C028009 | diallyl disulfide | diallyl disulfide results in increased activity of CASP9 protein | 14522920|1764724 |
C042577 | diallyl trisulfide | Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP9 protein] | 22578287 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased activity of CASP9 protein | 22595511 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased cleavage of CASP9 protein | 20055834|2257828 |
C042577 | diallyl trisulfide | [diallyl trisulfide results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP9 protein | 28571773 |
D016190 | Carboplatin | Carboplatin results in decreased expression of CASP9 mRNA | 15576332|1740401 |
D016190 | Carboplatin | Carboplatin results in increased activity of CASP9 protein | 15996812 |
D016190 | Carboplatin | Carboplatin results in increased expression of CASP9 protein | 18483861 |
D016190 | Carboplatin | Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | 18483861 |
D016190 | Carboplatin | Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | 18483861 |
D003976 | Diazinon | Diazinon results in increased activity of CASP9 protein | 27920530 |
D003976 | Diazinon | Diazinon results in increased expression of CASP9 mRNA | 27920530 |
D003976 | Diazinon | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP9 protein] | 27920530 |
D003976 | Diazinon | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA] | 27920530 |
D003976 | Diazinon | Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]] | 27920530 |
D003976 | Diazinon | crocin inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] | 27353299 |
D003976 | Diazinon | Diazinon affects the expression of CASP9 mRNA | 17452286 |
D003976 | Diazinon | Diazinon results in increased cleavage of CASP9 protein | 27353299 |
D003976 | Diazinon | Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] | 27353299 |
C061481 | dibenzoylmethane | ODC1 protein inhibits the reaction [dibenzoylmethane results in increased activity of CASP9 protein] | 21523861 |
C542282 | dibutyldi(4-chlorobenzohydroxamato)tin(IV) | dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in increased cleavage of CASP9 protein | 23041257 |
C542282 | dibutyldi(4-chlorobenzohydroxamato)tin(IV) | dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in increased expression of CASP9 mRNA | 23041257 |
C100106 | dicarbine | dicarbine inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 17481927 |
D015101 | 3,3'-Dichlorobenzidine | "3,3'-Dichlorobenzidine results in increased activity of CASP9 protein" | 24604609 |
D002945 | Cisplatin | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein | 21442130 |
D002945 | Cisplatin | ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 22269388 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | 17574045 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21166495 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 15496615 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein] | 25940438 |
D002945 | Cisplatin | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 23747833 |
D002945 | Cisplatin | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
D002945 | Cisplatin | [andrographolide co-treated with Cisplatin] results in increased expression of CASP9 mRNA | 24563380 |
D002945 | Cisplatin | BCL2 inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21618512 |
D002945 | Cisplatin | BCL2 protein inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | 17574045 |
D002945 | Cisplatin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | 17574045 |
D002945 | Cisplatin | beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 17619073 |
D002945 | Cisplatin | BMI1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21311599 |
D002945 | Cisplatin | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein" | 21214929 |
D002945 | Cisplatin | [Cisplatin co-treated with chrysin] results in increased cleavage of CASP9 protein | 25770930 |
D002945 | Cisplatin | [Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein | 18676776 |
D002945 | Cisplatin | [Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein | 17574045 |
D002945 | Cisplatin | [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein] | 21216935 |
D002945 | Cisplatin | [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP9 protein | 21216935 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CASP9 mRNA | 17404015 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP9 protein | 12565868|1472753 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of and results in increased activity of CASP9 protein | 22285227 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of CASP9 protein | 15496615|1805880 |
D002945 | Cisplatin | Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein | 20674069 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP9 mRNA | 24563380 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP9 protein | 16803524 |
D002945 | Cisplatin | CXCL2 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 21271225 |
D002945 | Cisplatin | [Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein | 20138251 |
D002945 | Cisplatin | DICER1 mutant form inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25940438 |
D002945 | Cisplatin | EGR1 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 21271225 |
D002945 | Cisplatin | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein | 16803524 |
D002945 | Cisplatin | [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP9 protein | 16803524 |
D002945 | Cisplatin | [GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 23747833 |
D002945 | Cisplatin | ING4 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | 21052098 |
D002945 | Cisplatin | MIR630 mRNA inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 20145152 |
D002945 | Cisplatin | MYC protein promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21324178 |
D002945 | Cisplatin | Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] | 18676776 |
D002945 | Cisplatin | Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein] | 20674069 |
D002945 | Cisplatin | oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
D002945 | Cisplatin | PRDX6 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21166495 |
D002945 | Cisplatin | Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 23482746 |
D002945 | Cisplatin | [Quercetin co-treated with Cisplatin] results in increased activity of CASP9 protein | 27514524 |
D002945 | Cisplatin | Quercetin promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25611565 |
D002945 | Cisplatin | [S100A11 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein | 25940438 |
D002945 | Cisplatin | [Sirolimus co-treated with Cisplatin] results in increased activity of CASP9 protein | 20138251 |
D002945 | Cisplatin | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 18058806 |
D002945 | Cisplatin | SMG1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21418860 |
D002945 | Cisplatin | SND1 mutant form promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25940438 |
D002945 | Cisplatin | [SND1 mutant form results in increased susceptibility to Cisplatin] which results in increased cleavage of CASP9 protein | 25940438 |
D002945 | Cisplatin | tauroursodeoxycholic acid inhibits the reaction [Quercetin promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 25611565 |
D002945 | Cisplatin | [TNFSF10 protein co-treated with Cisplatin] results in increased activity of CASP9 protein | 21252285 |
D002945 | Cisplatin | Tretinoin promotes the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
D002945 | Cisplatin | TYMP inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 14727531 |
D002945 | Cisplatin | TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 12565868 |
D002945 | Cisplatin | ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 22269388 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21616140 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 21616140 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP9 protein | 21526214|2226938 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of CASP9 protein | 21616140 |
D002945 | Cisplatin | rosemarinic acid inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21526214 |
D002945 | Cisplatin | salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21616140 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of CASP9 protein | 25184746 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP9 protein | 21525749 |
D002945 | Cisplatin | fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25184746 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP9 protein | 20435919 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP9 | 12712633 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein | 19545618 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein | 24576310 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased expression of CASP9 mRNA | 21384494|2457631 |
D003633 | Dichlorodiphenyl Dichloroethylene | [Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of CASP9 mRNA | 19175174 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased expression of CASP9 mRNA | 19175174 |
D004006 | Dichlorvos | [Amitrole co-treated with Ditiocarb] promotes the reaction [Dichlorvos results in increased activity of CASP9 protein] | 17640809 |
D004006 | Dichlorvos | Dichlorvos results in increased activity of CASP9 protein | 17640809 |
D004006 | Dichlorvos | Quercetin promotes the reaction [Dichlorvos results in increased activity of CASP9 protein] | 17640809 |
D004006 | Dichlorvos | Dichlorvos results in increased activity of CASP9 protein | 16973328 |
D004006 | Dichlorvos | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] | 16973328 |
D004008 | Diclofenac | Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP9 protein] | 27313093 |
D004008 | Diclofenac | Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein] | 27313093 |
D004008 | Diclofenac | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP9 protein] | 27313093 |
D004008 | Diclofenac | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein] | 27313093 |
D004008 | Diclofenac | Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | 16388830 |
D004008 | Diclofenac | Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] | 16388830 |
D004008 | Diclofenac | Diclofenac results in increased activity of CASP9 protein | 27313093 |
D004008 | Diclofenac | [TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein | 27313093 |
D004008 | Diclofenac | Diclofenac results in increased activity of CASP9 protein | 14609740|2501487 |
C499970 | dideoxypetrosynol A | dideoxypetrosynol A results in increased activity of CASP9 protein | 15547680 |
C552234 | didymin | didymin results in increased activity of CASP9 protein | 27899290 |
C552234 | didymin | locostatin inhibits the reaction [didymin results in increased activity of CASP9 protein] | 27899290 |
D004026 | Dieldrin | Dieldrin affects the expression of CASP9 mRNA | 23041725 |
D004026 | Dieldrin | Dieldrin results in increased activity of CASP9 protein | 12831855 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CASP9 mRNA | 15238619 |
D004041 | Dietary Fats | [Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA | 28916335 |
D004041 | Dietary Fats | [Fructose co-treated with Dietary Fats] results in increased expression of CASP9 protein | 28916335 |
D004041 | Dietary Fats | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA] | 28916335 |
D004041 | Dietary Fats | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 protein] | 28916335 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased activity of CASP9 protein | 22155658 |
C014476 | diethyl maleate | diethyl maleate results in increased expression of CASP9 mRNA | 11875189 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CASP9 mRNA | 18691550 |
D004052 | Diethylnitrosamine | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP9 mRNA] | 18691550 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA | 23830814 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CASP9 protein | 19931519 |
D004052 | Diethylnitrosamine | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP9 mRNA | 27048571 |
D004052 | Diethylnitrosamine | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein | 21907755 |
D004052 | Diethylnitrosamine | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA | 21907755 |
D004052 | Diethylnitrosamine | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein] | 21907755 |
D004052 | Diethylnitrosamine | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA] | 21907755 |
D004052 | Diethylnitrosamine | morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] | 19931519 |
D004074 | Digitoxin | Digitoxin analog results in increased cleavage of CASP9 protein | 22037315 |
D004074 | Digitoxin | Digitoxin results in increased cleavage of CASP9 protein | 22037315 |
C109343 | dihydroceramide | dihydroceramide metabolite results in increased cleavage of CASP9 protein | 17586710 |
C015144 | dihydrolipoic acid | "2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide inhibits the reaction [dihydrolipoic acid results in increased activity of CASP9 protein]" | 21462292 |
C015144 | dihydrolipoic acid | dihydrolipoic acid results in increased activity of CASP9 protein | 21462292 |
C472036 | dihydromyricetin | Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
C472036 | dihydromyricetin | dihydromyricetin results in increased cleavage of CASP9 protein | 27539140 |
C472036 | dihydromyricetin | pyrazolanthrone promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
C472036 | dihydromyricetin | U 0126 promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
C501843 | dihydrosanguinarine | dihydrosanguinarine results in increased activity of CASP9 protein | 19346183 |
D002117 | Calcitriol | [Calcitriol co-treated with gemcitabine] results in increased expression of CASP9 protein | 20699664 |
D017878 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | "4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 14766669 |
D017878 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | "4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [quinocetone results in increased cleavage of CASP9 protein]" | 28343033 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein" | 21294050 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 21294050 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D019813 | 1,2-Dimethylhydrazine | "1,2-Dimethylhydrazine results in decreased expression of CASP9 protein" | 29108773 |
D019813 | 1,2-Dimethylhydrazine | "asiatic acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP9 protein]" | 29108773 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased expression of CASP9 mRNA | 28219650 |
C019357 | dioscin | dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 24146112 |
C019357 | dioscin | dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 24146112 |
D004144 | Diosgenin | Diosgenin inhibits the reaction [Calcium Oxalate results in increased activity of CASP9 protein] | 25446497 |
D004145 | Diosmin | Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein] | 23665045 |
D004147 | Dioxins | Dioxins affects the expression of CASP9 mRNA | 20463971 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] | 26282491 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein] | 26282491 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein] | 26282491 |
C453079 | dipropylenetriamine-NONOate | dipropylenetriamine-NONOate inhibits the reaction [chromium hexavalent ion results in increased activity of CASP9 protein] | 19556603 |
C453079 | dipropylenetriamine-NONOate | dipropylenetriamine-NONOate inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 19556603 |
D004178 | Diquat | Diquat results in increased cleavage of and results in increased activity of CASP9 protein | 18164269 |
D004178 | Diquat | Diquat results in increased cleavage of CASP9 protein | 20826540 |
D004178 | Diquat | PROP1 protein affects the reaction [Diquat results in increased cleavage of CASP9 protein] | 20826540 |
D004178 | Diquat | TXN2 protein affects the reaction [Diquat results in increased cleavage of and results in increased activity of CASP9 protein] | 18164269 |
D004221 | Disulfiram | [Disulfiram binds to Copper] which results in increased activity of CASP9 protein | 24690739 |
D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] | 11226294 |
D004050 | Ditiocarb | [Amitrole co-treated with Ditiocarb] promotes the reaction [Dichlorvos results in increased activity of CASP9 protein] | 17640809 |
D004050 | Ditiocarb | [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | 22951949 |
D016291 | Dizocilpine Maleate | Dizocilpine Maleate results in increased activity of CASP9 protein | 19759125 |
C558638 | DLBS 1425 | DLBS 1425 results in increased activity of CASP9 protein | 20703095 |
C558638 | DLBS 1425 | DLBS 1425 results in increased cleavage of CASP9 protein | 20703095 |
C521792 | DMU-212 | DMU-212 results in increased activity of CASP9 protein | 24055891 |
C521792 | DMU-212 | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP9 mRNA | 27048571 |
C521792 | DMU-212 | DMU-212 results in decreased expression of CASP9 mRNA | 27048571 |
C067311 | docetaxel | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein] | 17308071 |
C067311 | docetaxel | Celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
C067311 | docetaxel | docetaxel promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
C067311 | docetaxel | docetaxel results in increased cleavage of and results in increased activity of CASP9 protein | 15688368|1730807 |
D004281 | Docosahexaenoic Acids | [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA | 19015929 |
C076946 | donepezil | donepezil results in increased activity of CASP9 protein | 20522977 |
D004317 | Doxorubicin | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18594523 |
D004317 | Doxorubicin | [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [SOD2 protein affects the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 18594523 |
D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 20856197 |
D004317 | Doxorubicin | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 17285121 |
D004317 | Doxorubicin | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein] | 17339365 |
D004317 | Doxorubicin | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein] | 17339365 |
D004317 | Doxorubicin | BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
D004317 | Doxorubicin | BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
D004317 | Doxorubicin | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin] | 18594523 |
D004317 | Doxorubicin | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Doxorubicin | 18594523 |
D004317 | Doxorubicin | CASP3 protein promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 17013758 |
D004317 | Doxorubicin | CASP9 protein mutant form inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin] | 20884855 |
D004317 | Doxorubicin | Doxorubicin affects the activity of CASP9 protein | 15870702 |
D004317 | Doxorubicin | Doxorubicin affects the expression of CASP9 mRNA | 16705698|2778073 |
D004317 | Doxorubicin | Doxorubicin analog results in increased activity of CASP9 protein | 15981920 |
D004317 | Doxorubicin | [Doxorubicin binds to TF protein] which results in increased activity of CASP9 protein | 24998637 |
D004317 | Doxorubicin | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein" | 21214929 |
D004317 | Doxorubicin | [Doxorubicin co-treated with FAS protein] results in increased activity of CASP9 protein | 15958570 |
D004317 | Doxorubicin | [Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein | 17339365 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein | 16168113 |
D004317 | Doxorubicin | [Doxorubicin co-treated with resveratrol] results in increased expression of CASP9 mRNA | 26969377 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein | 17339365 |
D004317 | Doxorubicin | Doxorubicin results in decreased expression of CASP9 mRNA | 17404015 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP9 protein | 11779855|1586892 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | 16024631|1636492 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of CASP9 protein | 15555623|1555779 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP9 mRNA | 15576332|1593950 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP9 protein | 25339540 |
D004317 | Doxorubicin | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein] | 16168113 |
D004317 | Doxorubicin | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 16311509 |
D004317 | Doxorubicin | [Indomethacin results in increased activity of CASP9 protein] which results in increased susceptibility to Doxorubicin | 15812552 |
D004317 | Doxorubicin | LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein] | 18508926 |
D004317 | Doxorubicin | MT3 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 19767621 |
D004317 | Doxorubicin | PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 20856197 |
D004317 | Doxorubicin | pluronic block copolymer p85 promotes the reaction [Doxorubicin results in increased expression of CASP9 mRNA] | 15939500 |
D004317 | Doxorubicin | PRKDC protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein] | 18508926 |
D004317 | Doxorubicin | Sildenafil Citrate promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] | 20884855 |
D004317 | Doxorubicin | SOD2 protein affects the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18594523 |
D004317 | Doxorubicin | TMSB4X protein inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 16364925 |
D004317 | Doxorubicin | TNFRSF10A protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein] | 17437844 |
D004317 | Doxorubicin | TP53 protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
D004317 | Doxorubicin | TP53 protein promotes the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
D004317 | Doxorubicin | Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] | 29141199 |
D004317 | Doxorubicin | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 17935137 |
D004317 | Doxorubicin | "5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) inhibits the reaction [Doxorubicin results in increased expression of CASP9 mRNA]" | 19286953 |
D004317 | Doxorubicin | dicarbine inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 17481927 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP9 protein | 16018998|1748192 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP9 mRNA | 19286953 |
D004317 | Doxorubicin | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of CASP9 mRNA] | 19286953 |
D004317 | Doxorubicin | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein | 19789217 |
D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | 19801490 |
D004317 | Doxorubicin | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 17285121 |
D004317 | Doxorubicin | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D004317 | Doxorubicin | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
D004317 | Doxorubicin | coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein] | 27087047 |
D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA] | 29133031 |
D004317 | Doxorubicin | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP9 protein | 15799720|1635736 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | 16687611|1728512 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of CASP9 protein | 18775851 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP9 protein | 27087047 |
D004317 | Doxorubicin | [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D004317 | Doxorubicin | hispidin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 26318906 |
D004317 | Doxorubicin | NOL3 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 19139834 |
D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 19801490 |
D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 16357363 |
D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 16687611 |
D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18775851 |
D004317 | Doxorubicin | U 0126 inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18775851 |
C060327 | dracorhodin | dracorhodin analog results in increased activity of CASP9 protein | 15215653 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased activity of CASP9 protein" | 15456542|1580253 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of and results in increased activity of CASP9 protein" | 23239598|2331583 |
D004365 | Drugs, Chinese Herbal | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in increased expression of CASP9 protein modified form]" | 28587418 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in increased expression of CASP9 protein modified form]" | 28587418 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CASP9 protein modified form" | 28587418 |
C042986 | ebselen | ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] | 23649643 |
C042986 | ebselen | ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | 18629305 |
C022999 | echinocystic acid | echinocystic acid analog results in increased activity of CASP9 protein | 15863893 |
D004610 | Ellagic Acid | Ellagic Acid results in increased expression of and results in increased activity of CASP9 protein | 23554011 |
C034192 | ellipticine | ellipticine results in increased activity of CASP9 protein | 16027529 |
C034192 | ellipticine | ellipticine results in increased cleavage of and results in increased activity of CASP9 protein | 21843585 |
D004640 | Emetine | Emetine results in increased activity of CASP9 protein | 14502240 |
D004656 | Enalapril | Enalapril results in decreased activity of CASP9 protein | 21153712 |
D004726 | Endosulfan | Endosulfan results in increased expression of CASP9 mRNA | 19874912 |
C530049 | ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate | "ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate results in increased cleavage of CASP9 protein" | 19509257 |
C034959 | enterotoxin C, staphylococcal | "concanamycin A inhibits the reaction [enterotoxin C, staphylococcal analog results in increased activity of CASP9 protein]" | 27742270 |
C034959 | enterotoxin C, staphylococcal | "concanamycin A inhibits the reaction [enterotoxin C, staphylococcal results in increased activity of CASP9 protein]" | 27742270 |
C034959 | enterotoxin C, staphylococcal | "enterotoxin C, staphylococcal analog results in increased activity of CASP9 protein" | 27742270 |
C034959 | enterotoxin C, staphylococcal | "enterotoxin C, staphylococcal results in increased activity of CASP9 protein" | 27742270 |
D004785 | Environmental Pollutants | Environmental Pollutants results in increased expression of CASP9 mRNA | 19118595 |
D015251 | Epirubicin | "3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA]" | 22914566 |
D015251 | Epirubicin | chrysophsin promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA] | 26335193 |
D015251 | Epirubicin | [Epirubicin analog co-treated with chrysophsin analog] results in increased expression of CASP9 mRNA | 26335193 |
D015251 | Epirubicin | "Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein]" | 22914566 |
D015251 | Epirubicin | "Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA]" | 22914566 |
D015251 | Epirubicin | Epirubicin promotes the reaction [chrysophsin results in increased expression of CASP9 mRNA] | 26335193 |
D015251 | Epirubicin | Epirubicin promotes the reaction [formononetin results in increased activity of CASP9 protein] | 23867903 |
D015251 | Epirubicin | Epirubicin promotes the reaction [formononetin results in increased expression of CASP9 mRNA] | 23867903 |
D015251 | Epirubicin | Epirubicin results in increased activity of CASP9 protein | 23867903 |
D015251 | Epirubicin | Epirubicin results in increased expression of CASP9 mRNA | 22914566|2386790 |
D015251 | Epirubicin | formononetin promotes the reaction [Epirubicin results in increased activity of CASP9 protein] | 23867903 |
D015251 | Epirubicin | formononetin promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA] | 23867903 |
C045651 | epigallocatechin gallate | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP9 protein]] | 26375285 |
C045651 | epigallocatechin gallate | epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP9 protein] | 26375285 |
C045651 | epigallocatechin gallate | epigallocatechin gallate affects the activity of CASP9 protein | 23954321 |
C045651 | epigallocatechin gallate | epigallocatechin gallate analog results in increased cleavage of CASP9 protein | 16115949 |
C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP9 protein] | 23665936 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased activity of CASP9 protein | 15764647 |
D060754 | Equol | Equol results in increased cleavage of CASP9 protein | 18973749 |
C472787 | erucylphospho-N,N,N-trimethylpropylammonium | "erucylphospho-N,N,N-trimethylpropylammonium results in increased cleavage of and results in increased activity of CASP9 protein" | 20177898 |
C007366 | erythritol anhydride | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [erythritol anhydride results in increased activity of CASP9 protein] | 14998682 |
C007366 | erythritol anhydride | erythritol anhydride results in increased activity of CASP9 protein | 14998682 |
C007628 | esculetin | esculetin results in increased activity of CASP9 protein | 24995577|2638840 |
C007628 | esculetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein] | 19786087 |
C007628 | esculetin | [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein | 19786087 |
C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein | 24316378 |
C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in increased expression of CASP9 mRNA | 24316378 |
C074283 | estradiol 3-benzoate | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein] | 24316378 |
C074283 | estradiol 3-benzoate | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP9 mRNA] | 24316378 |
D004976 | Ethacrynic Acid | arsenic trioxide promotes the reaction [Ethacrynic Acid results in increased cleavage of CASP9 protein] | 23082001 |
D004976 | Ethacrynic Acid | Ethacrynic Acid results in increased cleavage of CASP9 protein | 23082001 |
D004976 | Ethacrynic Acid | GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein] | 23082001 |
D004976 | Ethacrynic Acid | MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein] | 23082001 |
D000431 | Ethanol | dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 24146112 |
D000431 | Ethanol | Ethanol results in increased expression of CASP9 protein | 24146112 |
D000431 | Ethanol | caraway oil inhibits the reaction [Ethanol results in increased cleavage of CASP9 protein] | 25859307 |
D000431 | Ethanol | dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 24146112 |
D000431 | Ethanol | Ethanol results in increased activity of CASP9 protein | 25289771 |
D000431 | Ethanol | Ethanol results in increased cleavage of CASP9 protein | 25859307|2908558 |
D000431 | Ethanol | Ethanol results in increased expression of CASP9 mRNA | 23273579 |
D000431 | Ethanol | Ethanol results in increased expression of CASP9 protein | 24146112|2844237 |
D000431 | Ethanol | nymphayol inhibits the reaction [Ethanol results in increased activity of CASP9 protein] | 25289771 |
D000431 | Ethanol | thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP9 protein] | 29085585 |
D000431 | Ethanol | zingerone inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 28442378 |
D004997 | Ethinyl Estradiol | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA | 15451339 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of CASP9 protein | 15634644 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in increased activity of CASP9 protein | 15953346 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein] | 19786087 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein | 19786087 |
C004912 | ethylbenzene | ethylbenzene results in increased expression of CASP9 mRNA | 21241565|2551899 |
C004912 | ethylbenzene | ethylbenzene results in increased expression of CASP9 protein | 20137408|2015683 |
D017308 | Etodolac | Etodolac results in increased activity of CASP9 protein | 16046235|1610487 |
D005047 | Etoposide | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | 21801448 |
D005047 | Etoposide | CASP8 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP9 protein] | 21801448 |
D005047 | Etoposide | CASP9 mutant form inhibits the reaction [Etoposide results in increased cleavage of BID protein] | 21801448 |
D005047 | Etoposide | [Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein | 18676776 |
D005047 | Etoposide | Etoposide affects the expression of CASP9 protein | 15215046 |
D005047 | Etoposide | Etoposide results in increased activity of CASP9 protein | 18056177 |
D005047 | Etoposide | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | 16364925|2174546 |
D005047 | Etoposide | Etoposide results in increased cleavage of CASP9 protein | 12925536|1793513 |
D005047 | Etoposide | HTATIP2 protein promotes the reaction [Etoposide results in increased activity of CASP9 protein] | 16799960 |
D005047 | Etoposide | MYC protein promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] | 21324178 |
D005047 | Etoposide | Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] | 18676776 |
D005047 | Etoposide | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | 21745461 |
D005047 | Etoposide | TMSB4X protein inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | 16364925 |
D005047 | Etoposide | wortmannin promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] | 17935137 |
D005054 | Eugenol | Eugenol results in increased activity of CASP9 protein | 25455450 |
D005054 | Eugenol | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] | 20434464 |
C433928 | EUK-134 | EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein] | 21647434 |
C433928 | EUK-134 | EUK-134 inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 25005833 |
C433928 | EUK-134 | EUK-134 inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] | 25005833 |
D015025 | Zearalenone | Zearalenone results in increased activity of CASP9 protein | 24530352 |
C020326 | ferric nitrilotriacetate | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein | 21907755 |
C020326 | ferric nitrilotriacetate | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA | 21907755 |
C020326 | ferric nitrilotriacetate | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein] | 21907755 |
C020326 | ferric nitrilotriacetate | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA] | 21907755 |
C082360 | fipronil | fipronil results in increased activity of CASP9 protein | 22421270 |
C017875 | fisetin | [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein] | 21216935 |
C017875 | fisetin | [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP9 protein | 21216935 |
C017875 | fisetin | fisetin promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein] | 21216935 |
C017875 | fisetin | fisetin results in increased activity of CASP9 protein | 28181380 |
C017875 | fisetin | fisetin results in increased cleavage of and results in increased activity of CASP9 protein | 21216935 |
C017875 | fisetin | fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25184746 |
D005411 | Flame Retardants | Flame Retardants results in increased activity of CASP9 protein | 19356805 |
D005411 | Flame Retardants | Flame Retardants results in increased expression of CASP9 mRNA | 19356805 |
C028610 | flavanone | flavanone results in increased cleavage of and results in increased activity of CASP9 protein | 22056764 |
D047309 | Flavones | Flavones analog results in increased activity of CASP9 protein | 20674374 |
D005419 | Flavonoids | Flavonoids results in increased activity of CASP9 protein | 24036141 |
D005419 | Flavonoids | Flavonoids results in increased activity of CASP9 protein | 24036141 |
D005419 | Flavonoids | Flavonoids results in decreased expression of CASP9 mRNA | 18035473 |
D044948 | Flavonols | Flavonols results in increased activity of and results in increased cleavage of CASP9 protein | 28235426 |
C548902 | FLLL 32 | FLLL 32 results in increased activity of CASP9 protein | 20576164 |
C024352 | fludarabine | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP9 protein | 15850772 |
C024352 | fludarabine | BCL2 affects the reaction [fludarabine results in increased cleavage of and results in increased activity of CASP9 protein] | 15516989 |
C024352 | fludarabine | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein | 20933509 |
C024352 | fludarabine | fludarabine results in increased cleavage of and results in increased activity of CASP9 protein | 15516989 |
C024352 | fludarabine | [LAQ824 co-treated with fludarabine] results in increased activity of CASP9 protein | 18852132 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased activity of CASP9 protein | 23665045 |
D015073 | 2-Acetylaminofluorene | Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein] | 23665045 |
D005459 | Fluorides | Fluorides results in increased expression of CASP9 mRNA | 28158927 |
D005472 | Fluorouracil | Cadmium Chloride promotes the reaction [Fluorouracil results in decreased expression of CASP9 mRNA] | 23941782 |
D005472 | Fluorouracil | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]] | 19097688 |
D005472 | Fluorouracil | [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA | 19015929 |
D005472 | Fluorouracil | FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein] | 17056233 |
D005472 | Fluorouracil | [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9 | 19928967 |
D005472 | Fluorouracil | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein | 16803524 |
D005472 | Fluorouracil | [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP9 protein | 16803524 |
D005472 | Fluorouracil | Fluorouracil inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 23941782 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form] | 19928967 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein] | 19097688 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | 22963400 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein] | 16168113 |
D005472 | Fluorouracil | Fluorouracil results in decreased expression of CASP9 mRNA | 23941782 |
D005472 | Fluorouracil | Fluorouracil results in increased activity of CASP9 protein | 10779637|1241466 |
D005472 | Fluorouracil | Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein | 15546879 |
D005472 | Fluorouracil | Fluorouracil results in increased cleavage of CASP9 protein | 17498489|1981694 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of CASP9 protein | 16803524 |
D005472 | Fluorouracil | IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] | 17016659 |
D005472 | Fluorouracil | "N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]" | 15546879 |
D005472 | Fluorouracil | PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] | 12414664 |
D005472 | Fluorouracil | RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] | 16407826 |
D005472 | Fluorouracil | TP53 protein inhibits the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein] | 15546879 |
D005472 | Fluorouracil | "TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]]" | 15546879 |
D005472 | Fluorouracil | Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] | 28025107 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] | 28025107 |
D005472 | Fluorouracil | Fluorouracil results in increased activity of CASP9 protein | 28025107 |
D005473 | Fluoxetine | Fluoxetine results in increased activity of CASP9 protein | 28482088 |
D005485 | Flutamide | CBL protein affects the reaction [Flutamide results in increased activity of CASP9 protein] | 16301331 |
D005485 | Flutamide | Flutamide results in increased activity of CASP9 protein | 16301331 |
D005557 | Formaldehyde | Formaldehyde results in increased activity of CASP9 protein | 20347000 |
D005557 | Formaldehyde | PRDX2 protein inhibits the reaction [Formaldehyde results in increased activity of CASP9 protein] | 20347000 |
C007768 | formononetin | Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA] | 23867903 |
C007768 | formononetin | Epirubicin promotes the reaction [formononetin results in increased activity of CASP9 protein] | 23867903 |
C007768 | formononetin | Epirubicin promotes the reaction [formononetin results in increased expression of CASP9 mRNA] | 23867903 |
C007768 | formononetin | formononetin promotes the reaction [Epirubicin results in increased activity of CASP9 protein] | 23867903 |
C007768 | formononetin | formononetin promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA] | 23867903 |
C007768 | formononetin | formononetin results in increased activity of CASP9 protein | 23867903 |
C007768 | formononetin | formononetin results in increased expression of CASP9 mRNA | 23867903 |
C067584 | formosanin C | formosanin C results in increased expression of CASP9 protein | 27180204 |
D009240 | N-Formylmethionine Leucyl-Phenylalanine | Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein] | 20130848 |
D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein | 20130848 |
C058728 | fosbretabulin | fosbretabulin analog results in increased cleavage of CASP9 protein | 25529822 |
C105671 | fraxetin | fraxetin results in decreased activity of CASP9 protein | 15996779 |
D005620 | Freund's Adjuvant | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CASP9 mRNA | 12400877 |
D005632 | Fructose | [Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA | 28916335 |
D005632 | Fructose | [Fructose co-treated with Dietary Fats] results in increased expression of CASP9 protein | 28916335 |
D005632 | Fructose | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA] | 28916335 |
D005632 | Fructose | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 protein] | 28916335 |
C039281 | furan | furan results in increased expression of CASP9 mRNA | 20562052 |
D005665 | Furosemide | Furosemide affects the expression of CASP9 mRNA | 17497460 |
C002469 | fusarenon-X | fusarenon-X results in increased expression of CASP9 mRNA | 24983900 |
C000600490 | G226 compound | G226 compound results in increased activity of CASP9 protein | 25066322 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein | 20558151 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form | 20558151 |
D005688 | Galactosamine | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein] | 20558151 |
D005688 | Galactosamine | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form] | 20558151 |
D005688 | Galactosamine | "[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP9 protein" | 24830863 |
D005688 | Galactosamine | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP9 protein]" | 24830863 |
D005688 | Galactosamine | Galactosamine results in increased expression of CASP9 protein | 22118634 |
D005688 | Galactosamine | mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] | 22118634 |
D005690 | Galactose | [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D005707 | Gallic Acid | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Gallic Acid results in increased cleavage of CASP9 protein]" | 27060209 |
D005707 | Gallic Acid | Gallic Acid results in increased cleavage of CASP9 protein | 27060209 |
C052659 | gambogic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein] | 24291039 |
C052659 | gambogic acid | [gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein | 24291039 |
C052659 | gambogic acid | gambogic acid results in decreased expression of CASP9 protein alternative form | 19464570 |
C052659 | gambogic acid | [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP9 protein | 24373880 |
C025473 | gamma-sitosterol | gamma-sitosterol results in increased activity of CASP9 protein | 14612938 |
D024504 | gamma-Tocopherol | gamma-Tocopherol results in increased activity of CASP9 protein | 15596715 |
C556862 | ganoderic acid | Acetylcysteine inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] | 26282491 |
C556862 | ganoderic acid | CAT protein inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] | 26282491 |
C556862 | ganoderic acid | diphenyleneiodonium inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] | 26282491 |
C556862 | ganoderic acid | ganoderic acid analog results in increased activity of CASP9 protein | 26282491 |
C550530 | ganoderic acid T | Acetylcysteine inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | Acetylcysteine inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | CAT protein inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | CAT protein inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | diphenyleneiodonium inhibits the reaction [ganoderic acid T analog results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | diphenyleneiodonium inhibits the reaction [ganoderic acid T results in increased activity of CASP9 protein] | 26282491 |
C550530 | ganoderic acid T | ganoderic acid T analog results in increased activity of CASP9 protein | 26282491 |
C550530 | ganoderic acid T | ganoderic acid T results in increased activity of CASP9 protein | 26282491 |
C054597 | garcinol | garcinol results in increased cleavage of CASP9 protein | 16052481 |
C000591222 | gardenin B | gardenin B results in increased cleavage of and results in increased activity of CASP9 protein | 27423764 |
C045345 | gastrodin | gastrodin affects the activity of CASP9 protein | 23578476 |
C106014 | gedunin | gedunin results in increased activity of CASP9 protein | 21381696 |
C001277 | geldanamycin | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 16311509 |
C056507 | gemcitabine | [Calcitriol co-treated with gemcitabine] results in increased expression of CASP9 protein | 20699664 |
C056507 | gemcitabine | gemcitabine results in increased activity of CASP9 protein | 12479703|1547674 |
C056507 | gemcitabine | gemcitabine results in increased cleavage of CASP9 protein | 15726400 |
C056507 | gemcitabine | Quercetin promotes the reaction [gemcitabine results in increased activity of CASP9 protein] | 26050647 |
C056507 | gemcitabine | SMG1 protein inhibits the reaction [gemcitabine results in increased activity of CASP9 protein] | 21418860 |
C056507 | gemcitabine | [Curcumin co-treated with gemcitabine] results in decreased expression of CASP9 protein | 17440100 |
D019833 | Genistein | [Genistein co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 19497411 |
D019833 | Genistein | Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | 19959636 |
D019833 | Genistein | Genistein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 20219070 |
D019833 | Genistein | Genistein results in increased activity of CASP9 protein | 20219070 |
D019833 | Genistein | Genistein results in increased cleavage of CASP9 protein | 24299158 |
D019833 | Genistein | bisphenol A promotes the reaction [Genistein results in increased cleavage of CASP9 protein] | 24884420 |
D019833 | Genistein | Genistein results in increased cleavage of CASP9 protein | 24884420 |
D005839 | Gentamicins | cobaltous chloride inhibits the reaction [Gentamicins results in increased cleavage of CASP9 protein] | 23145036 |
D005839 | Gentamicins | Gentamicins results in increased cleavage of CASP9 protein | 23145036 |
D005839 | Gentamicins | Gentamicins results in increased activity of CASP9 protein | 17132701 |
D005839 | Gentamicins | Gentamicins results in increased cleavage of and results in increased activity of CASP9 protein | 18842672 |
D005839 | Gentamicins | tetramethylpyrazine inhibits the reaction [Gentamicins results in increased activity of CASP9 protein] | 17132701 |
C012997 | gentiopicroside | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein] | 20558151 |
C012997 | gentiopicroside | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form] | 20558151 |
C007836 | geraniol | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA]" | 24768735 |
C007836 | geraniol | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein]" | 24768735 |
C007836 | geraniol | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein] | 21907755 |
C007836 | geraniol | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP9 mRNA] | 21907755 |
C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | 18030663 |
C007845 | gingerol | gingerol results in increased cleavage of CASP9 protein | 28249781 |
C007845 | gingerol | gingerol results in increased expression of CASP9 mRNA | 19481070 |
C007845 | gingerol | gingerol results in increased expression of CASP9 protein | 18030663|1948107 |
C007845 | gingerol | gingerol affects the activity of CASP9 protein | 17454143 |
C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | 18030663 |
C097367 | ginsenoside Rg3 | "ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in decreased cleavage of CASP9 protein]" | 26427350 |
C055124 | glaucocalyxin A | glaucocalyxin A results in increased activity of CASP9 protein | 20851175 |
D005947 | Glucose | [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein | 17309078 |
D005947 | Glucose | [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein | 17309078 |
D005947 | Glucose | [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein | 17309078 |
D005947 | Glucose | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9] | 18791325 |
D005947 | Glucose | [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D005947 | Glucose | Glucose results in increased activity of CASP9 | 18791325 |
D005947 | Glucose | Glucose results in increased expression of and results in increased cleavage of CASP9 protein | 23192364 |
D005947 | Glucose | Glucose results in increased expression of CASP9 mRNA | 23192364 |
D005947 | Glucose | naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein] | 23192364 |
D005947 | Glucose | naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA] | 23192364 |
D005978 | Glutathione | Glutathione affects the reaction [SOD2 protein affects the activity of CASP9 protein] | 18594523 |
D005978 | Glutathione | Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] | 12140745 |
D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased activity of CASP9 protein | 16322111 |
D005999 | Glycochenodeoxycholic Acid | Sulfasalazine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP9 protein] | 16322111 |
D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased activity of CASP9 protein | 15767249 |
D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] | 22051199 |
C010974 | glyphosate | glyphosate results in decreased expression of CASP9 protein | 24073338 |
C010974 | glyphosate | [Surface-Active Agents co-treated with glyphosate] results in increased activity of CASP9 protein | 23099315 |
D006046 | Gold | [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein | 25846798 |
D006046 | Gold | [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA | 25846798 |
D006046 | Gold | Gold analog results in increased cleavage of CASP9 protein | 26551149 |
D006046 | Gold | "[Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein" | 27836789 |
D017612 | Gold Compounds | Gold Compounds results in increased activity of CASP9 protein | 20209498 |
C103280 | goniothalamin | goniothalamin results in increased activity of CASP9 protein | 20498002 |
C103280 | goniothalamin | goniothalamin results in increased cleavage of CASP9 protein | 21810437 |
D006072 | Gossypol | Gossypol results in increased cleavage of CASP9 protein | 18840529 |
D006072 | Gossypol | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA | 15451339 |
D006108 | Graphite | [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of and results in increased cleavage of CASP9 protein | 25446327 |
C058858 | grifolin | grifolin results in increased activity of CASP9 protein | 15949805 |
D006118 | Griseofulvin | Griseofulvin results in increased activity of CASP9 protein | 23329179 |
D005937 | Glucaric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D005937 | Glucaric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D005937 | Glucaric Acid | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D005937 | Glucaric Acid | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D005937 | Glucaric Acid | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D005937 | Glucaric Acid | "Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
C401311 | GW 7845 | GW 7845 results in increased activity of and results in increased cleavage of CASP9 protein | 17400580 |
C539481 | HCV 796 | HCV 796 results in increased activity of CASP9 protein | 19098685 |
C042349 | heminordihydroguaiaretic acid | heminordihydroguaiaretic acid results in increased activity of CASP9 protein | 17393435 |
D006569 | Hesperidin | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA] | 22093918 |
D006569 | Hesperidin | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 protein] | 22093918 |
D006575 | Heterocyclic Compounds, 3-Ring | "Heterocyclic Compounds, 3-Ring results in increased activity of CASP9 protein" | 21500194 |
C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased activity of CASP9 protein | 19356805 |
C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased expression of CASP9 mRNA | 19356805 |
C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased activity of CASP9 protein | 24780359 |
C533761 | hexabromodiphenyl ether 154 | hexabromodiphenyl ether 154 affects the expression of CASP9 protein | 27060917 |
D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased activity of CASP9 protein | 21787832 |
D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased cleavage of and results in increased activity of CASP9 protein | 19182106 |
C482862 | heyneanol A | heyneanol A results in increased cleavage of and results in increased activity of CASP9 protein | 16675471 |
C501367 | hispanolone | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [hispanolone analog results in increased activity of CASP9 protein] | 25930665 |
C501367 | hispanolone | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP9 protein]] | 25930665 |
C501367 | hispanolone | acetyl-leucyl-glutamyl-histidyl-aspartal analog inhibits the reaction [hispanolone analog results in increased activity of CASP9 protein] | 25930665 |
C501367 | hispanolone | acetyl-leucyl-glutamyl-histidyl-aspartal analog inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP9 protein]] | 25930665 |
C501367 | hispanolone | hispanolone analog results in increased activity of CASP9 protein | 25930665 |
C501367 | hispanolone | TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP9 protein] | 25930665 |
C007946 | hispidin | hispidin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 26318906 |
C007946 | hispidin | hispidin results in increased activity of CASP9 protein | 26318906 |
C001652 | homoharringtonine | homoharringtonine results in increased expression of CASP9 protein | 23980369 |
C005499 | honokiol | honokiol results in increased activity of CASP9 protein | 15802533|2510610 |
D017313 | Fenretinide | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein] | 16407847 |
D017313 | Fenretinide | 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein] | 16407847 |
D017313 | Fenretinide | [Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 17273769 |
C479128 | HS 1200 | HS 1200 results in increased cleavage of CASP9 protein | 18565645 |
C012351 | HT-2 toxin | Bentonite inhibits the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of CASP9 mRNA] | 25296281 |
C012351 | HT-2 toxin | [HT-2 toxin co-treated with T-2 Toxin] results in increased expression of CASP9 mRNA | 25296281 |
D006812 | Humic Substances | Humic Substances results in increased expression of CASP9 mRNA | 23042718 |
D006812 | Humic Substances | Humic Substances results in increased cleavage of CASP9 protein | 18683188 |
D006812 | Humic Substances | pifithrin inhibits the reaction [Humic Substances results in increased cleavage of CASP9 protein] | 18683188 |
C539018 | hwanggunchungyitang | hwanggunchungyitang inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19182378 |
D006835 | Hydrazones | Hydrazones results in increased cleavage of and results in increased activity of CASP9 protein | 22056764 |
D006851 | Hydrochloric Acid | Hydrochloric Acid results in decreased expression of CASP9 mRNA | 15046208 |
D006861 | Hydrogen Peroxide | Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 14753751 |
D006861 | Hydrogen Peroxide | EUK-134 inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 25005833 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CASP9 protein | 21179406 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of CASP9 protein | 14753751|2143136 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased cleavage of CASP9 protein | 25005833|2510816 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CASP9 mRNA | 20361964|2927443 |
D006861 | Hydrogen Peroxide | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 21431366 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 25108166 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 mRNA] | 20361964 |
D006861 | Hydrogen Peroxide | Saponins inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 mRNA] | 29274434 |
D006861 | Hydrogen Peroxide | [sodium cyanate co-treated with Hydrogen Peroxide] results in increased activity of CASP9 protein | 28400100 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased cleavage of CASP9 protein | 12626342|1587642 |
D006861 | Hydrogen Peroxide | PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 20878536 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 15876423 |
D006861 | Hydrogen Peroxide | "3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]" | 16505238 |
D006861 | Hydrogen Peroxide | 3-aminobenzamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of CASP9 protein | 14505808|1664717 |
D006861 | Hydrogen Peroxide | INO 1001 inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
D006861 | Hydrogen Peroxide | Niacinamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
D006861 | Hydrogen Peroxide | "N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]" | 16505238 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 14505808|1664717 |
C012353 | hydroperoxyisophosphamide | BAX promotes the reaction [hydroperoxyisophosphamide results in increased activity of CASP9 protein] | 11723234 |
C012353 | hydroperoxyisophosphamide | BCL2 inhibits the reaction [hydroperoxyisophosphamide results in increased activity of CASP9 protein] | 11723234 |
C012353 | hydroperoxyisophosphamide | hydroperoxyisophosphamide results in increased activity of CASP9 protein | 11723234 |
C031927 | hydroquinone | hydroquinone results in decreased expression of CASP9 mRNA | 15452088 |
C031927 | hydroquinone | hydroquinone results in increased activity of CASP9 protein | 15816534|2094694 |
C031927 | hydroquinone | hydroquinone results in increased cleavage of CASP9 protein | 15777082|2230239 |
D020155 | 3-Hydroxybutyric Acid | 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] | 16917840 |
C005044 | hydroxyethyl methacrylate | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C005044 | hydroxyethyl methacrylate | 3-methyladenine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C005044 | hydroxyethyl methacrylate | Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] | 28184909 |
C005044 | hydroxyethyl methacrylate | hydroxyethyl methacrylate results in increased expression of CASP9 mRNA | 28184909 |
C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased activity of CASP9 protein | 23776099 |
C559745 | hyperforin dicyclohexylammonium | hyperforin dicyclohexylammonium results in increased cleavage of CASP9 protein | 21376709 |
C492448 | ICG 001 | ICG 001 results in increased expression of CASP9 mRNA | 26191083 |
D007069 | Ifosfamide | BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] | 11723234 |
D007069 | Ifosfamide | Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP9 mRNA] | 23213347 |
D007069 | Ifosfamide | Ifosfamide results in increased expression of CASP9 mRNA | 23213347 |
D000068877 | Imatinib Mesylate | Imatinib Mesylate results in increased cleavage of CASP9 protein | 28315715 |
D000068877 | Imatinib Mesylate | SH3BP5 protein affects the reaction [Imatinib Mesylate results in increased cleavage of CASP9 protein] | 28315715 |
C082359 | imidacloprid | imidacloprid results in increased expression of CASP9 mRNA | 27444676 |
C428264 | indioside D | indioside D results in increased cleavage of CASP9 protein | 18376857 |
D007208 | Indocyanine Green | Indocyanine Green results in increased expression of CASP9 mRNA | 23675521 |
D007208 | Indocyanine Green | Indocyanine Green results in increased expression of CASP9 protein | 23675521 |
C016517 | indole-3-carbinol | indole-3-carbinol results in increased activity of CASP9 protein | 16082211 |
C016517 | indole-3-carbinol | indole-3-carbinol results in increased cleavage of and results in increased activity of CASP9 protein | 20335513 |
D007213 | Indomethacin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
D007213 | Indomethacin | 2-aminoethoxydiphenyl borate inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 23022152 |
D007213 | Indomethacin | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Indomethacin results in increased activity of CASP9 protein]" | 17341418 |
D007213 | Indomethacin | Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
D007213 | Indomethacin | Dantrolene inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 23022152 |
D007213 | Indomethacin | Indomethacin results in increased activity of CASP9 protein | 11005569|1581255 |
D007213 | Indomethacin | [Indomethacin results in increased activity of CASP9 protein] which results in increased susceptibility to Doxorubicin | 15812552 |
D007213 | Indomethacin | Indomethacin results in increased cleavage of and results in increased activity of CASP9 protein | 15804060 |
D007213 | Indomethacin | pyrazolanthrone inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
D007213 | Indomethacin | SB 203580 inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
D007213 | Indomethacin | U 0126 inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
D007213 | Indomethacin | Indomethacin results in increased activity of CASP9 protein | 16184425|1837538 |
D007213 | Indomethacin | Lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 18375387 |
D007213 | Indomethacin | Melatonin inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 19220725 |
D007213 | Indomethacin | rebamipide inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 16184425 |
D007213 | Indomethacin | tryptamine analog inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 22157011 |
C491685 | INO 1001 | INO 1001 inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP9 mRNA | 25613284 |
C033148 | iprodione | [iprodione co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrachlostrobin] results in increased expression of CASP9 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrimethanil] results in decreased expression of CASP9 mRNA | 29091792 |
C033148 | iprodione | iprodione results in decreased expression of CASP9 mRNA | 29091792 |
C506002 | ircinin-1 | ircinin-1 results in increased cleavage of and results in increased activity of CASP9 protein | 16163705 |
C051890 | irinotecan | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein] | 22898888 |
C051890 | irinotecan | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein] | 22898888 |
C051890 | irinotecan | irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP9 protein] | 18182997 |
C051890 | irinotecan | irinotecan results in increased activity of CASP9 protein | 22898888 |
C051890 | irinotecan | irinotecan results in increased cleavage of and results in increased activity of CASP9 protein | 18182997 |
C469852 | iroxanadine | iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein] | 15583868 |
C469852 | iroxanadine | Quercetin inhibits the reaction [iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]] | 15583868 |
D007510 | Isatin | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein | 17327230 |
D007510 | Isatin | [Copper binds to Isatin binds to trimethylenediamine] which results in increased cleavage of CASP9 protein | 17327230 |
C551631 | isoangustone A | isoangustone A results in increased cleavage of CASP9 protein | 20229524 |
C453300 | isocoumarin NM-3 | isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP9 protein] | 15574755 |
D007529 | Isoflavones | Isoflavones results in increased expression of CASP9 mRNA | 25035168 |
D007530 | Isoflurane | Isoflurane results in increased activity of CASP9 protein | 23922164 |
D007530 | Isoflurane | resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP9 protein] | 23922164 |
D007530 | Isoflurane | Isoflurane results in decreased expression of CASP9 mRNA | 16978161 |
C040920 | isoliquiritigenin | "20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]" | 25094029 |
C040920 | isoliquiritigenin | AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] | 25094029 |
C040920 | isoliquiritigenin | CAY 10580 inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] | 25094029 |
C040920 | isoliquiritigenin | Dinoprostone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] | 25094029 |
C040920 | isoliquiritigenin | isoliquiritigenin results in increased activity of CASP9 protein | 16158945 |
C040920 | isoliquiritigenin | isoliquiritigenin results in increased cleavage of and results in increased activity of CASP9 protein | 23747687 |
C040920 | isoliquiritigenin | isoliquiritigenin results in increased cleavage of CASP9 protein | 25094029 |
D007545 | Isoproterenol | Isoproterenol results in increased expression of CASP9 mRNA | 24286936|2579485 |
D007545 | Isoproterenol | Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] | 26996544 |
D007545 | Isoproterenol | Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] | 25794854 |
C545474 | JAI-51 | JAI-51 results in increased activity of CASP9 protein | 24134853 |
C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of CASP9 mRNA | 12832151 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CASP9 mRNA | 26830473 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of CASP9 mRNA | 24796395 |
C006552 | kaempferol | kaempferol inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 20594614 |
C006552 | kaempferol | kaempferol results in increased cleavage of CASP9 protein | 18331776 |
D007649 | Ketamine | Ketamine results in decreased activity of CASP9 protein | 28716577 |
D007649 | Ketamine | Ketamine results in increased expression of CASP9 mRNA | 28716577 |
D007649 | Ketamine | Ketamine results in increased activity of CASP9 protein | 19001360 |
D007649 | Ketamine | Ketamine results in increased expression of CASP9 mRNA | 20080153 |
D007654 | Ketoconazole | Ketoconazole results in increased expression of CASP9 mRNA | 25808816 |
C410027 | KNK 437 | KNK 437 promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | 19371599 |
C045492 | kolaviron | kolaviron inhibits the reaction [Atrazine results in increased expression of CASP9 mRNA] | 21333729 |
C045492 | kolaviron | kolaviron results in increased expression of CASP9 mRNA | 21333729 |
C045492 | kolaviron | kolaviron inhibits the reaction [Atrazine affects the expression of CASP9] | 21726175 |
C000620717 | kuntai capsule | kuntai capsule results in increased expression of CASP9 protein | 27597876 |
C500368 | labedipinedilol A | labedipinedilol A results in increased activity of CASP9 protein | 19056458 |
D064747 | Lansoprazole | Lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 18375387 |
C028521 | lanthanum chloride | lanthanum chloride results in increased expression of CASP9 protein | 21793157 |
C477361 | LAQ824 | [LAQ824 co-treated with fludarabine] results in increased activity of CASP9 protein | 18852132 |
C008261 | lead acetate | lead acetate results in increased activity of CASP9 protein | 27236077 |
C008261 | lead acetate | lead acetate results in increased expression of CASP9 protein | 27604105 |
C008261 | lead acetate | MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP9 protein] | 27604105 |
C008261 | lead acetate | PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP9 protein] | 27236077 |
C008261 | lead acetate | IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
C008261 | lead acetate | lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 23906897 |
C008261 | lead acetate | lead acetate results in increased expression of CASP9 mRNA | 23906897 |
C008261 | lead acetate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 23906897 |
C008261 | lead acetate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP9 mRNA]" | 23906897 |
C008261 | lead acetate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]]" | 23906897 |
C008261 | lead acetate | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
C008261 | lead acetate | [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein | 26396915 |
C008261 | lead acetate | sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA] | 23906897 |
C029891 | lead chloride | lead chloride results in increased cleavage of CASP9 protein | 24419708 |
C017461 | lead nitrate | lead nitrate results in increased expression of CASP9 protein | 23451106 |
C017461 | lead nitrate | mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] | 23451106 |
C045463 | leflunomide | leflunomide results in decreased expression of CASP9 mRNA | 28988120 |
D016729 | Leuprolide | Leuprolide results in increased expression of CASP9 protein | 15965100 |
D008012 | Lidocaine | Lidocaine results in decreased expression of CASP9 protein | 20194319 |
C018584 | linalool | linalool results in increased expression of CASP9 mRNA | 26703569 |
D001556 | Lindane | Lindane results in decreased activity of CASP9 protein | 19041923 |
D001556 | Lindane | Lindane results in increased activity of CASP9 protein | 22001173 |
D001556 | Lindane | Lindane results in increased expression of CASP9 protein | 19038305 |
D001556 | Lindane | Ro 31-8220 inhibits the reaction [Lindane results in increased activity of CASP9 protein] | 22001173 |
D001556 | Lindane | TEMPO inhibits the reaction [Lindane results in increased activity of CASP9 protein] | 22001173 |
D008055 | Lipids | Lipids inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | 25445725 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP9 protein" | 24830863 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP9 protein]" | 24830863 |
D008070 | Lipopolysaccharides | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] | 20848084 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of CASP9 protein | 20848084 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CASP9 protein | 21844306 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein | 20558151 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form | 20558151 |
D008070 | Lipopolysaccharides | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein] | 20558151 |
D008070 | Lipopolysaccharides | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form] | 20558151 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of CASP9 protein | 23170834 |
D008070 | Lipopolysaccharides | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] | 23170834 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of CASP9 mRNA | 25613284 |
D008070 | Lipopolysaccharides | Apigenin inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein] | 25557508 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased cleavage of CASP9 protein | 25557508 |
D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [quinocetone results in increased cleavage of CASP9 protein] | 28343033 |
D008095 | Lithocholic Acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Lithocholic Acid results in increased cleavage of and results in increased activity of CASP9 protein] | 19054763 |
D008095 | Lithocholic Acid | [[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein | 19054763 |
D008095 | Lithocholic Acid | [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein | 19054763 |
D008095 | Lithocholic Acid | Lithocholic Acid results in increased cleavage of and results in increased activity of CASP9 protein | 19054763 |
C000589248 | LL-202 | LL-202 results in increased cleavage of CASP9 protein | 24752227 |
C529490 | locostatin | locostatin inhibits the reaction [didymin results in increased activity of CASP9 protein] | 27899290 |
C115354 | lonafarnib | [lonafarnib co-treated with Bortezomib] results in increased cleavage of CASP9 protein | 16118318 |
C115354 | lonafarnib | lonafarnib results in increased cleavage of CASP9 protein | 16118318 |
C581034 | longikaurin A | longikaurin A results in increased expression of CASP9 protein modified form | 28801140 |
C016371 | lonidamine | arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein] | 21889928 |
C016371 | lonidamine | BCL2 protein inhibits the reaction [arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]] | 21889928 |
C016371 | lonidamine | BCL2 protein inhibits the reaction [lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein]] | 21889928 |
C016371 | lonidamine | [Curcumin co-treated with lonidamine] results in increased cleavage of CASP9 protein | 20605902 |
C016371 | lonidamine | lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein] | 21889928 |
C016371 | lonidamine | lonidamine results in increased cleavage of and results in increased activity of CASP9 protein | 21889928 |
D017336 | Loratadine | Loratadine results in increased cleavage of CASP9 protein | 20570632 |
D019808 | Losartan | Losartan results in increased cleavage of CASP9 protein | 12623880 |
D008148 | Lovastatin | Lovastatin results in increased activity of CASP9 protein | 12933658|1570560 |
D008148 | Lovastatin | Lovastatin results in increased activity of CASP9 protein | 15180944 |
D047311 | Luteolin | Luteolin results in increased activity of CASP9 protein | 21601631|2748919 |
D047311 | Luteolin | Luteolin results in increased cleavage of CASP9 protein | 18331776|1939799 |
C094099 | LY 293111 | LY 293111 results in increased cleavage of CASP9 protein | 16151469 |
C015329 | lycopene | lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP9 protein] | 27871895 |
C015329 | lycopene | lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] | 27871895 |
C015329 | lycopene | lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] | 27871895 |
C048341 | mafosfamide | BAX protein promotes the reaction [mafosfamide results in increased activity of CASP9 protein] | 11723234 |
C048341 | mafosfamide | mafosfamide results in increased activity of CASP9 protein | 11723234 |
D008277 | Magnesium Oxide | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP9 protein] | 27920530 |
D008277 | Magnesium Oxide | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA] | 27920530 |
D008277 | Magnesium Oxide | Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]] | 27920530 |
D008294 | Malathion | Malathion results in increased activity of CASP9 protein | 12505448 |
D008294 | Malathion | Malathion results in increased expression of CASP9 mRNA | 21628957 |
D008294 | Malathion | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | 21628957 |
C030290 | malonic acid | malonic acid inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | 21664962 |
C013099 | mancozeb | mancozeb results in increased activity of CASP9 protein | 22824503 |
C013099 | mancozeb | mancozeb results in increased cleavage of and results in increased activity of CASP9 protein | 22289270 |
D008344 | Maneb | Maneb results in increased activity of CASP9 protein | 22824503 |
D008344 | Maneb | [Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA | 23963992 |
D008344 | Maneb | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D008344 | Maneb | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D008344 | Maneb | [Paraquat co-treated with Maneb] results in increased expression of CASP9 protein | 20964710 |
D008344 | Maneb | Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D008344 | Maneb | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D008345 | Manganese | SNCA protein inhibits the reaction [Manganese results in increased activity of CASP9 protein] | 25416158 |
D008345 | Manganese | Manganese results in increased activity of CASP9 protein | 25416158 |
D008345 | Manganese | Manganese results in increased cleavage of CASP9 protein | 16787641 |
C025340 | manganese chloride | SNCA protein inhibits the reaction [manganese chloride results in increased activity of CASP9 protein] | 25416158 |
C025340 | manganese chloride | manganese chloride results in increased activity of CASP9 protein | 17483122 |
C025340 | manganese chloride | PRNP protein inhibits the reaction [manganese chloride results in increased activity of CASP9 protein] | 17483122 |
C025340 | manganese chloride | bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
C025340 | manganese chloride | CA 074 methyl ester inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
C025340 | manganese chloride | manganese chloride results in increased activity of CASP9 protein | 25416158 |
C025340 | manganese chloride | manganese chloride results in increased cleavage of CASP9 protein | 16787641|2170409 |
C025340 | manganese chloride | pepstatin inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
C431023 | manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin | manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin results in decreased expression of CASP9 protein modified form | 20584581 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [melamine results in increased cleavage of CASP9 protein] | 22915474 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol results in increased cleavage of CASP9 protein] | 22923501 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 18544562 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP9 protein] | 19464277 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] | 11343246 |
C013592 | mangiferin | mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] | 23451106 |
C013592 | mangiferin | mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] | 22118634 |
C021053 | mangostin | mangostin results in increased activity of CASP9 protein | 23954321|2448004 |
D008353 | Mannitol | Mannitol results in increased activity of CASP9 protein | 12011046 |
D009637 | Masoprocol | Masoprocol results in increased activity of CASP9 protein | 15034932 |
D008466 | Mechlorethamine | ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] | 23649643 |
D008466 | Mechlorethamine | Mechlorethamine results in increased activity of CASP9 protein | 16738803|2364964 |
D008466 | Mechlorethamine | Mechlorethamine results in increased cleavage of and results in increased activity of CASP9 protein | 22285227 |
C011907 | melamine | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased cleavage of CASP9 protein]" | 22915474 |
C011907 | melamine | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [melamine results in increased cleavage of CASP9 protein] | 22915474 |
C011907 | melamine | melamine results in increased cleavage of CASP9 protein | 22915474 |
C011907 | melamine | TGFB1 protein affects the reaction [melamine results in increased cleavage of CASP9 protein] | 22915474 |
D008550 | Melatonin | Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein] | 20130848 |
D008550 | Melatonin | Melatonin inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | 20130848 |
D008550 | Melatonin | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 21431366 |
D008550 | Melatonin | Melatonin results in increased activity of CASP9 protein | 19012662|1955276 |
D008550 | Melatonin | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D008550 | Melatonin | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D008550 | Melatonin | Melatonin inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 19220725 |
D008555 | Melitten | Melitten results in increased cleavage of and results in increased activity of CASP9 protein | 21456063 |
D008555 | Melitten | Melitten inhibits the reaction [TGFB1 protein results in increased cleavage of CASP9 protein] | 21871910 |
D008555 | Melitten | Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 mRNA] | 21354845 |
D008555 | Melitten | Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 protein] | 21354845 |
D008558 | Melphalan | Melphalan results in increased cleavage of and results in increased activity of CASP9 protein | 22285227 |
D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of CASP9 protein | 21373768 |
D008628 | Mercury | Mercury results in increased expression of CASP9 protein | 21186712 |
D008694 | Methamphetamine | ATF4 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008694 | Methamphetamine | ATF6 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008694 | Methamphetamine | DDIT3 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008694 | Methamphetamine | EIF2AK3 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008694 | Methamphetamine | ERN1 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008694 | Methamphetamine | Methamphetamine results in increased expression of and results in increased cleavage of CASP9 protein | 27323860 |
D008694 | Methamphetamine | RELA protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] | 27323860 |
D008701 | Methapyrilene | Methapyrilene results in increased expression of CASP9 mRNA | 17450226 |
D008713 | Methimazole | Methimazole results in increased cleavage of and results in increased activity of CASP9 protein | 17171702 |
D008727 | Methotrexate | Methotrexate results in decreased expression of CASP9 mRNA | 24449571 |
D008727 | Methotrexate | Methotrexate results in increased expression of CASP9 mRNA | 21678067 |
D008727 | Methotrexate | Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP9 protein] | 28479099 |
D008727 | Methotrexate | Methotrexate results in increased activity of CASP9 protein | 28479099 |
D008727 | Methotrexate | Methotrexate results in increased expression of CASP9 protein modified form | 23406595 |
C013598 | methoxyacetic acid | methoxyacetic acid results in increased activity of CASP9 protein | 16829022 |
C013598 | methoxyacetic acid | [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased expression of CASP9 protein | 26006246 |
C013598 | methoxyacetic acid | methoxyacetic acid results in increased activity of CASP9 protein | 12220648 |
D008731 | Methoxychlor | Methoxychlor results in increased activity of CASP9 protein | 20568958 |
D008731 | Methoxychlor | Methoxychlor results in increased expression of CASP9 protein | 20227399 |
D008730 | Methoxsalen | Methoxsalen results in decreased expression of CASP9 protein | 22796345 |
C555027 | methyl 5-chloro-4,5-didehydrojasmonate | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of CASP9 protein]" | 20696234 |
C555027 | methyl 5-chloro-4,5-didehydrojasmonate | "methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of and results in increased cleavage of CASP9 protein" | 20696234 |
C553655 | methyl antcinate A | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to methyl antcinate A | 20557081 |
C553655 | methyl antcinate A | methyl antcinate A results in increased activity of CASP9 protein | 20557081 |
D008748 | Methylcholanthrene | [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter | 29094188 |
D008748 | Methylcholanthrene | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]] | 29094188 |
D008748 | Methylcholanthrene | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA] | 29094188 |
D008748 | Methylcholanthrene | alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter] | 29094188 |
D008748 | Methylcholanthrene | Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter] | 29094188 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CASP9 mRNA | 23273579|2909418 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased methylation of CASP9 promoter | 29094188 |
C072239 | methyl jasmonate | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein] | 22079975 |
C072239 | methyl jasmonate | methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of CASP9 protein] | 22079975 |
C072239 | methyl jasmonate | methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 22079975 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CASP9 mRNA | 23458150 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased activity of CASP9 protein | 27178136 |
D008767 | Methylmercury Compounds | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 mRNA] | 21549813 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of CASP9 mRNA | 26558463 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased cleavage of CASP9 protein | 21549813 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of CASP9 mRNA | 21549813 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased activity of CASP9 protein | 16019050 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased activity of CASP9 protein" | 27255387 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased activity of CASP9 protein | 15589979 |
D008769 | Methylnitronitrosoguanidine | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] | 20434464 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in decreased expression of CASP9 protein | 20434464 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased activity of CASP9 protein | 16019050 |
D008770 | Methylnitrosourea | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA | 20732338 |
C400939 | methylone | methylone results in increased activity of CASP9 protein | 27255387 |
D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein | 18037221|2487532 |
D015655 | 1-Methyl-4-phenylpyridinium | Copper Sulfate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 28442376 |
D015655 | 1-Methyl-4-phenylpyridinium | Oligopeptides inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 25868679 |
D015655 | 1-Methyl-4-phenylpyridinium | Plant Preparations inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 24875324 |
D015655 | 1-Methyl-4-phenylpyridinium | Polysaccharides inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 24875324 |
D015655 | 1-Methyl-4-phenylpyridinium | Tat-JBD peptide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 18037221 |
D015655 | 1-Methyl-4-phenylpyridinium | Tat-JBD peptide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of CASP9 protein] | 18037221 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of and results in increased activity of CASP9 protein" | 23911879 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of CASP9 protein" | 23201480 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of and results in increased activity of CASP9 protein]" | 23911879 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "ACHE protein affects the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of CASP9 protein]" | 23201480 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA]" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA]" | 24768735 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein]" | 24768735 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CASP9 mRNA" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA]" | 20230807 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA" | 24768735 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein" | 24768735 |
C008493 | methylselenic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein" | 18444175 |
C008493 | methylselenic acid | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein] | 17339365 |
C008493 | methylselenic acid | [Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein | 17339365 |
C008493 | methylselenic acid | [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein | 18790785 |
C008493 | methylselenic acid | [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
C008493 | methylselenic acid | methylselenic acid results in increased cleavage of and results in increased activity of CASP9 protein | 28161410 |
C008493 | methylselenic acid | methylselenic acid results in increased cleavage of CASP9 protein | 18444175|1879078 |
C008493 | methylselenic acid | [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
C008493 | methylselenic acid | methylselenic acid results in increased expression of CASP9 mRNA | 12517777 |
D008777 | Methyltestosterone | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA | 15451339 |
D008790 | Metoprolol | Metoprolol results in increased cleavage of CASP9 protein | 19106745 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP9 protein] | 20045437 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium results in increased activity of CASP9 protein] | 18339080 |
D015735 | Mifepristone | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] | 22736252 |
D008898 | Mimosine | Mimosine results in increased cleavage of and results in increased activity of CASP9 protein | 18058236 |
D008911 | Minocycline | Minocycline results in decreased activity of CASP9 protein | 12930891 |
D008911 | Minocycline | Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP9 protein] | 12930891 |
D008911 | Minocycline | Minocycline results in decreased expression of and results in decreased activity of CASP9 protein | 14998631 |
D008911 | Minocycline | Minocycline results in decreased expression of CASP9 mRNA | 14998631 |
D016685 | Mitomycin | Mitomycin promotes the reaction [CASP9 protein results in increased secretion of CYCS protein] | 10960761 |
D016685 | Mitomycin | Mitomycin results in increased activity of CASP9 protein | 16186332|1709445 |
D016685 | Mitomycin | Mitomycin results in increased cleavage of and results in increased activity of CASP9 protein | 12181741 |
D016685 | Mitomycin | BCL2 protein inhibits the reaction [Mitomycin results in increased cleavage of and results in increased activity of CASP9 protein] | 12181741 |
C555916 | MitoTEMPO | MitoTEMPO inhibits the reaction [Chlorpyrifos results in increased expression of CASP9 protein] | 26435000 |
D008942 | Mitoxantrone | Mitoxantrone results in increased activity of CASP9 protein | 12948851 |
D008982 | Molybdenum | Molybdenum analog results in increased activity of CASP9 protein | 26391003 |
C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in increased activity of CASP9 protein | 24706461 |
D008999 | Monocrotophos | Monocrotophos results in increased expression of CASP9 mRNA | 20957986|2144529 |
D008999 | Monocrotophos | Monocrotophos results in increased expression of CASP9 protein | 21445290 |
D008999 | Monocrotophos | Monocrotophos results in increased expression of CASP9 protein modified form | 20957986 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein]" | 23681673 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "[Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 24184500 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]" | 24184500 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 23906897 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP9 mRNA]" | 23906897 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]]" | 23906897 |
C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in increased expression of CASP9 mRNA]" | 23906897 |
C406082 | monomethylarsonous acid | Acetylcysteine inhibits the reaction [monomethylarsonous acid results in decreased expression of CASP9 protein] | 18336854 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CASP9 protein | 18336854 |
C008548 | morin | morin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] | 26767949 |
C008548 | morin | morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] | 19931519 |
D009020 | Morphine | Morphine results in increased activity of CASP9 protein | 19292871 |
D009020 | Morphine | Morphine results in increased expression of CASP9 mRNA | 15183518 |
C568376 | MT19c compound | MT19c compound results in increased cleavage of and results in increased activity of CASP9 protein | 21803404 |
D009151 | Mustard Gas | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein] | 20226831 |
D009151 | Mustard Gas | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein] | 20226831 |
D009151 | Mustard Gas | BRCA2 protein inhibits the reaction [Mustard Gas results in increased cleavage of CASP9 protein] | 20435105 |
D009151 | Mustard Gas | CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of CASP9 protein] | 16935404 |
D009151 | Mustard Gas | Mustard Gas results in increased activity of CASP9 protein | 12482751|1673880 |
D009151 | Mustard Gas | Mustard Gas results in increased cleavage of and results in increased activity of CASP9 protein | 16935404|1816151 |
D009151 | Mustard Gas | Mustard Gas results in increased cleavage of CASP9 protein | 20435105|2544827 |
D009151 | Mustard Gas | pifithrin promotes the reaction [Mustard Gas results in increased cleavage of CASP9 protein] | 25448276 |
D009151 | Mustard Gas | Mustard Gas results in increased cleavage of CASP9 protein | 20659490 |
C040015 | myricetin | myricetin results in increased activity of CASP9 protein | 15748703 |
C005246 | myristicin | myristicin results in increased activity of CASP9 protein | 29174417 |
C455139 | myrtucommulone A | myrtucommulone A results in decreased expression of CASP9 mRNA | 26032814 |
C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Rotenone results in increased activity of CASP9 protein]" | 25263579 |
C531525 | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Rotenone results in increased activity of CASP9 protein]" | 25263579 |
C059685 | N(1),N(11)-diethylnorspermine | "N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]" | 15546879 |
C059685 | N(1),N(11)-diethylnorspermine | "TP53 protein inhibits the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein]]" | 15546879 |
C469937 | N(2)-(2-aminocyclohexyl)-N(6)-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine | "N(2)-(2-aminocyclohexyl)-N(6)-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine results in increased activity of CASP9 protein" | 16140939 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein | 12414664 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PTGS2 protein inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein] | 12414664 |
C479831 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]" | 20540935 |
C027513 | N(6)-cyclohexyladenosine | N(6)-cyclohexyladenosine results in increased activity of CASP9 protein | 16469385 |
C488176 | N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester | N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester results in increased cleavage of CASP9 protein | 21097689 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased activity of CASP9 protein" | 28673683 |
D037742 | Nanotubes, Carbon | "[benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Nanotubes, Carbon" | 22664788 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CASP9 mRNA" | 25620056 |
C031721 | naphthalene | "[naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of CASP9 protein" | 21732540 |
C073873 | naphtho(1,2-b)furan-4,5-dione | "naphtho(1,2-b)furan-4,5-dione results in increased activity of CASP9 protein" | 19747539|2019708 |
D009285 | Naphthoquinones | Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | 19497415 |
C005273 | naringenin | naringenin results in increased activity of CASP9 protein | 19124070 |
C005273 | naringenin | naringenin results in increased expression of CASP9 protein modified form | 27838343 |
C005273 | naringenin | naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein] | 23192364 |
C005273 | naringenin | naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA] | 23192364 |
C005274 | naringin | naringin results in increased expression of CASP9 mRNA | 22847135 |
C005274 | naringin | naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein] | 25773745 |
C528561 | navitoclax | navitoclax results in increased cleavage of CASP9 protein | 21562047|2894724 |
C112341 | NCQ 344 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [NCQ 344 results in increased activity of CASP9 protein] | 10996300 |
C112341 | NCQ 344 | NCQ 344 results in increased activity of CASP9 protein | 10996300 |
C084325 | NCQ 436 | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [NCQ 436 results in increased activity of CASP9 protein] | 10996300 |
C084325 | NCQ 436 | NCQ 436 results in increased activity of CASP9 protein | 10996300 |
C498045 | NCX 4040 | NCX 4040 results in increased cleavage of and results in increased activity of CASP9 protein | 16282376 |
C498045 | NCX 4040 | NCX 4040 results in increased expression of CASP9 mRNA | 20188076 |
C002443 | neem oil | CASP9 protein affects the reaction [neem oil results in increased cleavage of and results in increased activity of CASP3 protein] | 22915764 |
C002443 | neem oil | neem oil results in increased cleavage of and results in increased activity of CASP9 protein | 22915764 |
C051752 | nefazodone | nefazodone results in increased activity of CASP9 protein | 27288927 |
D019888 | Nelfinavir | Nelfinavir results in decreased activity of CASP9 protein | 18497877 |
C011947 | neoxanthin | neoxanthin results in increased cleavage of and results in increased activity of CASP9 protein | 17186379 |
C552435 | N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide | "N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide results in increased cleavage of and results in increased activity of CASP9 protein" | 20530905 |
D009532 | Nickel | [Nickel co-treated with austenitic steel analog] results in increased expression of CASP9 mRNA | 23638002 |
D009532 | Nickel | [Quercetin analog co-treated with Nickel] results in increased activity of CASP9 protein | 20577783 |
D009532 | Nickel | Nickel analog results in increased expression of CASP9 mRNA | 27257140 |
C119536 | nickel acetate | nickel acetate results in increased activity of CASP9 protein | 22245127 |
C022838 | nickel chloride | nickel chloride results in increased expression of CASP9 mRNA | 26585591 |
C022838 | nickel chloride | nickel chloride results in decreased expression of CASP9 protein | 28552779 |
C022838 | nickel chloride | nickel chloride results in increased activity of CASP9 protein | 23566959 |
C022838 | nickel chloride | pifithrin inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | 23566959 |
C022838 | nickel chloride | TP53 mutant form inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | 23566959 |
C022838 | nickel chloride | [TP53 mutant form inhibits the reaction [nickel chloride results in increased activity of CASP9 protein]] which results in decreased cleavage of CASP3 protein | 23566959 |
C022838 | nickel chloride | nickel chloride affects the expression of CASP9 mRNA | 22546817 |
C022838 | nickel chloride | nickel chloride results in increased activity of CASP9 protein | 21843586 |
C022838 | nickel chloride | pyrazolanthrone inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | 21843586 |
C550717 | nickel ferrite | nickel ferrite analog results in increased activity of CASP9 protein | 25966046 |
C550717 | nickel ferrite | nickel ferrite analog results in increased expression of CASP9 mRNA | 25966046 |
C550717 | nickel ferrite | nickel ferrite results in increased activity of CASP9 protein | 21382431 |
C550717 | nickel ferrite | nickel ferrite results in increased expression of CASP9 mRNA | 21382431 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of CASP9 mRNA | 28945320 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of CASP9 protein | 28945320 |
C029938 | nickel sulfate | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA] | 28296042 |
C029938 | nickel sulfate | Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] | 28296042 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of CASP9 mRNA | 28296042 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of CASP9 protein | 28296042 |
C029938 | nickel sulfate | TEMPO inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA] | 28296042 |
C029938 | nickel sulfate | TEMPO inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] | 28296042 |
D009534 | Niclosamide | Niclosamide results in increased cleavage of CASP9 protein | 26703449 |
D009534 | Niclosamide | Niclosamide results in increased expression of CASP9 protein modified form | 26116531 |
D009538 | Nicotine | Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] | 18676776 |
D009538 | Nicotine | Nicotine results in decreased expression of CASP9 mRNA | 16949557 |
D009538 | Nicotine | "[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CASP9 mRNA" | 20230807 |
D009538 | Nicotine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA]" | 20230807 |
D009544 | Niflumic Acid | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein] | 21067863 |
D009544 | Niflumic Acid | DDIT3 mutant form inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein] | 21067863 |
D009544 | Niflumic Acid | [Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein | 21067863 |
C042198 | nimbolide | nimbolide results in increased expression of CASP9 mRNA | 20429769 |
C042198 | nimbolide | nimbolide results in increased expression of CASP9 protein | 20429769 |
C012655 | nimesulide | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP9 protein] | 19360361 |
C012655 | nimesulide | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | 21745461 |
C012655 | nimesulide | nimesulide results in increased cleavage of and results in increased activity of CASP9 protein | 19360361 |
C012655 | nimesulide | nimesulide results in increased activity of CASP9 protein | 19772912 |
D015376 | Nimustine | BCL2L11 mutant form inhibits the reaction [Nimustine results in increased cleavage of CASP9 protein] | 26418950 |
D015376 | Nimustine | Nimustine results in increased cleavage of CASP9 protein | 26418950 |
D009569 | Nitric Oxide | Nitric Oxide results in increased activity of CASP9 protein | 15126337 |
D009569 | Nitric Oxide | Nitric Oxide results in decreased activity of CASP9 protein | 14634119 |
D009569 | Nitric Oxide | [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein | 22878015 |
D009589 | Nitrogen Oxides | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP9 protein] | 16041517 |
D009599 | Nitroprusside | epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP9 protein] | 23665936 |
D009599 | Nitroprusside | Nitroprusside binds to and results in increased activity of CASP9 protein | 23665936 |
D009599 | Nitroprusside | Nitroprusside results in decreased activity of CASP9 protein | 22543296 |
D009599 | Nitroprusside | Nitroprusside results in increased activity of CASP9 protein | 22178905 |
D009599 | Nitroprusside | Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP9 protein] | 22178905 |
D009599 | Nitroprusside | [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein | 22878015 |
C000591546 | NKCT1 protein, Naja kaouthia | "[Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein" | 27836789 |
C000591546 | NKCT1 protein, Naja kaouthia | "NKCT1 protein, Naja kaouthia results in increased expression of CASP9 protein" | 27836789 |
C542681 | N,N-dimethylphytosphingosine | "N,N-dimethylphytosphingosine results in increased activity of CASP9 protein" | 19481559 |
C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of CASP9 protein" | 17169355 |
D015739 | Nocodazole | Nocodazole analog results in increased cleavage of CASP9 protein | 28412508 |
C063998 | nodularin | nodularin results in increased activity of CASP9 protein | 25192816 |
C069741 | norcantharidin | norcantharidin results in increased activity of CASP9 protein | 20040369|2126619 |
D009638 | Norepinephrine | Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | 15158148 |
D009638 | Norepinephrine | Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | 15158148 |
D009638 | Norepinephrine | Norepinephrine affects the activity of CASP9 protein | 25437044 |
D009638 | Norepinephrine | Norepinephrine results in increased activity of CASP9 protein | 14732211|1515814 |
D009638 | Norepinephrine | Norepinephrine results in increased cleavage of CASP9 protein | 16338971 |
D009665 | Noscapine | Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein] | 20674069 |
D009665 | Noscapine | Noscapine results in increased expression of and results in increased cleavage of CASP9 protein | 20674069 |
C072936 | notoginsenoside R1 | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] | 23170834 |
C434926 | N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride | "N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]" | 16505238 |
C404397 | NSC 680410 | NSC 680410 results in increased cleavage of and results in increased activity of CASP9 protein | 14647418 |
C482205 | nutlin 3 | [nutlin 3 co-treated with Bortezomib] results in increased activity of CASP9 protein | 20850924 |
C482205 | nutlin 3 | nutlin 3 results in increased cleavage of and results in increased activity of CASP9 protein | 16014563 |
C000594859 | nymphayol | nymphayol inhibits the reaction [Ethanol results in increased activity of CASP9 protein] | 25289771 |
C067207 | obacunone | obacunone results in increased activity of CASP9 protein | 21333732 |
C067207 | obacunone | obacunone results in increased cleavage of CASP9 protein | 25592883 |
C411188 | obacunone glucoside | obacunone glucoside results in increased cleavage of CASP9 protein | 25592883 |
C025589 | ochratoxin A | BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA] | 24755393 |
C025589 | ochratoxin A | ochratoxin A results in decreased expression of CASP9 mRNA | 17316727|2475539 |
C025589 | ochratoxin A | ochratoxin A results in increased activity of CASP9 protein | 15056805 |
C025589 | ochratoxin A | ochratoxin A results in increased cleavage of and results in increased activity of CASP9 protein | 19367635 |
C025589 | ochratoxin A | ochratoxin A results in increased cleavage of CASP9 protein | 20549612 |
C025589 | ochratoxin A | ochratoxin A results in increased activity of CASP9 protein | 19562491 |
D019301 | Oleic Acid | IRS2 inhibits the reaction [Oleic Acid results in increased cleavage of CASP9 protein] | 14604813 |
D019301 | Oleic Acid | Oleic Acid results in increased cleavage of CASP9 protein | 14604813 |
D016627 | Oxidopamine | Oxidopamine results in increased activity of CASP9 protein | 19780897|1978156 |
D016627 | Oxidopamine | sulforafan inhibits the reaction [Oxidopamine results in increased activity of CASP9 protein] | 19780897 |
D016627 | Oxidopamine | Oxidopamine results in increased activity of CASP9 protein | 21846476 |
D016627 | Oxidopamine | Oxidopamine results in increased expression of CASP9 protein | 23274087 |
D019319 | Okadaic Acid | Okadaic Acid results in increased cleavage of and results in increased activity of CASP9 protein | 19084044 |
D019319 | Okadaic Acid | Okadaic Acid results in increased activity of CASP9 protein | 26732598 |
C013168 | olaquindox | CDKN1A protein affects the reaction [olaquindox results in increased cleavage of CASP9 protein] | 28757460 |
C013168 | olaquindox | olaquindox results in decreased expression of CASP9 protein | 21549799 |
C013168 | olaquindox | olaquindox results in increased activity of CASP9 protein | 21549799 |
C013168 | olaquindox | olaquindox results in increased cleavage of CASP9 protein | 28757460 |
D009828 | Oleanolic Acid | Oleanolic Acid analog results in decreased expression of CASP9 protein | 26612655 |
C029407 | oleylamide | oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
D009842 | Oligopeptides | Oligopeptides inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 25868679 |
C507134 | ON 01910 | ON 01910 results in increased cleavage of CASP9 protein | 19198627 |
C000594117 | ON123300 | ON123300 results in decreased expression of CASP9 mRNA | 26873845 |
C016340 | o,p'-DDT | "o,p'-DDT affects the expression of CASP9 mRNA" | 18925944 |
C016340 | o,p'-DDT | "o,p'-DDT analog results in decreased expression of CASP9 mRNA" | 22937105 |
C016340 | o,p'-DDT | "o,p'-DDT results in increased expression of CASP9 mRNA" | 22937105 |
D009942 | Organometallic Compounds | Organometallic Compounds results in decreased expression of CASP9 protein | 21437708 |
D009942 | Organometallic Compounds | Organometallic Compounds results in increased activity of CASP9 | 18760261 |
D009942 | Organometallic Compounds | Organometallic Compounds results in increased activity of CASP9 protein | 26391003 |
D009942 | Organometallic Compounds | Organometallic Compounds results in increased cleavage of and results in increased activity of CASP9 protein | 17210701 |
C055122 | orlistat | orlistat results in increased activity of CASP9 protein | 20805790 |
C552952 | oxazolinodaunorubicin | oxazolinodaunorubicin affects the expression of CASP9 mRNA | 27780733 |
D010100 | Oxygen | iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein] | 15583868 |
D010100 | Oxygen | Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased activity of CASP9 protein] | 24860939 |
D010100 | Oxygen | Oxygen deficiency results in increased activity of CASP9 protein | 15583868 |
D010100 | Oxygen | Quercetin inhibits the reaction [iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]] | 15583868 |
D010100 | Oxygen | CASP9 protein affects the susceptibility to Oxygen deficiency | 11042672 |
D010100 | Oxygen | naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein] | 25773745 |
D010100 | Oxygen | [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form | 24058562 |
D010100 | Oxygen | [Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein | 25773745 |
D010100 | Oxygen | Oxygen deficiency results in increased cleavage of CASP9 protein | 15786717|2146857 |
D010100 | Oxygen | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form] | 24058562 |
D010126 | Ozone | Ozone inhibits the reaction [Water Pollutants results in increased expression of CASP9 mRNA] | 23022117 |
D010126 | Ozone | Ozone results in increased cleavage of CASP9 protein | 22727909 |
D017239 | Paclitaxel | "[4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide co-treated with Paclitaxel] results in increased activity of CASP9 protein" | 16170024 |
D017239 | Paclitaxel | [6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine co-treated with Paclitaxel] results in increased activity of CASP9 protein | 16170024 |
D017239 | Paclitaxel | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel] | 18594523 |
D017239 | Paclitaxel | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Paclitaxel | 18594523 |
D017239 | Paclitaxel | CASP9 protein affects the susceptibility to Paclitaxel | 17652622 |
D017239 | Paclitaxel | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein | 16168113 |
D017239 | Paclitaxel | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein] | 16168113 |
D017239 | Paclitaxel | Paclitaxel results in increased activity of CASP9 protein | 18098270 |
D017239 | Paclitaxel | Paclitaxel results in increased cleavage of and results in increased activity of CASP9 protein | 24126434 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of CASP9 mRNA | 18058816 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of CASP9 protein | 15907983 |
D017239 | Paclitaxel | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | 14749477 |
D017239 | Paclitaxel | [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP9 protein | 15753396 |
D017239 | Paclitaxel | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | 17701358 |
D017239 | Paclitaxel | CASP9 protein affects the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] | 17652622 |
D017239 | Paclitaxel | BCL2 protein inhibits the reaction [Paclitaxel results in increased activity of CASP9 protein] | 14726646 |
D017239 | Paclitaxel | Paclitaxel results in increased activity of CASP9 protein | 14726646 |
C000588809 | paederosidic acid | MAPK8 protein affects the reaction [paederosidic acid results in increased cleavage of CASP9 protein] | 28185768 |
C000588809 | paederosidic acid | paederosidic acid results in increased cleavage of CASP9 protein | 28185768 |
C019248 | pamidronate | pamidronate results in increased cleavage of CASP9 protein | 16298452 |
C482884 | panduratin A | panduratin A results in increased cleavage of CASP9 protein | 16497706 |
C496932 | panobinostat | [resveratrol co-treated with panobinostat] results in increased cleavage of CASP9 protein | 22923501 |
D010261 | Paraoxon | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein] | 12831782 |
D010261 | Paraoxon | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein] | 12831782 |
D010261 | Paraoxon | Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein | 12831782 |
D010269 | Paraquat | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] | 22736252 |
D010269 | Paraquat | Paraquat results in decreased expression of CASP9 mRNA | 18836921 |
D010269 | Paraquat | Paraquat results in increased activity of CASP9 protein | 18253895|2668657 |
D010269 | Paraquat | Paraquat results in increased cleavage of CASP9 protein | 22043816 |
D010269 | Paraquat | Paraquat results in increased expression of CASP9 mRNA | 22736252 |
D010269 | Paraquat | Paraquat results in increased expression of CASP9 mRNA alternative form | 17064354 |
D010269 | Paraquat | Paraquat results in increased expression of CASP9 protein | 26649146 |
D010269 | Paraquat | PTGDS mutant form promotes the reaction [Paraquat results in increased cleavage of CASP9 protein] | 22043816 |
D010269 | Paraquat | [PTGDS protein results in decreased susceptibility to Paraquat] which results in decreased cleavage of CASP9 protein | 22043816 |
D010269 | Paraquat | salvin inhibits the reaction [Paraquat results in increased activity of CASP9 protein] | 26686574 |
D010269 | Paraquat | [Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA | 23963992 |
D010269 | Paraquat | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D010269 | Paraquat | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D010269 | Paraquat | [Paraquat co-treated with Maneb] results in increased expression of CASP9 protein | 20964710 |
D010269 | Paraquat | Paraquat results in increased expression of CASP9 protein modified form | 27442881 |
D010269 | Paraquat | Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D010269 | Paraquat | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D010269 | Paraquat | Paraquat results in increased activity of CASP9 protein | 24912633 |
D017374 | Paroxetine | Paroxetine results in increased activity of CASP9 protein | 28482088 |
C022097 | parthenin | parthenin analog results in increased activity of CASP9 protein | 25196075 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of CASP9 protein | 19675143 |
D052638 | Particulate Matter | Particulate Matter results in increased activity of CASP9 protein | 16946128 |
D052638 | Particulate Matter | Particulate Matter results in increased cleavage of CASP9 protein | 19675143 |
D052638 | Particulate Matter | pifithrin inhibits the reaction [Particulate Matter results in increased activity of CASP9 protein] | 16946128 |
D052638 | Particulate Matter | TRP53 protein affects the reaction [Particulate Matter results in increased activity of CASP9 protein] | 16946128 |
D052638 | Particulate Matter | Particulate Matter results in increased activity of CASP9 protein | 16946128 |
D052638 | Particulate Matter | pifithrin inhibits the reaction [Particulate Matter results in increased activity of CASP9 protein] | 16946128 |
C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of CASP9 mRNA | 18593933 |
D010396 | Penicillamine | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
D010396 | Penicillamine | Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] | 20946909 |
D010396 | Penicillamine | Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] | 20946909 |
C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased activity of CASP9 protein | 18453545 |
D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of CASP9 mRNA | 24642059 |
C572410 | pentedrone | pentedrone results in increased activity of CASP9 protein | 27255387 |
D004369 | Pentetic Acid | Pentetic Acid results in increased activity of CASP9 protein | 17169355 |
D010431 | Pentoxifylline | [Pentoxifylline co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 20804743 |
C031375 | pepstatin | pepstatin inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] | 28378122 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA | 19468714 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA | 21115943 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA | 24616003 |
C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of CASP9 protein | 24616003 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of CASP9 mRNA | 19468714 |
C011272 | perfosfamide | perfosfamide results in increased activity of CASP9 protein | 16488414 |
D030421 | Peroxynitrous Acid | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein] | 20869986 |
D030421 | Peroxynitrous Acid | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased expression of CASP9 mRNA] | 20869986 |
D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein | 20869986 |
D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in increased expression of CASP9 mRNA | 20869986 |
D010578 | Petroleum | Petroleum results in increased expression of CASP9 protein | 24106129 |
D015232 | Dinoprostone | Dinoprostone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] | 25094029 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased activity of CASP9 protein | 16054126 |
D010634 | Phenobarbital | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP9 mRNA | 27048571 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of CASP9 mRNA | 23273579 |
D019800 | Phenol | Phenol results in increased activity of CASP9 protein | 23776099 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone analog results in increased activity of CASP9 protein | 25684395 |
D010670 | Phenylthiourea | Phenylthiourea results in increased expression of CASP9 protein | 16447258 |
D010696 | Phloroglucinol | Phloroglucinol results in decreased expression of CASP9 protein modified form | 20188716 |
D010696 | Phloroglucinol | Phloroglucinol metabolite results in increased cleavage of CASP9 protein | 22796323 |
D010702 | Phorate | Phorate results in increased expression of CASP9 mRNA | 22197610 |
D010702 | Phorate | Phorate results in increased expression of CASP9 protein | 22197610 |
D015240 | Phorbol 12,13-Dibutyrate | "Phorbol 12,13-Dibutyrate results in increased cleavage of CASP9 protein" | 12626342 |
D015240 | Phorbol 12,13-Dibutyrate | "rottlerin inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased cleavage of CASP9 protein]" | 12626342 |
D010713 | Phosphatidylcholines | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP9 protein | 21695227 |
C107448 | phthalocyanine Pc 4 | phthalocyanine Pc 4 results in increased cleavage of and results in increased activity of CASP9 protein | 16007152 |
D010833 | Phytic Acid | "Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492|1476666 |
C012491 | phytosphingosine | "3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]" | 17237268 |
C012491 | phytosphingosine | [arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein | 17237268 |
C012491 | phytosphingosine | SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein] | 17237268 |
C522973 | PI103 | BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
C522973 | PI103 | PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 20856197 |
C522973 | PI103 | TP53 protein promotes the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]] | 20856197 |
C121565 | pifithrin | pifithrin inhibits the reaction [cobaltous chloride results in increased activity of CASP9 protein] | 23380477 |
C121565 | pifithrin | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] | 19732952 |
C121565 | pifithrin | pifithrin inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | 23566959 |
C121565 | pifithrin | pifithrin inhibits the reaction [Particulate Matter results in increased activity of CASP9 protein] | 16946128 |
C121565 | pifithrin | pifithrin inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP9 protein] | 26884717 |
C121565 | pifithrin | pifithrin inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
C121565 | pifithrin | pifithrin promotes the reaction [Mustard Gas results in increased cleavage of CASP9 protein] | 25448276 |
C121565 | pifithrin | "pifithrin inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 16357363 |
C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 16357363 |
C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | 16687611 |
C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18775851 |
C121565 | pifithrin | pifithrin inhibits the reaction [Humic Substances results in increased cleavage of CASP9 protein] | 18683188 |
C121565 | pifithrin | pifithrin inhibits the reaction [Particulate Matter results in increased activity of CASP9 protein] | 16946128 |
D010862 | Pilocarpine | Pilocarpine results in increased expression of CASP9 protein | 18708038 |
C004479 | pimagedine | pimagedine promotes the reaction [chromium hexavalent ion results in increased activity of CASP9 protein] | 19556603 |
C004479 | pimagedine | pimagedine promotes the reaction [sodium bichromate results in increased activity of CASP9 protein] | 19556603 |
C004479 | pimagedine | pimagedine inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] | 17786558 |
D020110 | Pinacidil | Pinacidil results in decreased expression of CASP9 mRNA | 17612592 |
C008922 | piperine | piperine results in increased cleavage of CASP9 protein | 28341137 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CASP9 mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of CASP9 mRNA | 17426115 |
D010936 | Plant Extracts | [arsenic trioxide co-treated with Plant Extracts] results in increased cleavage of CASP9 protein | 26160715 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] | 27050144 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 20971099 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CASP9 protein | 24021570 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of CASP9 protein | 17935706|1807062 |
D010936 | Plant Extracts | Plant Extracts results in increased cleavage of and results in increased activity of CASP9 protein | 17619071 |
D010936 | Plant Extracts | Plant Extracts results in increased cleavage of CASP9 protein | 20229524|2544919 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of and results in increased activity of CASP9 protein | 24677778 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of CASP9 mRNA | 26122529 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of CASP9 protein | 24534064 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CASP9 protein | 23994094 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of CASP9 protein | 24991116 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] | 19772912 |
D028321 | Plant Preparations | LRP1 protein promotes the reaction [Plant Preparations results in increased cleavage of CASP9 protein] | 27262837 |
D028321 | Plant Preparations | Plant Preparations results in increased cleavage of CASP9 protein | 27262837 |
D028321 | Plant Preparations | Plant Preparations inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 24875324 |
D010984 | Platinum | [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein | 25846798 |
D010984 | Platinum | [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA | 25846798 |
C014758 | plumbagin | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] | 20576514 |
C014758 | plumbagin | plumbagin results in increased activity of CASP9 protein | 20576514 |
C422648 | pluronic block copolymer p85 | pluronic block copolymer p85 promotes the reaction [Doxorubicin results in increased expression of CASP9 mRNA] | 15939500 |
D011034 | Podophyllotoxin | Podophyllotoxin results in increased activity of CASP9 protein | 21916509 |
C531249 | Poly(amidoamine) | Poly(amidoamine) results in increased cleavage of CASP9 protein | 19643170 |
D011070 | Poly I-C | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]] | 21418039 |
D011070 | Poly I-C | Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein]] | 21418039 |
D011070 | Poly I-C | arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein] | 21418039 |
D011070 | Poly I-C | Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 21418039 |
D011070 | Poly I-C | Poly I-C results in increased activity of CASP9 protein | 21418039 |
C043435 | polylactic acid-polyglycolic acid copolymer | [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP9 mRNA | 24070738 |
C043435 | polylactic acid-polyglycolic acid copolymer | [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in increased expression of CASP9 protein | 24070738 |
D059808 | Polyphenols | [Polyphenols co-treated with Bleomycin] results in increased expression of CASP9 mRNA | 26800624 |
D059808 | Polyphenols | Polyphenols results in decreased expression of CASP9 protein | 24021570 |
D059808 | Polyphenols | Polyphenols results in increased activity of CASP9 protein | 24021570 |
D059808 | Polyphenols | Polyphenols results in decreased expression of CASP9 mRNA | 16293270 |
C472086 | polyphenon E | polyphenon E results in increased cleavage of CASP9 protein | 23285096 |
D011134 | Polysaccharides | Polysaccharides inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 24875324 |
D011192 | Potassium Dichromate | [Cadmium Chloride co-treated with Potassium Dichromate] results in increased activity of CASP9 protein | 25409916 |
D011192 | Potassium Dichromate | [Cadmium Chloride co-treated with Potassium Dichromate] results in increased expression of CASP9 mRNA | 25409916 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased activity of CASP9 protein | 25409916 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of CASP9 mRNA | 25409916 |
C432807 | pramanicin | pramanicin analog results in increased activity of CASP9 protein | 23441183 |
D017035 | Pravastatin | Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | 18483861 |
D011224 | Prazosin | Prazosin results in increased activity of CASP9 protein | 26449523 |
C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione results in increased activity of CASP9 protein" | 17475222 |
D011339 | Probenecid | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA]" | 24768735 |
D011339 | Probenecid | "geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein]" | 24768735 |
D011339 | Probenecid | "[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA" | 24768735 |
D011339 | Probenecid | "[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 protein" | 24768735 |
C479580 | procyanidin B2 | procyanidin B2 inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] | 21505870 |
C479580 | procyanidin B2 | procyanidin B2 results in decreased activity of CASP9 protein | 21505870 |
D011353 | Prodigiosin | Prodigiosin results in increased cleavage of CASP9 protein | 15746575|1913328 |
D011374 | Progesterone | Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 23482746 |
D011374 | Progesterone | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA | 20732338 |
C045950 | propiconazole | propiconazole results in decreased expression of CASP9 mRNA | 21278054 |
D015742 | Propofol | Propofol results in increased expression of CASP9 mRNA | 26103940 |
D015742 | Propofol | Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein] | 28804952 |
D015742 | Propofol | Propofol results in increased cleavage of CASP9 protein | 28804952 |
D015742 | Propofol | Propofol results in increased activity of CASP9 protein | 21786383 |
D015742 | Propofol | Propofol results in decreased cleavage of CASP9 protein | 21468576 |
D011429 | Propolis | Propolis results in increased activity of CASP9 protein | 26367700 |
D011433 | Propranolol | Propranolol results in increased cleavage of CASP9 protein | 19106745 |
C107773 | pterostilbene | pterostilbene results in increased activity of CASP9 protein | 25341683 |
C107773 | pterostilbene | pterostilbene results in increased expression of CASP9 protein | 20152895 |
C107773 | pterostilbene | Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein] | 25341683 |
C107773 | pterostilbene | pterostilbene results in increased cleavage of CASP9 protein | 20681671 |
C527556 | Pt(O,O'-acac)(gamma-acac)(DMS) | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
C527556 | Pt(O,O'-acac)(gamma-acac)(DMS) | "Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein" | 21420390 |
C527556 | Pt(O,O'-acac)(gamma-acac)(DMS) | "pyrazolanthrone inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
C527556 | Pt(O,O'-acac)(gamma-acac)(DMS) | "SB 203580 inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
D011691 | Puromycin | Puromycin results in increased activity of CASP9 protein | 14502240 |
D011700 | Putrescine | Putrescine results in increased expression of CASP9 protein | 17606387 |
C513428 | pyrachlostrobin | [iprodione co-treated with pyrachlostrobin] results in increased expression of CASP9 mRNA | 29091792 |
C513428 | pyrachlostrobin | [pyrachlostrobin co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of CASP9 protein] | 15831436 |
C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP9 protein]" | 23212307 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | 21138480 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of CASP9 protein] | 15501958 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Quercetin results in increased cleavage of CASP9 protein] | 21165570 |
C432165 | pyrazolanthrone | pyrazolanthrone promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
C432165 | pyrazolanthrone | pyrazolanthrone results in increased activity of CASP9 protein | 15034932 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | 16322078 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] | 17786558 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] | 20920558 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | 21843586 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] | 16310883 |
C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [Asbestos, Serpentine results in increased expression of CASP9 protein]" | 25530474 |
D011722 | Pyrethrins | Pyrethrins results in increased activity of CASP9 protein | 27939866 |
D011739 | Pyrimethamine | Pyrimethamine results in increased activity of CASP9 protein | 18593930 |
C108337 | pyrimethanil | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C108337 | pyrimethanil | [iprodione co-treated with pyrimethanil] results in decreased expression of CASP9 mRNA | 29091792 |
C108337 | pyrimethanil | [pyrachlostrobin co-treated with pyrimethanil co-treated with acetamiprid] results in decreased expression of CASP9 mRNA | 29091792 |
C108337 | pyrimethanil | pyrimethanil results in decreased expression of CASP9 mRNA | 29091792 |
C009131 | pyrimidin-2-one beta-ribofuranoside | pyrimidin-2-one beta-ribofuranoside results in increased activity of CASP9 protein | 23320119 |
C010423 | pyrithione zinc | pyrithione zinc results in increased activity of CASP9 protein | 20151177 |
D011748 | Pyrogallol | Pyrogallol results in increased expression of CASP9 mRNA | 20362636 |
C005719 | pyrovalerone | pyrovalerone analog results in increased activity of CASP9 protein | 28578026 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in increased activity of CASP9 protein | 12198114 |
C020972 | pyrrolidine dithiocarbamic acid | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | 22085843 |
C020972 | pyrrolidine dithiocarbamic acid | [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein | 22085843 |
C020972 | pyrrolidine dithiocarbamic acid | [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein | 20920558 |
C020972 | pyrrolidine dithiocarbamic acid | MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein] | 20920558 |
C020972 | pyrrolidine dithiocarbamic acid | pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] | 20920558 |
D011763 | Pyrrolizidine Alkaloids | Pyrrolizidine Alkaloids results in increased activity of CASP9 protein | 24641316 |
C438462 | pyrrolo(2,1-c)(1,4)benzodiazepine | "[naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of CASP9 protein" | 21732540 |
D011765 | Pyruvaldehyde | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein]] | 26577515 |
D011765 | Pyruvaldehyde | Pyruvaldehyde results in increased expression of CASP9 protein | 26577515 |
D011765 | Pyruvaldehyde | salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein] | 26577515 |
D019289 | Pyruvic Acid | [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 25997894 |
D011794 | Quercetin | Quercetin promotes the reaction [Dichlorvos results in increased activity of CASP9 protein] | 17640809 |
D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP9 protein] | 21165570 |
D011794 | Quercetin | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Quercetin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein] | 20096292 |
D011794 | Quercetin | DDIT3 protein affects the reaction [[TNFSF10 protein co-treated with Quercetin] results in increased cleavage of CASP9 protein] | 24612139 |
D011794 | Quercetin | MCL1 protein inhibits the reaction [Quercetin results in increased activity of CASP9 protein] | 21138867 |
D011794 | Quercetin | pyrazolanthrone inhibits the reaction [Quercetin results in increased cleavage of CASP9 protein] | 21165570 |
D011794 | Quercetin | [Quercetin analog co-treated with Nickel] results in increased activity of CASP9 protein | 20577783 |
D011794 | Quercetin | Quercetin analog results in increased cleavage of CASP9 protein | 25289772 |
D011794 | Quercetin | Quercetin analog results in increased expression of CASP9 mRNA | 25289772 |
D011794 | Quercetin | [Quercetin co-treated with Cisplatin] results in increased activity of CASP9 protein | 27514524 |
D011794 | Quercetin | [Quercetin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | 20096292 |
D011794 | Quercetin | Quercetin inhibits the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
D011794 | Quercetin | Quercetin inhibits the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of CASP9 protein] | 22002103 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 25108166 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 mRNA] | 20361964 |
D011794 | Quercetin | Quercetin inhibits the reaction [iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]] | 15583868 |
D011794 | Quercetin | Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] | 27050144 |
D011794 | Quercetin | Quercetin promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 25611565 |
D011794 | Quercetin | Quercetin promotes the reaction [gemcitabine results in increased activity of CASP9 protein] | 26050647 |
D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 18377872 |
D011794 | Quercetin | Quercetin results in increased activity of CASP9 protein | 16158945|1723477 |
D011794 | Quercetin | Quercetin results in increased cleavage of CASP9 protein | 18331776|1845570 |
D011794 | Quercetin | Quercetin results in increased expression of CASP9 protein | 25339540 |
D011794 | Quercetin | Quercetin results in increased expression of CASP9 protein modified form | 22983795 |
D011794 | Quercetin | [Quercetin results in increased susceptibility to ABT-737] which results in increased activity of CASP9 protein | 23353698 |
D011794 | Quercetin | tauroursodeoxycholic acid inhibits the reaction [Quercetin promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 25611565 |
D011794 | Quercetin | [temozolomide co-treated with Quercetin] results in increased activity of CASP9 protein | 24126416 |
D011794 | Quercetin | [TNFSF10 protein co-treated with Quercetin] results in increased cleavage of CASP9 protein | 24612139 |
D011794 | Quercetin | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 21294050 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 15876423 |
D011794 | Quercetin | Quercetin results in increased activity of CASP9 protein | 26076811 |
D011794 | Quercetin | Quercetin results in increased expression of CASP9 protein | 18586010 |
D011794 | Quercetin | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] | 23281070 |
D011794 | Quercetin | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein] | 24316378 |
D011794 | Quercetin | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP9 mRNA] | 24316378 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | 14505808|1664717 |
D011794 | Quercetin | Quercetin inhibits the reaction [triptolide results in increased activity of CASP9 protein] | 26277538 |
D011794 | Quercetin | Quercetin results in decreased expression of CASP9 mRNA | 23281070 |
D011794 | Quercetin | Quercetin results in increased activity of CASP9 protein | 24126416 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | 23711929 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] | 25845326 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in increased activity of CASP9 protein] | 25845326 |
D011796 | Quinacrine | Quinacrine results in increased cleavage of CASP9 protein | 28867437 |
C502851 | quinocetone | "4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [quinocetone results in increased cleavage of CASP9 protein]" | 28343033 |
C502851 | quinocetone | Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein] | 27375190 |
C502851 | quinocetone | Lithium Chloride inhibits the reaction [quinocetone results in increased cleavage of CASP9 protein] | 28343033 |
C502851 | quinocetone | quinocetone results in increased activity of CASP9 protein | 27375190 |
C502851 | quinocetone | quinocetone results in increased cleavage of CASP9 protein | 28343033 |
C502851 | quinocetone | zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein]] | 27375190 |
C502851 | quinocetone | zinc protoporphyrin promotes the reaction [quinocetone results in increased activity of CASP9 protein] | 27375190 |
C468548 | quinoline-val-asp(OMe)-CH2-OPH | quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein] | 27732882 |
D011899 | Ranitidine | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 19723537 |
D017382 | Reactive Oxygen Species | Cyclosporine inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP9 protein] | 26884717 |
D017382 | Reactive Oxygen Species | [[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein | 19054763 |
D017382 | Reactive Oxygen Species | [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein | 19054763 |
D017382 | Reactive Oxygen Species | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP9 protein] | 19464277 |
D017382 | Reactive Oxygen Species | pifithrin inhibits the reaction [Reactive Oxygen Species results in increased activity of CASP9 protein] | 26884717 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased activity of CASP9 protein | 26884717 |
D017382 | Reactive Oxygen Species | [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in increased activity of CASP9 protein | 23660334 |
D017382 | Reactive Oxygen Species | [XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP9 protein | 19464277 |
C052785 | rebamipide | rebamipide inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 16184425 |
D012116 | Resins, Plant | "Resins, Plant results in increased activity of CASP9 protein" | 27268964 |
C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA] | 15536054 |
C059514 | resveratrol | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein" | 18444175 |
C059514 | resveratrol | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | 19423619 |
C059514 | resveratrol | [Doxorubicin co-treated with resveratrol] results in increased expression of CASP9 mRNA | 26969377 |
C059514 | resveratrol | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol results in increased cleavage of CASP9 protein] | 22923501 |
C059514 | resveratrol | resveratrol analog results in increased activity of CASP9 protein | 24398169 |
C059514 | resveratrol | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | 14749477 |
C059514 | resveratrol | [resveratrol co-treated with panobinostat] results in increased cleavage of CASP9 protein | 22923501 |
C059514 | resveratrol | [resveratrol co-treated with SB 203580] results in increased activity of CASP9 protein | 22644961 |
C059514 | resveratrol | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | 15763656 |
C059514 | resveratrol | resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | 19959636 |
C059514 | resveratrol | resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] | 21505870 |
C059514 | resveratrol | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] | 17823925 |
C059514 | resveratrol | resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein] | 20060927 |
C059514 | resveratrol | resveratrol results in decreased activity of CASP9 protein | 21505870 |
C059514 | resveratrol | [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein | 19423619 |
C059514 | resveratrol | resveratrol results in increased activity of CASP9 protein | 11406544|1582732 |
C059514 | resveratrol | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | 12902349|1661705 |
C059514 | resveratrol | resveratrol results in increased cleavage of CASP9 protein | 18347188|1844417 |
C059514 | resveratrol | sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] | 20697895 |
C059514 | resveratrol | BIRC5 protein affects the reaction [resveratrol results in increased cleavage of CASP9 protein] | 22137261 |
C059514 | resveratrol | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | 16322078 |
C059514 | resveratrol | resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP9 protein] | 23922164 |
C059514 | resveratrol | resveratrol results in decreased activity of CASP9 protein | 20940732 |
C059514 | resveratrol | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | 16675471|1879181 |
C059514 | resveratrol | resveratrol results in increased cleavage of CASP9 protein | 17872969|1820172 |
C059514 | resveratrol | resveratrol results in increased expression of CASP9 protein | 25505154 |
C059514 | resveratrol | SIRT1 protein affects the reaction [resveratrol results in increased cleavage of CASP9 protein] | 22137261 |
C059514 | resveratrol | resveratrol results in decreased activity of CASP9 protein | 20861279 |
C059514 | resveratrol | resveratrol results in decreased expression of CASP9 protein modified form | 24040416 |
D019782 | Riluzole | Riluzole results in increased activity of CASP9 protein | 19528481 |
D000068296 | Risedronate Sodium | Risedronate Sodium results in increased activity of CASP9 protein | 19505369 |
C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [Lindane results in increased activity of CASP9 protein] | 22001173 |
C087123 | romidepsin | Bortezomib promotes the reaction [romidepsin results in increased cleavage of CASP9 protein] | 18223231 |
C087123 | romidepsin | romidepsin results in increased cleavage of CASP9 protein | 18223231 |
C046649 | ropinirole | ropinirole inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 18242171 |
C037663 | ropivacaine | ropivacaine results in decreased expression of CASP9 protein | 20194319 |
C104586 | roscovitine | roscovitine results in increased activity of CASP9 protein | 16140939 |
C530393 | rosemarinic acid | rosemarinic acid inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | 21526214 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [decamethrin results in increased activity of CASP9 protein] | 27553674 |
C089730 | rosiglitazone | rosiglitazone results in increased activity of CASP9 protein | 17506947 |
D012402 | Rotenone | 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] | 16917840 |
D012402 | Rotenone | ALDH2 protein inhibits the reaction [Rotenone results in increased activity of CASP9 protein] | 25263579 |
D012402 | Rotenone | kaempferol inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 20594614 |
D012402 | Rotenone | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Rotenone results in increased activity of CASP9 protein]" | 25263579 |
D012402 | Rotenone | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 19723537 |
D012402 | Rotenone | ropinirole inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 18242171 |
D012402 | Rotenone | Rotenone results in increased activity of CASP9 protein | 16917840|2526357 |
D012402 | Rotenone | Rotenone results in increased cleavage of CASP9 protein | 18242171|1953900 |
D012402 | Rotenone | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 19539006 |
D012402 | Rotenone | CASP2 protein affects the reaction [Rotenone results in increased activity of CASP9 protein] | 21216964 |
D012402 | Rotenone | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP9 protein]" | 24830863 |
D012402 | Rotenone | Rotenone results in increased activity of CASP9 protein | 21216964 |
D012402 | Rotenone | Rotenone results in increased expression of CASP9 mRNA | 25428620 |
D012402 | Rotenone | "N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Rotenone results in increased activity of CASP9 protein]" | 25263579 |
D012402 | Rotenone | Rotenone inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | 21664962 |
D012402 | Rotenone | Rotenone results in increased activity of CASP9 protein | 25263579 |
D012402 | Rotenone | Rotenone results in increased expression of CASP9 mRNA | 25502462 |
D012402 | Rotenone | Rotenone results in increased expression of CASP9 protein | 25502462 |
D012402 | Rotenone | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP9 mRNA] | 25502462 |
D012402 | Rotenone | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP9 protein] | 25502462 |
C085746 | rottlerin | rottlerin results in increased cleavage of CASP9 protein | 22902833 |
C085746 | rottlerin | "rottlerin inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of CASP9 protein]" | 12626342 |
C085746 | rottlerin | "rottlerin inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased cleavage of CASP9 protein]" | 12626342 |
C046245 | rubimaillin | BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP9 protein] | 19716835 |
C046245 | rubimaillin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone affects the reaction [rubimaillin results in increased activity of CASP9 protein] | 19716835 |
C046245 | rubimaillin | rubimaillin results in increased activity of CASP9 protein | 19716835 |
C079905 | rubitecan | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP9 protein | 21695227 |
C079905 | rubitecan | rubitecan results in increased expression of CASP9 protein | 21695227 |
D012428 | Ruthenium | Ruthenium results in increased cleavage of and results in increased activity of CASP9 protein | 17210701 |
D017975 | Ruthenium Compounds | Ruthenium Compounds results in decreased expression of CASP9 protein | 21437708 |
D017975 | Ruthenium Compounds | Ruthenium Compounds results in increased cleavage of and results in increased activity of CASP9 protein | 17210701 |
C039961 | S-(1,2-dichlorovinyl)cysteine | "S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP9 protein" | 29129777 |
C039961 | S-(1,2-dichlorovinyl)cysteine | "S-(1,2-dichlorovinyl)cysteine results in increased cleavage of CASP9 protein" | 15967204 |
C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of CASP9 mRNA | 21427059 |
C571832 | saccharic acid-1,4-lactone | "saccharic acid-1,4-lactone inhibits the reaction [Alloxan results in increased activity of CASP9 protein]" | 21982801 |
D012451 | Safrole | Safrole results in increased activity of CASP9 protein | 21591240 |
D012451 | Safrole | Safrole results in increased expression of CASP9 mRNA | 21591240 |
C025759 | saikosaponin | saikosaponin results in increased cleavage of and results in increased activity of CASP9 protein | 23994742 |
C025759 | saikosaponin | saikosaponin results in increased expression of CASP9 protein modified form | 23994742 |
C413684 | salicylaldehyde isonicotinoyl hydrazone | salicylaldehyde isonicotinoyl hydrazone analog results in increased activity of CASP9 protein | 22521999 |
C000687 | salicyl hydrazide | salicyl hydrazide analog results in increased activity of CASP9 protein | 25684395 |
C496827 | salubrinal | Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 21616140 |
C496827 | salubrinal | salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 21616140 |
C018381 | salvin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein]] | 26577515 |
C018381 | salvin | Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP9 protein] | 28918123 |
C018381 | salvin | salvin inhibits the reaction [Acrylamide results in increased expression of CASP9 mRNA] | 28159594 |
C018381 | salvin | salvin inhibits the reaction [Paraquat results in increased activity of CASP9 protein] | 26686574 |
C018381 | salvin | salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein] | 26577515 |
C018381 | salvin | salvin promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 23239002 |
C018381 | salvin | salvin results in increased activity of CASP9 protein | 23239002 |
C018381 | salvin | salvin results in increased cleavage of CASP9 protein | 28918123 |
C005705 | sanguinarine | sanguinarine results in decreased expression of CASP9 protein alternative form | 19135517 |
C005705 | sanguinarine | sanguinarine results in increased activity of CASP9 protein | 19346183|2221541 |
C005705 | sanguinarine | [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in increased activity of CASP9 protein | 23660334 |
D012503 | Saponins | Saponins inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 mRNA] | 29274434 |
D012503 | Saponins | Saponins results in increased cleavage of CASP9 protein | 28088315 |
D012503 | Saponins | Saponins results in increased metabolism of CASP9 protein | 12856725 |
D012503 | Saponins | Saponins results in decreased expression of CASP9 protein | 23994094 |
C044363 | sappanchalcone | sappanchalcone results in increased activity of CASP9 protein | 21963806 |
D019258 | Saquinavir | Saquinavir results in increased cleavage of CASP9 protein | 19147209 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
C093642 | SB 203580 | [resveratrol co-treated with SB 203580] results in increased activity of CASP9 protein | 22644961 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein] | 17237268 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
C093642 | SB 203580 | "SB 203580 inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of CASP9 protein]" | 21420390 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] | 15365088 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
C420822 | SB 273005 | SB 273005 results in increased activity of CASP9 protein | 22964516 |
C499748 | SCIO-469 | SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP9 protein] | 16617327 |
D012604 | Scorpion Venoms | Scorpion Venoms results in increased activity of CASP9 protein | 19913524 |
C524947 | Scutellaria barbata extract | Scutellaria barbata extract results in increased cleavage of and results in increased activity of CASP9 protein | 15369734 |
C552033 | S-dimethylaminoarsino-thiosuccinic acid | S-dimethylaminoarsino-thiosuccinic acid analog results in increased cleavage of CASP9 protein | 19468689 |
D012643 | Selenium | Selenium inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 25035189 |
D012643 | Selenium | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein] | 17339365 |
D012643 | Selenium | [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein | 17339365 |
D012643 | Selenium | Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]] | 27920530 |
D012643 | Selenium | Selenium results in decreased activity of CASP9 protein | 17997286 |
D012643 | Selenium | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | 21628957 |
D012643 | Selenium | Selenium inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | 19135140 |
C002979 | selenomethylselenocysteine | BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form] | 25321483 |
C002979 | selenomethylselenocysteine | selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form | 25321483 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased cleavage of CASP9 protein" | 18300051 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CASP9 protein" | 24735948 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased cleavage of CASP9 protein" | 18300051 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CASP9 mRNA" | 25530474 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CASP9 protein" | 25530474 |
D017632 | Asbestos, Serpentine | "pyrazolanthrone inhibits the reaction [Asbestos, Serpentine results in increased expression of CASP9 protein]" | 25530474 |
D020280 | Sertraline | Sertraline results in increased cleavage of and results in increased activity of CASP9 protein | 24194395 |
C025583 | sesamol | sesamol results in increased activity of CASP9 protein | 27270451 |
D012717 | Sesquiterpenes | Sesquiterpenes results in increased activity of CASP9 protein | 18070620 |
C516024 | SH-6 compound | SH-6 compound results in increased activity of CASP9 protein | 14990993 |
C040115 | shogaol | shogaol results in increased cleavage of and results in increased activity of CASP9 protein | 18384088 |
D000068677 | Sildenafil Citrate | CASP9 protein affects the susceptibility to Sildenafil Citrate | 20884855 |
D000068677 | Sildenafil Citrate | CASP9 protein mutant form inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin] | 20884855 |
D000068677 | Sildenafil Citrate | Sildenafil Citrate promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] | 20884855 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CASP9 mRNA | 26263183 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CASP9 protein | 26263183 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CASP9 protein | 26865670 |
D012822 | Silicon Dioxide | ZC3H12A affects the reaction [Silicon Dioxide results in increased expression of CASP9 protein] | 26865670 |
D012834 | Silver | Silver results in increased activity of CASP9 protein | 23804405 |
D018030 | Silver Compounds | Silver Compounds results in increased activity of CASP9 protein | 21182908 |
C440975 | silybin | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
C440975 | silybin | Caffeine inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
C440975 | silybin | pifithrin inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | 16777994 |
C440975 | silybin | silybin results in increased cleavage of and results in increased activity of CASP9 protein | 16777994 |
D012838 | Silymarin | Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] | 23963992 |
D012838 | Silymarin | Silymarin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | 20964710 |
D012838 | Silymarin | Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] | 19772912 |
D019821 | Simvastatin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased activity of CASP9 protein] | 12438947 |
D019821 | Simvastatin | DIABLO protein promotes the reaction [Simvastatin results in increased activity of CASP9 protein] | 20045437 |
D019821 | Simvastatin | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP9 protein] | 20045437 |
D019821 | Simvastatin | Simvastatin results in decreased activity of CASP9 protein | 12438947 |
D019821 | Simvastatin | Simvastatin results in increased activity of CASP9 protein | 15705602|1647022 |
D019821 | Simvastatin | Simvastatin results in increased cleavage of and results in increased activity of CASP9 protein | 19253821|2004543 |
D019821 | Simvastatin | Simvastatin results in increased cleavage of CASP9 protein | 12962723 |
C574383 | sinularin | Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP9 protein] | 28548367 |
C574383 | sinularin | sinularin results in increased cleavage of CASP9 protein | 28548367 |
D020123 | Sirolimus | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of CASP9 protein | 15767555 |
D020123 | Sirolimus | [Curcumin co-treated with Sirolimus] results in increased activity of CASP9 protein | 19373661 |
D020123 | Sirolimus | [Sirolimus co-treated with Cisplatin] results in increased activity of CASP9 protein | 20138251 |
D020123 | Sirolimus | [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP9 protein | 15753396 |
D020123 | Sirolimus | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | 18058806 |
D020123 | Sirolimus | [tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP9 protein | 17121904 |
D020123 | Sirolimus | Sirolimus inhibits the reaction [TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]] | 28342888 |
D020123 | Sirolimus | Sirolimus results in decreased activity of CASP9 protein | 18097008 |
D020123 | Sirolimus | Sirolimus inhibits the reaction [Staurosporine results in increased cleavage of CASP9 protein] | 16497721 |
C439060 | sirtinol | sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] | 20697895 |
C534922 | SNX 2112 | SNX 2112 results in increased expression of CASP9 protein modified form | 23777986 |
C017947 | sodium arsenite | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein] | 19082730 |
C017947 | sodium arsenite | [acetyl-leucyl-glutamyl-histidyl-aspartal results in decreased activity of CASP9 protein] which results in decreased susceptibility to sodium arsenite | 23219847 |
C017947 | sodium arsenite | CASP9 protein affects the susceptibility to sodium arsenite | 23219847 |
C017947 | sodium arsenite | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein]" | 23681673 |
C017947 | sodium arsenite | [sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein | 19082730 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CASP9 protein | 26404762 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of CASP9 protein | 23681673 |
C017947 | sodium arsenite | sodium arsenite results in increased cleavage of and results in increased activity of CASP9 protein | 23219847 |
C017947 | sodium arsenite | sodium arsenite results in increased cleavage of CASP9 protein | 24100277 |
C017947 | sodium arsenite | tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of CASP9 protein] | 26404762 |
C017947 | sodium arsenite | [GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein] | 20006689 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of CASP9 protein | 20006689 |
C017947 | sodium arsenite | Calcium affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 24184500 |
C017947 | sodium arsenite | "[Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 24184500 |
C017947 | sodium arsenite | IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
C017947 | sodium arsenite | lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 23906897 |
C017947 | sodium arsenite | "monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]" | 24184500 |
C017947 | sodium arsenite | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 23906897 |
C017947 | sodium arsenite | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]]" | 23906897 |
C017947 | sodium arsenite | "monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in increased expression of CASP9 mRNA]" | 23906897 |
C017947 | sodium arsenite | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] | 26396915 |
C017947 | sodium arsenite | [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein | 26396915 |
C017947 | sodium arsenite | sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA] | 23906897 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CASP9 mRNA | 23906897|2418450 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CASP9 protein | 20830294 |
C017947 | sodium arsenite | Taurine inhibits the reaction [sodium arsenite results in increased expression of CASP9 protein] | 20830294 |
C017947 | sodium arsenite | Zinc affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 24184500 |
D020160 | Sodium Benzoate | "Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]" | 12540492 |
C016104 | sodium bichromate | CAT protein inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 18544562 |
C016104 | sodium bichromate | dipropylenetriamine-NONOate inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 19556603 |
C016104 | sodium bichromate | FBP1 protein promotes the reaction [sodium bichromate results in increased expression of CASP9 protein modified form] | 28624442 |
C016104 | sodium bichromate | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 18544562 |
C016104 | sodium bichromate | pimagedine promotes the reaction [sodium bichromate results in increased activity of CASP9 protein] | 19556603 |
C016104 | sodium bichromate | sodium bichromate results in increased activity of CASP9 protein | 18544562|1955660 |
C016104 | sodium bichromate | sodium bichromate results in increased expression of CASP9 protein modified form | 28624442 |
C016104 | sodium bichromate | CAT protein inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 20298709 |
C016104 | sodium bichromate | sodium bichromate results in increased activity of CASP9 protein | 20298709 |
C016104 | sodium bichromate | TRP53 mutant form inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein] | 20298709 |
C025451 | sodium bisulfide | sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form] | 24058562 |
C009281 | sodium cyanate | [sodium cyanate co-treated with Hydrogen Peroxide] results in increased activity of CASP9 protein | 28400100 |
C009281 | sodium cyanate | sodium cyanate results in increased activity of CASP9 protein | 28400100 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased cleavage of and results in increased activity of CASP9 protein | 21708216 |
D012969 | Sodium Fluoride | lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP9 protein] | 27871895 |
D012969 | Sodium Fluoride | lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] | 27871895 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased activity of CASP9 protein | 27871895 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CASP9 mRNA | 27871895 |
D012969 | Sodium Fluoride | lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] | 27871895 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased activity of CASP9 protein | 18696052|2787189 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CASP9 mRNA | 19009284|2787189 |
D018038 | Sodium Selenite | Sodium Selenite results in increased cleavage of CASP9 protein | 28161410 |
D018038 | Sodium Selenite | Sodium Selenite results in increased expression of CASP9 mRNA | 16705456 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased activity of CASP9 protein | 18209489 |
D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein] | 26607349 |
D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein] | 26607349 |
D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP9 protein] | 26607349 |
C471405 | sorafenib | AKT1 protein inhibits the reaction [[Bortezomib co-treated with sorafenib] results in increased cleavage of CASP9 protein] | 16985072 |
C471405 | sorafenib | arsenic trioxide promotes the reaction [sorafenib results in increased activity of CASP9 protein] | 25416439 |
C471405 | sorafenib | [Bortezomib co-treated with sorafenib] results in increased cleavage of CASP9 protein | 16985072 |
C471405 | sorafenib | MCL1 protein inhibits the reaction [sorafenib results in increased cleavage of and results in increased activity of CASP9 protein] | 16109713 |
C471405 | sorafenib | "[sorafenib co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] results in increased cleavage of CASP9 protein" | 20117835 |
C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein | 17909059 |
C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | 20071162 |
C471405 | sorafenib | sorafenib promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | 25416439 |
C471405 | sorafenib | sorafenib results in increased activity of CASP9 protein | 21293487|2541643 |
C471405 | sorafenib | sorafenib results in increased cleavage of and results in increased activity of CASP9 protein | 16109713 |
C471405 | sorafenib | sorafenib results in increased cleavage of CASP9 protein | 18200035|2005464 |
D013012 | Sorbitol | Sorbitol results in increased activity of CASP9 protein | 20609311 |
D013012 | Sorbitol | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | 20609311 |
D013012 | Sorbitol | Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein] | 20609311 |
D013096 | Spermine | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein] | 11399061 |
D013096 | Spermine | Spermine results in decreased expression of CASP9 protein | 17606387 |
D013148 | Spironolactone | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | 20609311 |
D019311 | Staurosporine | Staurosporine results in increased activity of CASP9 protein | 14642398 |
D019311 | Staurosporine | ACHE protein affects the susceptibility to [Staurosporine results in increased activity of CASP9 protein] | 20338155 |
D019311 | Staurosporine | Staurosporine results in increased activity of CASP9 protein | 19352495|2033815 |
D019311 | Staurosporine | Staurosporine results in increased cleavage of and results in increased activity of CASP9 protein | 16007152 |
D019311 | Staurosporine | Staurosporine results in increased cleavage of CASP9 protein | 26124276 |
D019311 | Staurosporine | 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein] | 16497721 |
D019311 | Staurosporine | Sirolimus inhibits the reaction [Staurosporine results in increased cleavage of CASP9 protein] | 16497721 |
D013267 | Stilbenes | Stilbenes analog results in increased activity of CASP9 protein | 25980588 |
D013267 | Stilbenes | Stilbenes results in increased activity of CASP9 protein | 22293408|2305997 |
D013267 | Stilbenes | [Stilbenes results in increased activity of CASP9 protein] which results in increased cleavage of CASP3 protein | 22293408 |
D013311 | Streptozocin | Streptozocin results in increased activity of CASP9 protein | 22940631 |
D013311 | Streptozocin | Streptozocin results in increased expression of and results in increased cleavage of CASP9 protein | 15976052 |
D013311 | Streptozocin | Streptozocin results in increased expression of CASP9 protein | 19951573 |
D013311 | Streptozocin | Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | 19951573 |
D020058 | Styrene | Styrene results in increased activity of CASP9 protein | 17420221 |
C061636 | suillin | suillin results in increased cleavage of and results in increased activity of CASP9 protein | 19616521 |
D012460 | Sulfasalazine | Sulfasalazine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP9 protein] | 16322111 |
D012460 | Sulfasalazine | Sulfasalazine results in increased cleavage of CASP9 protein | 19859796 |
C016766 | sulforafan | sulforafan inhibits the reaction [Oxidopamine results in increased activity of CASP9 protein] | 19780897 |
C016766 | sulforafan | sulforafan results in increased activity of CASP9 protein | 26833863 |
D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of and results in increased activity of CASP9 protein | 19621461 |
D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of CASP9 mRNA | 19621461 |
D013467 | Sulindac | [Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein | 18281123 |
D013467 | Sulindac | Sulindac results in increased activity of CASP9 protein | 15713900 |
D013467 | Sulindac | [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein | 15713900 |
C025462 | sulindac sulfide | BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]] | 12203115 |
C025462 | sulindac sulfide | PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP9 protein] | 12414664 |
C025462 | sulindac sulfide | sulindac sulfide results in increased activity of CASP9 protein | 12414664 |
C025462 | sulindac sulfide | sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein | 12203115 |
C025462 | sulindac sulfide | TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein] | 12203115 |
C473643 | sulphoraphene | sulphoraphene results in increased cleavage of CASP9 protein | 29247643 |
D013501 | Surface-Active Agents | [Surface-Active Agents co-treated with glyphosate] results in increased activity of CASP9 protein | 23099315 |
C009365 | surfactin peptide | surfactin peptide results in increased cleavage of and results in increased activity of CASP9 protein | 19954742 |
D013605 | T-2 Toxin | Bentonite inhibits the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of CASP9 mRNA] | 25296281 |
D013605 | T-2 Toxin | [HT-2 toxin co-treated with T-2 Toxin] results in increased expression of CASP9 mRNA | 25296281 |
D013605 | T-2 Toxin | T-2 Toxin results in increased activity of CASP9 protein | 19524637 |
D013605 | T-2 Toxin | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [T-2 Toxin results in increased activity of CASP9 protein]" | 21296132 |
D013605 | T-2 Toxin | T-2 Toxin results in increased cleavage of and results in increased activity of CASP9 protein | 21296132 |
D016559 | Tacrolimus | Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] | 15548389 |
C061133 | tamibarotene | tamibarotene results in increased expression of CASP9 mRNA | 15498508 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of CASP9 mRNA | 26908177 |
D013629 | Tamoxifen | AKT1 protein inhibits the reaction [Tamoxifen analog results in increased activity of CASP9 protein] | 14990993 |
D013629 | Tamoxifen | AKT1 protein inhibits the reaction [Tamoxifen results in increased activity of CASP9 protein] | 14990993 |
D013629 | Tamoxifen | [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein | 18790785 |
D013629 | Tamoxifen | [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
D013629 | Tamoxifen | Tamoxifen analog results in increased activity of CASP9 protein | 14990993 |
D013629 | Tamoxifen | [Tamoxifen co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | 17767197 |
D013629 | Tamoxifen | Tamoxifen results in increased activity of CASP9 protein | 14990993 |
D013629 | Tamoxifen | Tamoxifen results in increased cleavage of CASP9 protein | 17767197 |
C112765 | tanespimycin | [tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP9 protein | 17121904 |
C112765 | tanespimycin | tanespimycin results in increased cleavage of CASP9 protein | 17121904 |
C523979 | tapentadol | tapentadol affects the activity of CASP9 protein | 27317026 |
C548497 | Tat-JBD peptide | Tat-JBD peptide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] | 18037221 |
C548497 | Tat-JBD peptide | Tat-JBD peptide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of CASP9 protein] | 18037221 |
D013654 | Taurine | Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein] | 23092809 |
D013654 | Taurine | Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form] | 22138235 |
D013654 | Taurine | Taurine inhibits the reaction [sodium arsenite results in increased expression of CASP9 protein] | 20830294 |
D013656 | Taurocholic Acid | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | 12388182 |
D013657 | Taurodeoxycholic Acid | Taurodeoxycholic Acid results in increased activity of CASP9 protein | 12773247 |
D013657 | Taurodeoxycholic Acid | tauroursodeoxycholic acid inhibits the reaction [Taurodeoxycholic Acid results in increased activity of CASP9 protein] | 12773247 |
C031655 | tauroursodeoxycholic acid | [Chenodeoxycholic Acid co-treated with tauroursodeoxycholic acid] results in increased activity of CASP9 protein | 14976352 |
C031655 | tauroursodeoxycholic acid | tauroursodeoxycholic acid inhibits the reaction [Quercetin promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]] | 25611565 |
C031655 | tauroursodeoxycholic acid | tauroursodeoxycholic acid inhibits the reaction [Taurodeoxycholic Acid results in increased activity of CASP9 protein] | 12773247 |
C003377 | taxifolin | taxifolin results in decreased activity of CASP9 protein | 24269735 |
C041348 | tcdA protein, Clostridium difficile | "tcdA protein, Clostridium difficile results in increased activity of CASP9 protein" | 16368960 |
D013662 | Tea | [Tea co-treated with Bleomycin] results in increased expression of CASP9 mRNA | 26800624 |
C047246 | temozolomide | BCL2L11 mutant form inhibits the reaction [temozolomide results in increased cleavage of CASP9 protein] | 26418950 |
C047246 | temozolomide | [temozolomide co-treated with Quercetin] results in increased activity of CASP9 protein | 24126416 |
C047246 | temozolomide | temozolomide results in increased cleavage of CASP9 protein | 26418950 |
C003959 | TEMPO | TEMPO inhibits the reaction [Lindane results in increased activity of CASP9 protein] | 22001173 |
C003959 | TEMPO | TEMPO inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA] | 28296042 |
C003959 | TEMPO | TEMPO inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] | 28296042 |
C001803 | tempol | tempol results in decreased expression of CASP9 protein | 18714161 |
D016593 | Terfenadine | Terfenadine results in increased activity of CASP9 protein | 16569656 |
D016593 | Terfenadine | Terfenadine results in increased cleavage of CASP9 protein | 20570632 |
D016593 | Terfenadine | Terfenadine results in increased activity of CASP9 protein | 15288570 |
D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | 18030663 |
D013739 | Testosterone | Testosterone results in decreased expression of CASP9 protein | 18030663 |
D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | 18030663 |
D013739 | Testosterone | Testosterone results in decreased expression of CASP9 protein | 18030663 |
D013739 | Testosterone | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | 20609311 |
D013739 | Testosterone | Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein] | 20609311 |
C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased expression of CASP9 mRNA | 24596333 |
D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA] | 15536054 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA | 15536054 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CASP9 mRNA | 23152189 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA | 15667827 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP9 protein | 15972635 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA | 19520675 |
C117155 | tetracycline CMT-3 | Celecoxib promotes the reaction [tetracycline CMT-3 results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
C117155 | tetracycline CMT-3 | tetracycline CMT-3 promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP9 protein] | 15688368 |
C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in increased activity of CASP9 protein | 16039551 |
C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in increased cleavage of and results in increased activity of CASP9 protein | 15688368 |
D013755 | Tetradecanoylphorbol Acetate | [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein | 17309078 |
D013755 | Tetradecanoylphorbol Acetate | [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of and results in increased cleavage of CASP9 protein | 25446327 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of CASP9 protein | 24073338 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP9 mRNA | 25613284 |
C040733 | tetraethoxysilane | tetraethoxysilane analog results in increased expression of CASP9 protein | 27362941 |
C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of CASP9 mRNA] | 19286953 |
C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of CASP9 protein] | 26404762 |
C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [Gentamicins results in increased activity of CASP9 protein] | 17132701 |
C009438 | tetrandrine | tetrandrine results in increased cleavage of and results in increased activity of CASP9 protein | 26822499 |
C009438 | tetrandrine | tetrandrine results in increased cleavage of CASP9 protein | 25266202 |
D013792 | Thalidomide | Thalidomide results in decreased activity of CASP9 protein | 15067094 |
C042172 | thallium nitrate | thallium nitrate analog results in increased activity of CASP9 protein | 19371624 |
C042172 | thallium nitrate | thallium nitrate results in increased activity of CASP9 protein | 19371624 |
D019284 | Thapsigargin | Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | 16388830 |
D019284 | Thapsigargin | Melatonin inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | 20130848 |
D019284 | Thapsigargin | Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein] | 25341683 |
D019284 | Thapsigargin | Thapsigargin results in increased activity of CASP9 protein | 16388830|2013084 |
D019284 | Thapsigargin | Thapsigargin results in increased activity of CASP9 protein | 16018998 |
C056068 | theaflavin | theaflavin results in increased cleavage of and results in increased activity of CASP9 protein | 17499812 |
D013827 | Thiabendazole | Thiabendazole results in increased activity of CASP9 protein | 26748015 |
D013849 | Thimerosal | Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] | 12140745 |
D013849 | Thimerosal | Thimerosal results in increased activity of CASP9 protein | 12140745 |
D013849 | Thimerosal | Thimerosal results in increased cleavage of CASP9 protein | 15869795 |
D013849 | Thimerosal | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | Thimerosal results in increased cleavage of CASP9 protein | 23145070 |
D013849 | Thimerosal | wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
D013849 | Thimerosal | Thimerosal results in increased activity of CASP9 protein | 16273274 |
D013853 | Thioacetamide | Thioacetamide results in increased activity of CASP9 protein | 20713078 |
D013853 | Thioacetamide | TXNIP gene mutant form inhibits the reaction [Thioacetamide results in increased activity of CASP9 protein] | 20713078 |
D013853 | Thioacetamide | chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA] | 29133031 |
D013853 | Thioacetamide | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA | 23830814 |
D013853 | Thioacetamide | Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA] | 29133031 |
D013853 | Thioacetamide | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP9 mRNA]] | 29133031 |
D013853 | Thioacetamide | Thioacetamide results in decreased expression of CASP9 mRNA | 29133031 |
D013859 | Thiocarbamates | Thiocarbamates results in increased activity of CASP9 protein | 20209498 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
D008063 | Thioctic Acid | Thioctic Acid results in increased activity of CASP9 protein | 16990509 |
D008063 | Thioctic Acid | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA | 23830814 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | 19951573 |
D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in increased expression of CASP9 protein | 20931265 |
C100040 | thiosulfinic acids | thiosulfinic acids results in increased activity of CASP9 protein | 19446247 |
D013936 | Thymidine | Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein] | 11570579 |
C557007 | thymiplatin | thymiplatin results in increased activity of CASP9 protein | 20981665 |
D013943 | Thymol | Thymol results in increased activity of CASP9 protein | 21640085 |
D013943 | Thymol | Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] | 26996544 |
C003466 | thymoquinone | thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP9 protein] | 29085585 |
C009495 | titanium dioxide | titanium dioxide results in increased activity of CASP9 protein | 20541599 |
C009495 | titanium dioxide | titanium dioxide results in increased cleavage of CASP9 protein | 20362650 |
C009495 | titanium dioxide | titanium dioxide results in increased activity of CASP9 protein | 20381595 |
D014028 | Tobacco Smoke Pollution | resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein] | 20060927 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased activity of CASP9 protein | 20060927 |
D014050 | Toluene | Toluene affects the expression of CASP9 mRNA | 21827849 |
D019772 | Topotecan | APAF1 promotes the reaction [Topotecan results in increased cleavage of CASP9 protein] | 19812371 |
D019772 | Topotecan | Topotecan results in increased activity of CASP9 protein | 19812371 |
D019772 | Topotecan | Topotecan results in increased cleavage of CASP9 protein | 19812371 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of and results in increased activity of CASP9 protein | 19679660 |
D014148 | Tranexamic Acid | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | 19539006 |
C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in increased activity of CASP9 protein" | 16005259 |
D014212 | Tretinoin | Tretinoin results in increased activity of CASP9 protein | 16829022 |
D014212 | Tretinoin | CRABP2 protein promotes the reaction [Tretinoin results in increased cleavage of and results in increased activity of CASP9 protein] | 16166294 |
D014212 | Tretinoin | CRABP2 protein promotes the reaction [Tretinoin results in increased expression of CASP9 mRNA] | 16166294 |
D014212 | Tretinoin | [IFNB1 protein co-treated with Tretinoin] results in increased cleavage of and results in increased activity of CASP9 protein | 16826196 |
D014212 | Tretinoin | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | 17701358 |
D014212 | Tretinoin | Tretinoin promotes the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] | 23747833 |
D014212 | Tretinoin | Tretinoin results in increased activity of CASP9 protein | 16568081 |
D014212 | Tretinoin | Tretinoin results in increased cleavage of and results in increased activity of CASP9 protein | 16166294|1738734 |
D014212 | Tretinoin | Tretinoin results in increased expression of CASP9 mRNA | 15498508|1616629 |
D014212 | Tretinoin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Tretinoin results in increased activity of CASP9 protein] | 16291826 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CASP9 mRNA | 22498432 |
D014212 | Tretinoin | Tretinoin results in increased activity of CASP9 protein | 16291826 |
D014212 | Tretinoin | Tretinoin results in increased expression of CASP9 protein | 16764683 |
C032910 | triadimefon | triadimefon results in decreased expression of CASP9 mRNA | 16730040 |
D014221 | Triamcinolone | Triamcinolone results in increased activity of CASP9 protein | 11734450 |
C012589 | trichostatin A | [Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP9 protein | 16904634 |
C012589 | trichostatin A | trichostatin A affects the expression of CASP9 mRNA | 28542535 |
C012589 | trichostatin A | [trichostatin A co-treated with Bortezomib] results in increased cleavage of CASP9 protein | 21345073 |
C012589 | trichostatin A | trichostatin A promotes the reaction [CASP9 protein affects the localization of BID protein] | 12556448 |
C012589 | trichostatin A | trichostatin A results in increased cleavage of and results in increased activity of CASP9 protein | 16010430 |
D014266 | Trientine | Trientine results in increased activity of CASP9 protein | 14513838 |
C020946 | triethylene glycol dimethacrylate | triethylene glycol dimethacrylate results in increased activity of CASP9 protein | 24307521 |
D014271 | Trifluridine | Trifluridine results in increased cleavage of CASP9 protein | 19816940 |
C009475 | trimethylenediamine | [Copper binds to Isatin binds to trimethylenediamine] which results in increased cleavage of CASP9 protein | 17327230 |
C040533 | trimethyltin chloride | trimethyltin chloride results in increased expression of CASP9 mRNA | 23000284 |
C050414 | tripterine | tripterine results in increased cleavage of CASP9 protein | 21466843|2737409 |
C050414 | tripterine | tripterine results in increased expression of CASP9 mRNA | 27374097 |
C050414 | tripterine | Uridine inhibits the reaction [tripterine results in increased cleavage of CASP9 protein] | 27374097 |
C001899 | triptolide | triptolide results in increased expression of and results in increased activity of CASP9 protein | 26990902 |
C001899 | triptolide | Quercetin inhibits the reaction [triptolide results in increased activity of CASP9 protein] | 26277538 |
C001899 | triptolide | triptolide results in increased activity of CASP9 protein | 26277538 |
C057693 | troglitazone | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP9 protein] | 20540935 |
C057693 | troglitazone | "[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]" | 20540935 |
C057693 | troglitazone | troglitazone results in increased activity of CASP9 protein | 14508522 |
C057693 | troglitazone | troglitazone results in increased expression of CASP9 protein | 20540935 |
C080163 | trovafloxacin | [trovafloxacin co-treated with TNF protein] results in increased activity of CASP9 protein | 24097668 |
C005865 | troxerutin | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA] | 28916335 |
C005865 | troxerutin | troxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of CASP9 protein] | 28916335 |
D014361 | Trypsin Inhibitors | Trypsin Inhibitors results in increased activity of CASP9 protein | 19481592 |
C030820 | tryptamine | tryptamine analog inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 22157011 |
D014415 | Tunicamycin | Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] | 16388830 |
D014415 | Tunicamycin | Tunicamycin results in increased activity of CASP9 protein | 16388830 |
D014415 | Tunicamycin | Tunicamycin results in increased cleavage of CASP9 protein | 17553788 |
D014415 | Tunicamycin | Tunicamycin results in increased expression of CASP9 mRNA | 22378314 |
D014415 | Tunicamycin | Tunicamycin results in increased cleavage of CASP9 protein | 14747384 |
C113580 | U 0126 | U 0126 inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
C113580 | U 0126 | U 0126 inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | 17341418 |
C113580 | U 0126 | U 0126 promotes the reaction [dihydromyricetin results in increased cleavage of CASP9 protein] | 27539140 |
C113580 | U 0126 | U 0126 inhibits the reaction [Atorvastatin Calcium results in increased activity of CASP9 protein] | 18339080 |
C113580 | U 0126 | U 0126 inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 18775851 |
C113580 | U 0126 | U 0126 inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] | 15618436 |
D014502 | Uranyl Nitrate | Uranyl Nitrate results in increased activity of CASP9 protein | 17522072 |
D014520 | Urethane | Urethane results in increased expression of CASP9 mRNA | 28818685 |
D014520 | Urethane | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CASP9 mRNA | 12400877 |
D014520 | Urethane | Urethane results in increased expression of CASP9 mRNA | 12400877 |
D014529 | Uridine | Uridine inhibits the reaction [tripterine results in increased cleavage of CASP9 protein] | 27374097 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP9 protein] | 22178905 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP9 mRNA] | 25502462 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP9 protein] | 25502462 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CASP9 mRNA | 25979313 |
D014635 | Valproic Acid | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP9 mRNA | 25815518 |
D014635 | Valproic Acid | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP9 protein | 25815518 |
D014635 | Valproic Acid | Valproic Acid results in increased cleavage of and results in increased activity of CASP9 protein | 22814014 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of CASP9 gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CASP9 mRNA | 17292431|1796380 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CASP9 mRNA | 21427059 |
D017968 | Vanadium Compounds | Vanadium Compounds results in increased activity of CASP9 protein | 26391003 |
C066075 | vanadium pentoxide | vanadium pentoxide results in increased activity of CASP9 protein | 19646462 |
D014641 | Vanillic Acid | Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] | 25794854 |
C459559 | vaticanol C | vaticanol C results in increased activity of CASP9 protein | 12844481 |
D014700 | Verapamil | [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP9 protein | 24373880 |
C063155 | violacein | violacein results in increased activity of CASP9 protein | 20416285 |
D014757 | Viper Venoms | Viper Venoms results in increased cleavage of CASP9 protein | 25417048 |
D012256 | Riboflavin | Riboflavin analog results in increased activity of CASP9 protein | 20688149 |
D009536 | Niacinamide | [Berberine co-treated with Niacinamide] results in increased cleavage of CASP9 protein | 26712469 |
D009536 | Niacinamide | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D009536 | Niacinamide | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D009536 | Niacinamide | "[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D009536 | Niacinamide | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]" | 25478867 |
D009536 | Niacinamide | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]" | 25478867 |
D009536 | Niacinamide | "Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]" | 25478867 |
D009536 | Niacinamide | Niacinamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | 16505238 |
D002762 | Cholecalciferol | Cholecalciferol results in decreased expression of CASP9 protein | 18628207 |
D014810 | Vitamin E | Vitamin E results in increased expression of CASP9 mRNA | 19244175 |
D014810 | Vitamin E | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] | 16973328 |
D014810 | Vitamin E | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | 21628957 |
D014810 | Vitamin E | Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] | 27353299 |
D024483 | Vitamin K 3 | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein] | 19082730 |
D024483 | Vitamin K 3 | EUK-134 inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] | 25005833 |
D024483 | Vitamin K 3 | [sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein | 19082730 |
D024483 | Vitamin K 3 | Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] | 29141199 |
D024483 | Vitamin K 3 | Vitamin K 3 results in increased cleavage of CASP9 protein | 25005833 |
D024483 | Vitamin K 3 | pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] | 16310883 |
D024483 | Vitamin K 3 | Vitamin K 3 results in increased cleavage of CASP9 protein | 16310883 |
C111237 | vorinostat | [Bortezomib co-treated with vorinostat] results in increased activity of CASP9 protein | 18005386|1864136 |
C111237 | vorinostat | [Bortezomib co-treated with vorinostat] results in increased cleavage of and results in increased activity of CASP9 protein | 12893773 |
C111237 | vorinostat | Bortezomib promotes the reaction [vorinostat results in increased activity of CASP9 protein] | 15173093 |
C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein | 19643600 |
C111237 | vorinostat | vorinostat results in increased activity of CASP9 protein | 15173093|1802528 |
C111237 | vorinostat | vorinostat results in increased cleavage of CASP9 protein | 15897598 |
C111237 | vorinostat | [vorinostat co-treated with MYC protein] results in increased cleavage of CASP9 protein | 17331788 |
C111237 | vorinostat | [carfilzomib co-treated with vorinostat] results in increased activity of CASP9 protein | 20233973 |
D014873 | Water Pollutants | Ozone inhibits the reaction [Water Pollutants results in increased expression of CASP9 mRNA] | 23022117 |
D014873 | Water Pollutants | Water Pollutants results in increased expression of CASP9 mRNA | 23022117 |
C528002 | Weichang'an | Weichang'an results in increased cleavage of CASP9 protein | 17498489 |
C070417 | Win 55212-2 | AM 281 inhibits the reaction [Win 55212-2 results in increased activity of CASP9 protein] | 28495606 |
C070417 | Win 55212-2 | Win 55212-2 results in increased activity of CASP9 protein | 28495606 |
C085514 | wogonin | wogonin inhibits the reaction [IL1B protein results in increased cleavage of CASP9 protein] | 28688942 |
C009687 | wortmannin | wortmannin inhibits the reaction [Acrolein results in increased activity of CASP9 protein] | 17196791 |
C009687 | wortmannin | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] | 20104024 |
C009687 | wortmannin | wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein] | 20104024 |
C009687 | wortmannin | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | 17935137 |
C009687 | wortmannin | wortmannin promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] | 17935137 |
C009687 | wortmannin | Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein] | 23145070 |
C009687 | wortmannin | wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
C009687 | wortmannin | wortmannin results in increased cleavage of CASP9 protein | 22137261 |
C009687 | wortmannin | "wortmannin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP9 protein]" | 24726520 |
C104426 | WP 631 | WP 631 results in increased activity of CASP9 protein | 24287111 |
C451735 | WP 744 | WP 744 results in increased cleavage of CASP9 protein | 15555623 |
C104536 | xanthohumol | xanthohumol results in increased activity of CASP9 protein | 26297991 |
C104536 | xanthohumol | xanthohumol results in increased cleavage of and results in increased activity of CASP9 protein | 15995977 |
C488234 | XCT790 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP9 protein] | 19464277 |
C488234 | XCT790 | [XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP9 protein | 19464277 |
C108830 | Y 27632 | Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP9 protein] | 22564901 |
D015018 | Ytterbium | Ytterbium analog results in increased activity of CASP9 protein | 19632212 |
D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of CASP9 mRNA | 18593933 |
D015032 | Zinc | "[Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2,3-dimercaptosuccinate affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]" | 24184500 |
D015032 | Zinc | Zinc affects the reaction [sodium arsenite results in increased expression of CASP9 mRNA] | 24184500 |
C016837 | zinc chloride | zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] | 28390674 |
D015034 | Zinc Oxide | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
D015034 | Zinc Oxide | Cyclosporine inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
D015034 | Zinc Oxide | Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] | 27544635 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased activity of CASP9 protein | 27544635 |
D015034 | Zinc Oxide | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP9 protein] | 24614525 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased activity of CASP9 protein | 25680694 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased cleavage of CASP9 protein | 24614525 |
C017803 | zinc protoporphyrin | zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein]] | 27375190 |
C017803 | zinc protoporphyrin | zinc protoporphyrin promotes the reaction [quinocetone results in increased activity of CASP9 protein] | 27375190 |
C013738 | zingerone | zingerone inhibits the reaction [Ethanol results in increased expression of CASP9 protein] | 28442378 |
D015039 | Ziram | Ziram results in increased activity of CASP9 protein | 22159898 |
C088658 | zoledronic acid | zoledronic acid results in increased activity of CASP9 protein | 19036117 |
C088658 | zoledronic acid | zoledronic acid results in increased cleavage of and results in increased activity of CASP9 protein | 12799645 |
C088658 | zoledronic acid | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein | 19789217 |